[{"arc":[[52.421459197998,-1.43792998790741],[25.8990993499756,45.3538589477539]],"countries":["United Kingdom","Saudi Arabia"],"title":"Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease"},{"arc":[[40.9437103271484,40.2619209289551],[53.403148651123,-2.96319007873535]],"countries":["Turkey","United Kingdom"],"title":"Potential Impact of Antiviral Drug Use during Influenza Pandemic"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Potential Impact of Antiviral Drug Use during Influenza Pandemic"},{"arc":[[53.403148651123,-2.96319007873535],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"Potential Impact of Antiviral Drug Use during Influenza Pandemic"},{"arc":[[38.0169372558594,-87.5912551879883],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Whole-genome Sequencing for Tracing the Transmission Link between Two ARD Outbreaks Caused by a Novel HAdV Serotype 7 Variant, China OPEN"},{"arc":[[57.0153617858887,9.98657989501953],[56.1693496704102,10.1982297897339]],"countries":["Denmark"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[57.0153617858887,9.98657989501953],[46.72547,-116.99277]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[57.0153617858887,9.98657989501953],[37.8056831359863,-122.268104553223]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[57.0153617858887,9.98657989501953],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[56.1693496704102,10.1982297897339],[46.72547,-116.99277]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[56.1693496704102,10.1982297897339],[37.8056831359863,-122.268104553223]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[56.1693496704102,10.1982297897339],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[46.72547,-116.99277],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[46.72547,-116.99277],[55.6756706237793,12.5675601959229]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[37.8056831359863,-122.268104553223],[55.6756706237793,12.5675601959229]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[39.4827499389648,-76.1320495605469],[39.3291282653809,-76.6179275512695]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.4827499389648,-76.1320495605469],[35.8810081481934,-106.305221557617]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.4827499389648,-76.1320495605469],[54.9739990234375,-1.66799998283386]],"countries":["United States","United Kingdom"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.4827499389648,-76.1320495605469],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.3291282653809,-76.6179275512695],[35.8810081481934,-106.305221557617]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.3291282653809,-76.6179275512695],[54.9739990234375,-1.66799998283386]],"countries":["United States","United Kingdom"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.3291282653809,-76.6179275512695],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[35.8810081481934,-106.305221557617],[54.9739990234375,-1.66799998283386]],"countries":["United States","United Kingdom"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[35.8810081481934,-106.305221557617],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[54.9739990234375,-1.66799998283386],[44.6417846679688,-89.7367401123047]],"countries":["United Kingdom","United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[40.5150184631348,20.8693809509277],[23.7489929199219,120.971282958984]],"countries":["Albania","Taiwan"],"title":"Membrane protein assembly: two cytoplasmic phosphorylated serine sites of Vpu from HIV-1 affect oligomerization OPEN"},{"arc":[[40.5150184631348,20.8693809509277],[33.2227516174316,107.54564666748]],"countries":["Albania","China"],"title":"Membrane protein assembly: two cytoplasmic phosphorylated serine sites of Vpu from HIV-1 affect oligomerization OPEN"},{"arc":[[23.7489929199219,120.971282958984],[33.2227516174316,107.54564666748]],"countries":["Taiwan","China"],"title":"Membrane protein assembly: two cytoplasmic phosphorylated serine sites of Vpu from HIV-1 affect oligomerization OPEN"},{"arc":[[40.5150184631348,20.8693809509277],[34.7472496032715,113.624931335449]],"countries":["Albania","China"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[40.5150184631348,20.8693809509277],[35.7130813598633,139.445846557617]],"countries":["Albania","Japan"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[34.7472496032715,113.624931335449],[35.7130813598633,139.445846557617]],"countries":["China","Japan"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[40.5150184631348,20.8693809509277],[63.513111114502,10.0196399688721]],"countries":["Albania","Norway"],"title":"BMC Microbiology CAPIH: A Web interface for comparative analyses and visualization of host-HIV protein-protein interactions"},{"arc":[[40.5150184631348,20.8693809509277],[36.1670608520508,-86.8253326416016]],"countries":["Albania","United States"],"title":"BMC Microbiology CAPIH: A Web interface for comparative analyses and visualization of host-HIV protein-protein interactions"},{"arc":[[63.513111114502,10.0196399688721],[36.1670608520508,-86.8253326416016]],"countries":["United States","Norway"],"title":"BMC Microbiology CAPIH: A Web interface for comparative analyses and visualization of host-HIV protein-protein interactions"},{"arc":[[40.5150184631348,20.8693809509277],[63.513111114502,10.0196399688721]],"countries":["Albania","Norway"],"title":"Supporting Information Crowning Proteins: Modulating the Protein Surface Properties using Crown Ethers**"},{"arc":[[40.9437103271484,40.2619209289551],[31.2988891601562,121.499168395996]],"countries":["Turkey","China"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[-20.8712291717529,144.602111816406]],"countries":["Turkey","Australia"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[46.7798385620117,-71.2695007324219]],"countries":["Turkey","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[49.8096008300781,-97.1333312988281]],"countries":["Turkey","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[52.1374397277832,-106.627517700195]],"countries":["Turkey","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[52.08896,5.1784]],"countries":["Turkey","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[-20.8712291717529,144.602111816406]],"countries":["China","Australia"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[46.7798385620117,-71.2695007324219]],"countries":["China","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[49.8096008300781,-97.1333312988281]],"countries":["China","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[52.1374397277832,-106.627517700195]],"countries":["China","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[52.08896,5.1784]],"countries":["China","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[46.7798385620117,-71.2695007324219]],"countries":["Canada","Australia"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[49.8096008300781,-97.1333312988281]],"countries":["Australia","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[52.1374397277832,-106.627517700195]],"countries":["Australia","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[52.08896,5.1784]],"countries":["Australia","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[46.7798385620117,-71.2695007324219],[49.8096008300781,-97.1333312988281]],"countries":["Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[46.7798385620117,-71.2695007324219],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[46.7798385620117,-71.2695007324219],[52.08896,5.1784]],"countries":["Canada","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[49.8096008300781,-97.1333312988281],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[49.8096008300781,-97.1333312988281],[52.08896,5.1784]],"countries":["Canada","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[52.1374397277832,-106.627517700195],[52.08896,5.1784]],"countries":["Canada","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[43.8378410339355,126.549438476562]],"countries":["Turkey","China"],"title":"Identification of NCAM that interacts with the PHE-CoV spike protein"},{"arc":[[40.9437103271484,40.2619209289551],[23.1290798187256,113.264358520508]],"countries":["Turkey","China"],"title":"An outbreak of acute respiratory disease caused by a virus associated RNA II gene mutation strain of human adenovirus 7 in China, 2015"},{"arc":[[40.9437103271484,40.2619209289551],[23.1290798187256,113.264358520508]],"countries":["Turkey","China"],"title":"Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China"},{"arc":[[40.9437103271484,40.2619209289551],[29.7107791900635,-95.3966522216797]],"countries":["Turkey","United States"],"title":"Profiling the immune vulnerability landscape of the 2019 Novel Coronavirus"},{"arc":[[40.9437103271484,40.2619209289551],[32.8126068115234,-96.8384094238281]],"countries":["Turkey","United States"],"title":"Profiling the immune vulnerability landscape of the 2019 Novel Coronavirus"},{"arc":[[29.7107791900635,-95.3966522216797],[32.8126068115234,-96.8384094238281]],"countries":["United States"],"title":"Profiling the immune vulnerability landscape of the 2019 Novel Coronavirus"},{"arc":[[40.9437103271484,40.2619209289551],[31.2988891601562,121.499168395996]],"countries":["Turkey","China"],"title":"The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development"},{"arc":[[40.9437103271484,40.2619209289551],[22.2802925109863,114.142951965332]],"countries":["Turkey","Hong Kong SAR"],"title":"The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development"},{"arc":[[41.0080909729004,29.0522594451904],[37.7697296142578,-122.466094970703]],"countries":["United States","Turkey"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[41.0080909729004,29.0522594451904],[20.2663593292236,85.8105697631836]],"countries":["Turkey","India"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[41.0080909729004,29.0522594451904],[-33.9343490600586,18.6259994506836]],"countries":["Turkey","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[41.0080909729004,29.0522594451904],[51.9735984802246,5.66384315490723]],"countries":["Turkey","Netherlands"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[37.7697296142578,-122.466094970703],[20.2663593292236,85.8105697631836]],"countries":["United States","India"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[37.7697296142578,-122.466094970703],[-33.9343490600586,18.6259994506836]],"countries":["United States","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[37.7697296142578,-122.466094970703],[51.9735984802246,5.66384315490723]],"countries":["United States","Netherlands"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[20.2663593292236,85.8105697631836],[-33.9343490600586,18.6259994506836]],"countries":["India","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[20.2663593292236,85.8105697631836],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","India"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[-33.9343490600586,18.6259994506836],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[52.1751708984375,0.140450000762939],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.1751708984375,0.140450000762939],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.1751708984375,0.140450000762939],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.598876953125,-1.46688103675842],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.598876953125,-1.46688103675842],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.2025413513184,0.119549997150898],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[23.2024116516113,113.38606262207],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.2024116516113,113.38606262207],[23.0218505859375,113.121917724609]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.2024116516113,113.38606262207],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.2024116516113,113.38606262207],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.2024116516113,113.38606262207],[23.3535003662109,116.68221282959]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.2024116516113,113.38606262207],[22.5159492492676,113.392601013184]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.1290798187256,113.264358520508],[23.0218505859375,113.121917724609]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.1290798187256,113.264358520508],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.1290798187256,113.264358520508],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.1290798187256,113.264358520508],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.1290798187256,113.264358520508],[23.3535003662109,116.68221282959]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.1290798187256,113.264358520508],[22.5159492492676,113.392601013184]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.0218505859375,113.121917724609],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.0218505859375,113.121917724609],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.0218505859375,113.121917724609],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.0218505859375,113.121917724609],[23.3535003662109,116.68221282959]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.0218505859375,113.121917724609],[22.5159492492676,113.392601013184]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[31.2988891601562,121.499168395996],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[31.2988891601562,121.499168395996],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[31.2988891601562,121.499168395996],[23.3535003662109,116.68221282959]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[31.2988891601562,121.499168395996],[22.5159492492676,113.392601013184]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[36.4687042236328,118.517120361328],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[36.4687042236328,118.517120361328],[23.3535003662109,116.68221282959]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[36.4687042236328,118.517120361328],[22.5159492492676,113.392601013184]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[23.3535003662109,116.68221282959],[22.5159492492676,113.392601013184]],"countries":["China"],"title":"National Natural Science Foundation of China (81970071), the Special Project for Emergency of the Ministry of Science and Technology (2020YFC0841300), the Special Project of Guangdong Science and Technology Department"},{"arc":[[36.6518402099609,117.120086669922],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[36.6518402099609,117.120086669922],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[36.4687042236328,118.517120361328],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[47.9635314941406,-1.3861700296402],[52.5014038085938,13.4023313522339]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[44.9948196411133,-93.41455078125]],"countries":["France","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[50.5807495117188,8.67675018310547]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[49.0094413757324,8.41166973114014]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","France"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[48.150390625,11.5805997848511]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[48.1129989624023,11.4739198684692]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[48.2128105163574,16.3610992431641]],"countries":["France","Austria"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[50.7338905334473,7.10222196578979]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[37.8056831359863,-122.268104553223]],"countries":["France","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[53.8391494750977,10.7079601287842]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[47.9635314941406,-1.3861700296402],[52.3722686767578,9.73814964294434]],"countries":["France","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[44.9948196411133,-93.41455078125]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[50.5807495117188,8.67675018310547]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[49.0094413757324,8.41166973114014]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[48.150390625,11.5805997848511]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[48.1129989624023,11.4739198684692]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[48.2128105163574,16.3610992431641]],"countries":["Germany","Austria"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[37.8056831359863,-122.268104553223]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.5014038085938,13.4023313522339],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[50.5807495117188,8.67675018310547]],"countries":["United States","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[49.0094413757324,8.41166973114014]],"countries":["United States","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[48.150390625,11.5805997848511]],"countries":["United States","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[48.1129989624023,11.4739198684692]],"countries":["United States","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[48.2128105163574,16.3610992431641]],"countries":["United States","Austria"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[53.8391494750977,10.7079601287842]],"countries":["United States","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[44.9948196411133,-93.41455078125],[52.3722686767578,9.73814964294434]],"countries":["United States","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[49.0094413757324,8.41166973114014]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[48.150390625,11.5805997848511]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[48.1129989624023,11.4739198684692]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[48.2128105163574,16.3610992431641]],"countries":["Austria","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[37.8056831359863,-122.268104553223]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.5807495117188,8.67675018310547],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[48.150390625,11.5805997848511]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[48.1129989624023,11.4739198684692]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[48.2128105163574,16.3610992431641]],"countries":["Austria","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[37.8056831359863,-122.268104553223]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[49.0094413757324,8.41166973114014],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.421459197998,-1.43792998790741],[48.150390625,11.5805997848511]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.421459197998,-1.43792998790741],[48.1129989624023,11.4739198684692]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.421459197998,-1.43792998790741],[48.2128105163574,16.3610992431641]],"countries":["United Kingdom","Austria"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.421459197998,-1.43792998790741],[50.7338905334473,7.10222196578979]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.421459197998,-1.43792998790741],[37.8056831359863,-122.268104553223]],"countries":["United Kingdom","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.421459197998,-1.43792998790741],[53.8391494750977,10.7079601287842]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[52.421459197998,-1.43792998790741],[52.3722686767578,9.73814964294434]],"countries":["United Kingdom","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.150390625,11.5805997848511],[48.1129989624023,11.4739198684692]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.150390625,11.5805997848511],[48.2128105163574,16.3610992431641]],"countries":["Austria","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.150390625,11.5805997848511],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.150390625,11.5805997848511],[37.8056831359863,-122.268104553223]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.150390625,11.5805997848511],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.150390625,11.5805997848511],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.1129989624023,11.4739198684692],[48.2128105163574,16.3610992431641]],"countries":["Austria","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.1129989624023,11.4739198684692],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.1129989624023,11.4739198684692],[37.8056831359863,-122.268104553223]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.1129989624023,11.4739198684692],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.1129989624023,11.4739198684692],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.2128105163574,16.3610992431641],[50.7338905334473,7.10222196578979]],"countries":["Austria","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.2128105163574,16.3610992431641],[37.8056831359863,-122.268104553223]],"countries":["Austria","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.2128105163574,16.3610992431641],[53.8391494750977,10.7079601287842]],"countries":["Austria","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[48.2128105163574,16.3610992431641],[52.3722686767578,9.73814964294434]],"countries":["Austria","Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.7338905334473,7.10222196578979],[37.8056831359863,-122.268104553223]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.7338905334473,7.10222196578979],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[50.7338905334473,7.10222196578979],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[37.8056831359863,-122.268104553223],[53.8391494750977,10.7079601287842]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[37.8056831359863,-122.268104553223],[52.3722686767578,9.73814964294434]],"countries":["Germany","United States"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[53.8391494750977,10.7079601287842],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[53.8391494750977,10.7079601287842],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors"},{"arc":[[11.0134401321411,76.9366226196289],[30.5701999664307,104.064758300781]],"countries":["India","China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[11.0134401321411,76.9366226196289],[30.973201751709,112.276123046875]],"countries":["China","India"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[11.0134401321411,76.9366226196289],[22.6545104980469,110.180976867676]],"countries":["India","China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[30.5701999664307,104.064758300781],[30.973201751709,112.276123046875]],"countries":["China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[30.5701999664307,104.064758300781],[22.6545104980469,110.180976867676]],"countries":["China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[30.973201751709,112.276123046875],[22.6545104980469,110.180976867676]],"countries":["China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[53.4858894348145,-2.94901990890503],[51.4948616027832,-0.178790003061295]],"countries":["United Kingdom"],"title":"European Journal of Case Reports in Internal Medicine An Uncommon Cause of Spontaneous Pneumomediastinum and Subcutaneous Emphysema"},{"arc":[[43.305290222168,5.38076019287109],[48.5444183349609,12.1591682434082]],"countries":["France","Germany"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.305290222168,5.38076019287109],[51.9582099914551,66.4045791625977]],"countries":["France","Kazakhstan"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.305290222168,5.38076019287109],[43.6319427490234,3.86388897895813]],"countries":["France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.305290222168,5.38076019287109],[48.7505416870117,30.2246208190918]],"countries":["France","Ukraine"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[48.5444183349609,12.1591682434082],[51.9582099914551,66.4045791625977]],"countries":["Germany","Kazakhstan"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[48.5444183349609,12.1591682434082],[43.6319427490234,3.86388897895813]],"countries":["Germany","France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[48.5444183349609,12.1591682434082],[48.7505416870117,30.2246208190918]],"countries":["Ukraine","Germany"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[51.9582099914551,66.4045791625977],[43.6319427490234,3.86388897895813]],"countries":["Kazakhstan","France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[51.9582099914551,66.4045791625977],[48.7505416870117,30.2246208190918]],"countries":["Ukraine","Kazakhstan"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.6319427490234,3.86388897895813],[48.7505416870117,30.2246208190918]],"countries":["Ukraine","France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[49.0121917724609,0.703100025653839],[53.3750495910645,5.25634002685547]],"countries":["France","Netherlands"],"title":"Development of a Single Leg Knee Exoskeleton and Sensing Knee Center of Rotation Change for Intention Detection"},{"arc":[[49.0121917724609,0.703100025653839],[40.9437103271484,40.2619209289551]],"countries":["Turkey","France"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[49.0121917724609,0.703100025653839],[14.477560043335,120.89826965332]],"countries":["France","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.9437103271484,40.2619209289551],[14.477560043335,120.89826965332]],"countries":["Turkey","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[14.477560043335,120.89826965332],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[32.7665023803711,-86.8403091430664],[56.4618301391602,-2.98967003822327]],"countries":["United States","United Kingdom"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[50.5807495117188,8.67675018310547]],"countries":["United States","Germany"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[21.4919700622559,39.2515716552734]],"countries":["United States","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[0.335489988327026,32.5687217712402]],"countries":["United States","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[40.9241600036621,-73.9446411132812]],"countries":["United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[45.7740211486816,-72.9880828857422]],"countries":["United States","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[32.7665023803711,-86.8403091430664],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[50.5807495117188,8.67675018310547]],"countries":["United Kingdom","Germany"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[21.4919700622559,39.2515716552734]],"countries":["United Kingdom","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[42.9547386169434,-78.8192367553711]],"countries":["United States","United Kingdom"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[0.335489988327026,32.5687217712402]],"countries":["United Kingdom","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[-37.7035598754883,145.180358886719]],"countries":["Australia","United Kingdom"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[40.9241600036621,-73.9446411132812]],"countries":["United Kingdom","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[45.7740211486816,-72.9880828857422]],"countries":["United Kingdom","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[22.333080291748,114.191223144531]],"countries":["United Kingdom","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[22.2802925109863,114.142951965332]],"countries":["United Kingdom","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[56.4618301391602,-2.98967003822327],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[21.4919700622559,39.2515716552734]],"countries":["Germany","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[42.9547386169434,-78.8192367553711]],"countries":["United States","Germany"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[0.335489988327026,32.5687217712402]],"countries":["Germany","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[-37.7035598754883,145.180358886719]],"countries":["Australia","Germany"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[40.9241600036621,-73.9446411132812]],"countries":["Germany","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[45.7740211486816,-72.9880828857422]],"countries":["Germany","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","Germany"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Germany"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Germany"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[42.9547386169434,-78.8192367553711]],"countries":["United States","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[0.335489988327026,32.5687217712402]],"countries":["Saudi Arabia","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[-37.7035598754883,145.180358886719]],"countries":["Australia","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[40.9241600036621,-73.9446411132812]],"countries":["Saudi Arabia","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[45.7740211486816,-72.9880828857422]],"countries":["Saudi Arabia","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[21.4919700622559,39.2515716552734],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Saudi Arabia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[42.9547386169434,-78.8192367553711],[0.335489988327026,32.5687217712402]],"countries":["United States","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[42.9547386169434,-78.8192367553711],[-37.7035598754883,145.180358886719]],"countries":["United States","Australia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[42.9547386169434,-78.8192367553711],[40.9241600036621,-73.9446411132812]],"countries":["United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[42.9547386169434,-78.8192367553711],[45.7740211486816,-72.9880828857422]],"countries":["United States","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[42.9547386169434,-78.8192367553711],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[42.9547386169434,-78.8192367553711],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[42.9547386169434,-78.8192367553711],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[0.335489988327026,32.5687217712402],[-37.7035598754883,145.180358886719]],"countries":["Australia","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[0.335489988327026,32.5687217712402],[40.9241600036621,-73.9446411132812]],"countries":["Uganda","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[0.335489988327026,32.5687217712402],[45.7740211486816,-72.9880828857422]],"countries":["Uganda","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[0.335489988327026,32.5687217712402],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[0.335489988327026,32.5687217712402],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[0.335489988327026,32.5687217712402],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Uganda"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[-37.7035598754883,145.180358886719],[40.9241600036621,-73.9446411132812]],"countries":["Australia","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[-37.7035598754883,145.180358886719],[45.7740211486816,-72.9880828857422]],"countries":["Australia","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[-37.7035598754883,145.180358886719],[22.333080291748,114.191223144531]],"countries":["Australia","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[-37.7035598754883,145.180358886719],[22.2802925109863,114.142951965332]],"countries":["Australia","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[-37.7035598754883,145.180358886719],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Australia"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[40.9241600036621,-73.9446411132812],[45.7740211486816,-72.9880828857422]],"countries":["United States","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[40.9241600036621,-73.9446411132812],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[40.9241600036621,-73.9446411132812],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[40.9241600036621,-73.9446411132812],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[45.7740211486816,-72.9880828857422],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[45.7740211486816,-72.9880828857422],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[45.7740211486816,-72.9880828857422],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Canada"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[22.333080291748,114.191223144531],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[22.2802925109863,114.142951965332],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Hong Kong SAR"],"title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East"},{"arc":[[40.8510894775391,-73.8444290161133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[43.383487701416,142.571090698242]],"countries":["United States","Japan"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[43.383487701416,142.571090698242]],"countries":["Turkey","Japan"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[39.0048141479492,-77.0975341796875]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[42.8098297119141,-88.3805541992188]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[30.2787208557129,-97.7324523925781]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[43.0670013427734,-89.4000015258789]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[39.0048141479492,-77.0975341796875]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[42.8098297119141,-88.3805541992188]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[37.8056831359863,-122.268104553223]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[30.2787208557129,-97.7324523925781]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[43.0670013427734,-89.4000015258789]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[42.8098297119141,-88.3805541992188],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[42.8098297119141,-88.3805541992188],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[42.8098297119141,-88.3805541992188],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[37.8056831359863,-122.268104553223],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[37.8056831359863,-122.268104553223],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[30.2787208557129,-97.7324523925781],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[39.0048141479492,-77.0975341796875]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[42.8098297119141,-88.3805541992188]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[30.2787208557129,-97.7324523925781]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[43.0670013427734,-89.4000015258789]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[42.8098297119141,-88.3805541992188],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[42.8098297119141,-88.3805541992188],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[42.8098297119141,-88.3805541992188],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[37.8056831359863,-122.268104553223],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[37.8056831359863,-122.268104553223],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[30.2787208557129,-97.7324523925781],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[37.9761390686035,23.736400604248]],"countries":["Turkey","Greece"],"title":"Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece"},{"arc":[[40.9437103271484,40.2619209289551],[30.1303195953369,-81.7378082275391]],"countries":["Turkey","United States"],"title":"Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece"},{"arc":[[37.9761390686035,23.736400604248],[30.1303195953369,-81.7378082275391]],"countries":["Greece","United States"],"title":"Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece"},{"arc":[[43.2490539550781,-79.0781478881836],[41.9031715393066,12.5151195526123]],"countries":["Canada","Italy"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[43.2490539550781,-79.0781478881836],[46.199821472168,6.14272022247314]],"countries":["Canada","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[43.2490539550781,-79.0781478881836],[39.1260528564453,-84.5591812133789]],"countries":["Canada","United States"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[43.2490539550781,-79.0781478881836],[-6.26754713058472,34.8109664916992]],"countries":["Canada","Tanzania"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[43.2490539550781,-79.0781478881836],[47.5585289001465,7.58259010314941]],"countries":["Canada","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[43.2490539550781,-79.0781478881836],[46.2083282470703,6.14274978637695]],"countries":["Canada","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[43.2490539550781,-79.0781478881836],[46.19841,6.1437]],"countries":["Canada","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[41.9031715393066,12.5151195526123],[46.199821472168,6.14272022247314]],"countries":["Italy","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[41.9031715393066,12.5151195526123],[39.1260528564453,-84.5591812133789]],"countries":["Italy","United States"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[41.9031715393066,12.5151195526123],[-6.26754713058472,34.8109664916992]],"countries":["Italy","Tanzania"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[41.9031715393066,12.5151195526123],[47.5585289001465,7.58259010314941]],"countries":["Italy","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[41.9031715393066,12.5151195526123],[46.2083282470703,6.14274978637695]],"countries":["Italy","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[41.9031715393066,12.5151195526123],[46.19841,6.1437]],"countries":["Italy","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[46.199821472168,6.14272022247314],[39.1260528564453,-84.5591812133789]],"countries":["Switzerland","United States"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[46.199821472168,6.14272022247314],[-6.26754713058472,34.8109664916992]],"countries":["Switzerland","Tanzania"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[46.199821472168,6.14272022247314],[47.5585289001465,7.58259010314941]],"countries":["Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[46.199821472168,6.14272022247314],[46.2083282470703,6.14274978637695]],"countries":["Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[46.199821472168,6.14272022247314],[46.19841,6.1437]],"countries":["Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[39.1260528564453,-84.5591812133789],[-6.26754713058472,34.8109664916992]],"countries":["United States","Tanzania"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[39.1260528564453,-84.5591812133789],[47.5585289001465,7.58259010314941]],"countries":["United States","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[39.1260528564453,-84.5591812133789],[46.2083282470703,6.14274978637695]],"countries":["United States","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[39.1260528564453,-84.5591812133789],[46.19841,6.1437]],"countries":["Switzerland","United States"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[-6.26754713058472,34.8109664916992],[47.5585289001465,7.58259010314941]],"countries":["Tanzania","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[-6.26754713058472,34.8109664916992],[46.2083282470703,6.14274978637695]],"countries":["Tanzania","Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[-6.26754713058472,34.8109664916992],[46.19841,6.1437]],"countries":["Switzerland","Tanzania"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[47.5585289001465,7.58259010314941],[46.2083282470703,6.14274978637695]],"countries":["Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[47.5585289001465,7.58259010314941],[46.19841,6.1437]],"countries":["Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[46.2083282470703,6.14274978637695],[46.19841,6.1437]],"countries":["Switzerland"],"title":"Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa"},{"arc":[[40.7840995788574,-84.1892776489258],[42.3354797363281,-71.1043930053711]],"countries":["United States"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[40.7840995788574,-84.1892776489258],[30.5934391021729,31.2882404327393]],"countries":["United States","Egypt"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[42.3354797363281,-71.1043930053711],[30.5934391021729,31.2882404327393]],"countries":["United States","Egypt"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[54.4185829162598,-105.888847351074],[32.0583801269531,118.79647064209]],"countries":["Canada","China"],"title":"Human Bocavirus Infection, Canada"},{"arc":[[51.7589988708496,-1.26400005817413],[22.5428600311279,114.059562683105]],"countries":["United Kingdom","China"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[17.51869,78.39728]],"countries":["United Kingdom","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[29.649730682373,-82.3411331176758]],"countries":["United Kingdom","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[44.9734497070312,-93.2378997802734]],"countries":["United Kingdom","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[17.51869,78.39728]],"countries":["China","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[22.5428600311279,114.059562683105]],"countries":["China"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[29.649730682373,-82.3411331176758]],"countries":["China","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[22.5428600311279,114.059562683105]],"countries":["China","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[29.649730682373,-82.3411331176758]],"countries":["India","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[44.9734497070312,-93.2378997802734]],"countries":["India","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[29.649730682373,-82.3411331176758],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[29.649730682373,-82.3411331176758],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[44.9734497070312,-93.2378997802734],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[31.823558807373,117.231567382812],[1.29718005657196,103.77774810791]],"countries":["China","Singapore"],"title":"Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants"},{"arc":[[31.823558807373,117.231567382812],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Genome-wide data inferring the evolution and population 1 demography of the novel pneumonia coronavirus (SARS-CoV-2)"},{"arc":[[31.823558807373,117.231567382812],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","China"],"title":"Genome-wide data inferring the evolution and population 1 demography of the novel pneumonia coronavirus (SARS-CoV-2)"},{"arc":[[40.9437103271484,40.2619209289551],[52.3687591552734,4.89012002944946]],"countries":["Turkey","Netherlands"],"title":"Genome-wide data inferring the evolution and population 1 demography of the novel pneumonia coronavirus (SARS-CoV-2)"},{"arc":[[38.500358581543,43.3803405761719],[14.477560043335,120.89826965332]],"countries":["Turkey","Philippines"],"title":"Detection of Colorectal Cancer by Serum and Tissue Protein Profi ling: A Prospective Study in a Population at Risk"},{"arc":[[38.500358581543,43.3803405761719],[38.500358581543,43.3803405761719]],"countries":["Turkey"],"title":"Detection of Colorectal Cancer by Serum and Tissue Protein Profi ling: A Prospective Study in a Population at Risk"},{"arc":[[38.500358581543,43.3803405761719],[52.3523597717285,4.83232021331787]],"countries":["Turkey","Netherlands"],"title":"Detection of Colorectal Cancer by Serum and Tissue Protein Profi ling: A Prospective Study in a Population at Risk"},{"arc":[[14.477560043335,120.89826965332],[38.500358581543,43.3803405761719]],"countries":["Turkey","Philippines"],"title":"Detection of Colorectal Cancer by Serum and Tissue Protein Profi ling: A Prospective Study in a Population at Risk"},{"arc":[[14.477560043335,120.89826965332],[52.3523597717285,4.83232021331787]],"countries":["Philippines","Netherlands"],"title":"Detection of Colorectal Cancer by Serum and Tissue Protein Profi ling: A Prospective Study in a Population at Risk"},{"arc":[[41.7091674804688,-87.9819946289062],[33.9756317138672,-117.331169128418]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[41.7091674804688,-87.9819946289062],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[33.9756317138672,-117.331169128418],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[33.4219207763672,-111.934936523438],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Extracting geographic locations from the literature for virus phylogeography using supervised and distant supervision methods"},{"arc":[[33.4219207763672,-111.934936523438],[33.7531509399414,-84.384880065918]],"countries":["United States"],"title":"Title: Transmission potential of COVID-19 in South Korea"},{"arc":[[33.4219207763672,-111.934936523438],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Title: Transmission potential of COVID-19 in South Korea"},{"arc":[[33.7531509399414,-84.384880065918],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Title: Transmission potential of COVID-19 in South Korea"},{"arc":[[25.2651195526123,82.9921417236328],[40.7182693481445,46.4133987426758]],"countries":["India","Azerbaijan"],"title":"Elevated transmission of upper respiratory illness among new recruits in military barracks in Thailand"},{"arc":[[40.9437103271484,40.2619209289551],[42.373161315918,-71.1181182861328]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[42.3600006103516,-71.0920028686523]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[39.0048141479492,-77.0975341796875]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[11.5965204238892,124.39527130127]],"countries":["Turkey","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[48.6535606384277,-0.836489975452423]],"countries":["Turkey","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[38.9969291687012,-77.0291366577148]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[32.2988700866699,-90.1804504394531]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[42.8098297119141,-88.3805541992188]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[39.4959106445312,-98.9899826049805]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[9.51126956939697,-83.7094879150391]],"countries":["Turkey","Costa Rica"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[42.3600006103516,-71.0920028686523]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[11.5965204238892,124.39527130127]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[48.6535606384277,-0.836489975452423]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[38.9969291687012,-77.0291366577148]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[11.5965204238892,124.39527130127]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[48.6535606384277,-0.836489975452423]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[38.9969291687012,-77.0291366577148]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[11.5965204238892,124.39527130127]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[48.6535606384277,-0.836489975452423]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[38.9969291687012,-77.0291366577148]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[48.6535606384277,-0.836489975452423]],"countries":["Philippines","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[38.9969291687012,-77.0291366577148]],"countries":["Philippines","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[32.2988700866699,-90.1804504394531]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[42.8098297119141,-88.3805541992188]],"countries":["Philippines","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[39.4959106445312,-98.9899826049805]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[38.9969291687012,-77.0291366577148]],"countries":["France","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[32.2988700866699,-90.1804504394531]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[42.8098297119141,-88.3805541992188]],"countries":["France","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[39.4959106445312,-98.9899826049805]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[32.2988700866699,-90.1804504394531],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[32.2988700866699,-90.1804504394531],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[32.2988700866699,-90.1804504394531],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.8098297119141,-88.3805541992188],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.8098297119141,-88.3805541992188],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.4959106445312,-98.9899826049805],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[-85.0169982910156,-167.5]],"countries":["Turkey","NOCOUNTRY"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[42.373161315918,-71.1181182861328]],"countries":["Turkey","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[39.2882804870605,-76.6251754760742]],"countries":["Turkey","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[38.987850189209,-76.9389038085938]],"countries":["Turkey","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[34.39375,-87.11915]],"countries":["Turkey","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.4762802124023,-133.153335571289]],"countries":["Turkey","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[-85.0169982910156,-167.5],[42.373161315918,-71.1181182861328]],"countries":["NOCOUNTRY","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[-85.0169982910156,-167.5],[39.2882804870605,-76.6251754760742]],"countries":["NOCOUNTRY","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[-85.0169982910156,-167.5],[38.987850189209,-76.9389038085938]],"countries":["NOCOUNTRY","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[-85.0169982910156,-167.5],[34.39375,-87.11915]],"countries":["NOCOUNTRY","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.4762802124023,-133.153335571289]],"countries":["NOCOUNTRY","United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[42.373161315918,-71.1181182861328],[39.2882804870605,-76.6251754760742]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[42.373161315918,-71.1181182861328],[38.987850189209,-76.9389038085938]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[42.373161315918,-71.1181182861328],[34.39375,-87.11915]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[42.373161315918,-71.1181182861328],[55.4762802124023,-133.153335571289]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[39.2882804870605,-76.6251754760742],[38.987850189209,-76.9389038085938]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[39.2882804870605,-76.6251754760742],[34.39375,-87.11915]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[39.2882804870605,-76.6251754760742],[55.4762802124023,-133.153335571289]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[38.987850189209,-76.9389038085938],[34.39375,-87.11915]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[38.987850189209,-76.9389038085938],[55.4762802124023,-133.153335571289]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[34.39375,-87.11915],[55.4762802124023,-133.153335571289]],"countries":["United States"],"title":"Standards for Sequencing Viral Genomes in the Era of High- Throughput Sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[40.8081588745117,-73.9636535644531]],"countries":["Turkey","United States"],"title":"Identifying Hosts of Families of Viruses: A Machine Learning Approach"},{"arc":[[40.9437103271484,40.2619209289551],[29.3106803894043,-94.7768173217773]],"countries":["Turkey","United States"],"title":"Interferon-β β 1a and SARS Coronavirus Replication"},{"arc":[[36.835375,126.965889],[37.4599990844727,126.949996948242]],"countries":["South Korea"],"title":"Characteristics and trends of traumatic injuries in children visiting emergency departments in South Korea: A retrospective serial cross-sectional study using both nationwide-sample and single-institutional data"},{"arc":[[18.5423393249512,73.828727722168],[36.5631141662598,103.735809326172]],"countries":["China","India"],"title":"The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles"},{"arc":[[18.5423393249512,73.828727722168],[9.36855030059814,-83.6394882202148]],"countries":["India","Costa Rica"],"title":"The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles"},{"arc":[[36.5631141662598,103.735809326172],[9.36855030059814,-83.6394882202148]],"countries":["China","Costa Rica"],"title":"The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles"},{"arc":[[43.377571105957,5.36300992965698],[33.5566825866699,23.774206161499]],"countries":["France","NOCOUNTRY"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[43.377571105957,5.36300992965698],[40.9437103271484,40.2619209289551]],"countries":["Turkey","France"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[43.377571105957,5.36300992965698],[51.1218070983887,10.4006948471069]],"countries":["France","Germany"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[33.5566825866699,23.774206161499],[40.9437103271484,40.2619209289551]],"countries":["Turkey","NOCOUNTRY"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[33.5566825866699,23.774206161499],[51.1218070983887,10.4006948471069]],"countries":["Germany","NOCOUNTRY"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[40.9437103271484,40.2619209289551],[51.1218070983887,10.4006948471069]],"countries":["Turkey","Germany"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[32.6041412353516,-85.4818801879883],[50.7345085144043,-3.53552007675171]],"countries":["United States","United Kingdom"],"title":"Bacterial Pathogen Emergence Requires More than Direct Contact with a Novel Passerine Host"},{"arc":[[52.7308082580566,-122.448257446289],[-37.797981262207,144.959045410156]],"countries":["Canada","Australia"],"title":"Improving immunological insights into the ferret model of human viral infectious disease"},{"arc":[[52.7308082580566,-122.448257446289],[45.5065994262695,-73.5779571533203]],"countries":["Canada"],"title":"Going to Bat(s) for Studies of Disease Tolerance"},{"arc":[[52.7308082580566,-122.448257446289],[37.4378814697266,-122.166603088379]],"countries":["Canada","United States"],"title":"Going to Bat(s) for Studies of Disease Tolerance"},{"arc":[[45.5065994262695,-73.5779571533203],[37.4378814697266,-122.166603088379]],"countries":["Canada","United States"],"title":"Going to Bat(s) for Studies of Disease Tolerance"},{"arc":[[52.7308082580566,-122.448257446289],[52.7308082580566,-122.448257446289]],"countries":["Canada"],"title":"Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto OPEN"},{"arc":[[52.7308082580566,-122.448257446289],[1.29718005657196,103.77774810791]],"countries":["Canada","Singapore"],"title":"Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto OPEN"},{"arc":[[-35.2775688171387,149.12646484375],[32.9052963256836,-117.243560791016]],"countries":["Australia","United States"],"title":"Ministry of Health, Jakarta, Indonesia, 2 National Health Institute Research and Development, Ministry of Health"},{"arc":[[-33.5961112976074,-58.1748695373535],[48.5203514099121,9.0491304397583]],"countries":["Uruguay","Germany"],"title":"molecules Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins"},{"arc":[[-33.5961112976074,-58.1748695373535],[-23.5594444274902,-46.7238883972168]],"countries":["Uruguay","NOCOUNTRY"],"title":"molecules Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins"},{"arc":[[48.5203514099121,9.0491304397583],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","Germany"],"title":"molecules Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins"},{"arc":[[35.6504898071289,139.73161315918],[34.6636085510254,133.910079956055]],"countries":["Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[35.6504898071289,139.73161315918],[34.8172721862793,135.526458740234]],"countries":["Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[35.6504898071289,139.73161315918],[42.6500015258789,-7.33330011367798]],"countries":["Spain","Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[35.6504898071289,139.73161315918],[37.7954292297363,139.225219726562]],"countries":["Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[34.6636085510254,133.910079956055],[34.8172721862793,135.526458740234]],"countries":["Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[34.6636085510254,133.910079956055],[42.6500015258789,-7.33330011367798]],"countries":["Spain","Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[34.6636085510254,133.910079956055],[37.7954292297363,139.225219726562]],"countries":["Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[34.8172721862793,135.526458740234],[42.6500015258789,-7.33330011367798]],"countries":["Spain","Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[34.8172721862793,135.526458740234],[37.7954292297363,139.225219726562]],"countries":["Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[42.6500015258789,-7.33330011367798],[37.7954292297363,139.225219726562]],"countries":["Spain","Japan"],"title":"inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha"},{"arc":[[44.773998260498,-117.829887390137],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Expression of 9-O-and 7,9-O-acetyl modified sialic acid in cells and their effects 5 on influenza viruses 6 7"},{"arc":[[41.7278709411621,44.764778137207],[24.8964900970459,91.8767623901367]],"countries":["Georgia","Bangladesh"],"title":"The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh"},{"arc":[[41.7278709411621,44.764778137207],[4.80505990982056,-75.6937026977539]],"countries":["Georgia","Colombia"],"title":"The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh"},{"arc":[[41.7278709411621,44.764778137207],[51.7589988708496,-1.26400005817413]],"countries":["Georgia","United Kingdom"],"title":"The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh"},{"arc":[[24.8964900970459,91.8767623901367],[4.80505990982056,-75.6937026977539]],"countries":["Bangladesh","Colombia"],"title":"The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh"},{"arc":[[24.8964900970459,91.8767623901367],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Bangladesh"],"title":"The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh"},{"arc":[[4.80505990982056,-75.6937026977539],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Colombia"],"title":"The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh"},{"arc":[[47.8398208618164,8.53275966644287],[41.7278709411621,44.764778137207]],"countries":["Georgia","Germany"],"title":"IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections"},{"arc":[[47.8398208618164,8.53275966644287],[40.0063018798828,-83.0163803100586]],"countries":["Germany","United States"],"title":"IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections"},{"arc":[[41.7278709411621,44.764778137207],[40.0063018798828,-83.0163803100586]],"countries":["Georgia","United States"],"title":"IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections"},{"arc":[[43.0435333251953,-2.61686491966248],[51.1218070983887,10.4006948471069]],"countries":["Spain","Germany"],"title":"Detection of alpha and betacoronaviruses in multiple Iberian bat species"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Detection of alpha and betacoronaviruses in multiple Iberian bat species"},{"arc":[[29.7107791900635,-95.3966522216797],[33.7483100891113,-84.39111328125]],"countries":["United States"],"title":"Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen HHS Public Access"},{"arc":[[29.7107791900635,-95.3966522216797],[27.1148796081543,42.5166816711426]],"countries":["United States","Saudi Arabia"],"title":"MicroRNA-221-5p Inhibits Porcine Epidemic Diarrhea Virus Replication by Targeting Genomic Viral RNA and Activating the NF-κB Pathway"},{"arc":[[29.7107791900635,-95.3966522216797],[28.261251449585,-82.7311248779297]],"countries":["United States"],"title":"MicroRNA-221-5p Inhibits Porcine Epidemic Diarrhea Virus Replication by Targeting Genomic Viral RNA and Activating the NF-κB Pathway"},{"arc":[[29.7107791900635,-95.3966522216797],[30.6250877380371,102.697288513184]],"countries":["United States","China"],"title":"MicroRNA-221-5p Inhibits Porcine Epidemic Diarrhea Virus Replication by Targeting Genomic Viral RNA and Activating the NF-κB Pathway"},{"arc":[[27.1148796081543,42.5166816711426],[28.261251449585,-82.7311248779297]],"countries":["Saudi Arabia","United States"],"title":"MicroRNA-221-5p Inhibits Porcine Epidemic Diarrhea Virus Replication by Targeting Genomic Viral RNA and Activating the NF-κB Pathway"},{"arc":[[27.1148796081543,42.5166816711426],[30.6250877380371,102.697288513184]],"countries":["China","Saudi Arabia"],"title":"MicroRNA-221-5p Inhibits Porcine Epidemic Diarrhea Virus Replication by Targeting Genomic Viral RNA and Activating the NF-κB Pathway"},{"arc":[[28.261251449585,-82.7311248779297],[30.6250877380371,102.697288513184]],"countries":["China","United States"],"title":"MicroRNA-221-5p Inhibits Porcine Epidemic Diarrhea Virus Replication by Targeting Genomic Viral RNA and Activating the NF-κB Pathway"},{"arc":[[29.7107791900635,-95.3966522216797],[42.3374290466309,-71.1058197021484]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[39.75265,30.48148]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[51.4269409179688,-0.174720004200935]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[32.8808288574219,-84.6852798461914]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[39.75265,30.48148]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[51.4269409179688,-0.174720004200935]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[32.8808288574219,-84.6852798461914]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[51.4269409179688,-0.174720004200935]],"countries":["Turkey","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[32.8808288574219,-84.6852798461914]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[47.3191909790039,5.06463003158569]],"countries":["Turkey","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[51.1638,4.40115]],"countries":["Turkey","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[-26.193000793457,28.18630027771]],"countries":["Turkey","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[32.8808288574219,-84.6852798461914]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[47.3191909790039,5.06463003158569]],"countries":["United Kingdom","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[51.1638,4.40115]],"countries":["United Kingdom","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[-26.193000793457,28.18630027771]],"countries":["United Kingdom","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[47.3191909790039,5.06463003158569],[51.1638,4.40115]],"countries":["France","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[47.3191909790039,5.06463003158569],[-26.193000793457,28.18630027771]],"countries":["France","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.1638,4.40115],[-26.193000793457,28.18630027771]],"countries":["Belgium","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[33.6674194335938,-93.5898513793945],[31.2988891601562,121.499168395996]],"countries":["China","United States"],"title":"Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV)"},{"arc":[[39.9219017028809,116.443550109863],[40.1861572265625,116.418983459473]],"countries":["China"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[27.3303279876709,128.57194519043]],"countries":["China","Japan"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[42.3354797363281,-71.1043930053711]],"countries":["China","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[27.3303279876709,128.57194519043]],"countries":["China","Japan"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[42.3354797363281,-71.1043930053711]],"countries":["China","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[27.3303279876709,128.57194519043],[42.3354797363281,-71.1043930053711]],"countries":["Japan","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[27.3303279876709,128.57194519043],[39.9925537109375,116.310485839844]],"countries":["China","Japan"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[27.3303279876709,128.57194519043],[14.3596153259277,-14.4684610366821]],"countries":["Japan","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[42.3354797363281,-71.1043930053711],[39.9925537109375,116.310485839844]],"countries":["China","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[42.3354797363281,-71.1043930053711],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9925537109375,116.310485839844],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[43.9928398132324,0.229560002684593]],"countries":["France","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[40.1861572265625,116.418983459473],[38.0427589416504,114.514297485352]],"countries":["China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[40.1861572265625,116.418983459473],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[43.9928398132324,0.229560002684593],[38.0427589416504,114.514297485352]],"countries":["France","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[43.9928398132324,0.229560002684593],[37.7697296142578,-122.466094970703]],"countries":["United States","France"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[38.0427589416504,114.514297485352],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[40.1861572265625,116.418983459473],[32.8808288574219,-84.6852798461914]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[38.0572509765625,-97.9326782226562]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[38.9907493591309,48.5817184448242]],"countries":["China","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[38.0572509765625,-97.9326782226562]],"countries":["United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[31.2988891601562,121.499168395996]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[38.9907493591309,48.5817184448242]],"countries":["United States","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[42.3402290344238,-71.0890197753906]],"countries":["United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[31.2988891601562,121.499168395996]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[38.9907493591309,48.5817184448242]],"countries":["United States","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[42.3402290344238,-71.0890197753906]],"countries":["United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[38.9907493591309,48.5817184448242]],"countries":["China","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[22.333080291748,114.191223144531],[38.9907493591309,48.5817184448242]],"countries":["Hong Kong SAR","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[22.333080291748,114.191223144531],[42.3402290344238,-71.0890197753906]],"countries":["Hong Kong SAR","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[42.3402290344238,-71.0890197753906]],"countries":["Azerbaijan","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[42.3402290344238,-71.0890197753906],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[39.2892150878906,117.349395751953]],"countries":["China"],"title":"polymers Preparation, Characterization and Application of Polysaccharide-Based Metallic Nanoparticles: A Review"},{"arc":[[40.1861572265625,116.418983459473],[30.3002605438232,108.037666320801]],"countries":["China"],"title":"Incidence and Outcomes of Acute Respiratory Distress Syndrome A Nationwide Registry-Based Study in Taiwan, 1997 to 2011"},{"arc":[[40.1861572265625,116.418983459473],[21.1991405487061,81.2897262573242]],"countries":["China","India"],"title":"Profiling ACE2 expression in colon tissue of healthy adults and colorectal cancer patients by single-cell transcriptome analysis"},{"arc":[[40.1861572265625,116.418983459473],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Profiling ACE2 expression in colon tissue of healthy adults and colorectal cancer patients by single-cell transcriptome analysis"},{"arc":[[21.1991405487061,81.2897262573242],[31.0254402160645,121.436302185059]],"countries":["China","India"],"title":"Profiling ACE2 expression in colon tissue of healthy adults and colorectal cancer patients by single-cell transcriptome analysis"},{"arc":[[35.6814384460449,-88.8572692871094],[38.8350486755371,-77.3112411499023]],"countries":["United States"],"title":"Institute of Geographical Sciences and Natural Resources Research"},{"arc":[[35.6814384460449,-88.8572692871094],[32.7721481323242,-117.071929931641]],"countries":["United States"],"title":"Institute of Geographical Sciences and Natural Resources Research"},{"arc":[[38.8350486755371,-77.3112411499023],[32.7721481323242,-117.071929931641]],"countries":["United States"],"title":"Institute of Geographical Sciences and Natural Resources Research"},{"arc":[[39.9925537109375,116.310485839844],[27.3303279876709,128.57194519043]],"countries":["China","Japan"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[39.9925537109375,116.310485839844],[42.2077713012695,-78.1342010498047]],"countries":["China","United States"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[39.9925537109375,116.310485839844],[-31.61016,-60.69643]],"countries":["China","Argentina"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[27.3303279876709,128.57194519043],[42.2077713012695,-78.1342010498047]],"countries":["Japan","United States"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[27.3303279876709,128.57194519043],[-31.61016,-60.69643]],"countries":["Japan","Argentina"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[42.2077713012695,-78.1342010498047],[-31.61016,-60.69643]],"countries":["United States","Argentina"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[40.1861572265625,116.418983459473],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"Thin-Section Computed Tomography Manifestations During Convalescence and Long- Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS) This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)"},{"arc":[[30.85131,34.78235],[40.3495407104492,-74.6600875854492]],"countries":["Israel","United States"],"title":"Concerted 2-5A-Mediated mRNA Decay and Transcription Reprogram Protein Synthesis in dsRNA Response"},{"arc":[[52.5014038085938,13.4023313522339],[46.8767318725586,7.36887979507446]],"countries":["Germany","Switzerland"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[41.9982795715332,-87.6571731567383]],"countries":["Germany","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[41.9982795715332,-87.6571731567383]],"countries":["Switzerland","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Switzerland"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[50.7338905334473,7.10222196578979]],"countries":["Switzerland","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[40.9437103271484,40.2619209289551],[50.7338905334473,7.10222196578979]],"countries":["Turkey","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[52.5251808166504,13.3792200088501]],"countries":["Germany"],"title":"Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus"},{"arc":[[52.5251808166504,13.3792200088501],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus"},{"arc":[[52.5014038085938,13.4023313522339],[57.6894683837891,11.9732599258423]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[55.84738,-4.25425]],"countries":["Germany","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[47.4264907836914,9.37360954284668]],"countries":["Germany","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[57.6986312866211,11.9708204269409]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[51.9735984802246,5.66384315490723]],"countries":["Germany","Netherlands"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[55.84738,-4.25425]],"countries":["United Kingdom","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[47.4264907836914,9.37360954284668]],"countries":["Sweden","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[50.7338905334473,7.10222196578979]],"countries":["Sweden","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[57.6986312866211,11.9708204269409]],"countries":["Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[47.4264907836914,9.37360954284668]],"countries":["United Kingdom","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[50.7338905334473,7.10222196578979]],"countries":["United Kingdom","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[57.6986312866211,11.9708204269409]],"countries":["United Kingdom","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[51.9735984802246,5.66384315490723]],"countries":["United Kingdom","Netherlands"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[50.7338905334473,7.10222196578979]],"countries":["Switzerland","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[57.6986312866211,11.9708204269409]],"countries":["Sweden","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[57.6986312866211,11.9708204269409]],"countries":["Sweden","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[44.9948196411133,-93.41455078125],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"Virology Journal Identification of a contemporary human parechovirus type 1 by VIDISCA and characterisation of its full genome"},{"arc":[[40.9437103271484,40.2619209289551],[39.6785011291504,-104.966621398926]],"countries":["Turkey","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[51.9100685119629,4.46534013748169]],"countries":["Turkey","Netherlands"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[29.9353504180908,-90.123176574707]],"countries":["Turkey","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[52.2025413513184,0.119549997150898]],"countries":["Turkey","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[50.8659515380859,-0.0823199972510338]],"countries":["Turkey","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[51.9100685119629,4.46534013748169]],"countries":["United States","Netherlands"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[29.9353504180908,-90.123176574707]],"countries":["United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[50.8659515380859,-0.0823199972510338]],"countries":["United States","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[51.9100685119629,4.46534013748169],[29.9353504180908,-90.123176574707]],"countries":["Netherlands","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[51.9100685119629,4.46534013748169],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","Netherlands"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[51.9100685119629,4.46534013748169],[50.8659515380859,-0.0823199972510338]],"countries":["Netherlands","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[29.9353504180908,-90.123176574707],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[29.9353504180908,-90.123176574707],[50.8659515380859,-0.0823199972510338]],"countries":["United States","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[52.2025413513184,0.119549997150898],[50.8659515380859,-0.0823199972510338]],"countries":["United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[29.7095108032227,-95.3981781005859],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[29.7095108032227,-95.3981781005859],[51.5229187011719,-0.0402299985289574]],"countries":["United States","United Kingdom"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[29.7095108032227,-95.3981781005859],[40.6795196533203,-102.838851928711]],"countries":["United States"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[29.7095108032227,-95.3981781005859],[45.1917495727539,5.77174997329712]],"countries":["United States","France"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[29.7095108032227,-95.3981781005859],[51.5235214233398,-0.132312998175621]],"countries":["United States","United Kingdom"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[29.7095108032227,-95.3981781005859],[52.2025413513184,0.119549997150898]],"countries":["United States","United Kingdom"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[51.5229187011719,-0.0402299985289574],[40.6795196533203,-102.838851928711]],"countries":["United Kingdom","United States"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[51.5229187011719,-0.0402299985289574],[45.1917495727539,5.77174997329712]],"countries":["United Kingdom","France"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[51.5229187011719,-0.0402299985289574],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[51.5229187011719,-0.0402299985289574],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[40.6795196533203,-102.838851928711],[45.1917495727539,5.77174997329712]],"countries":["United States","France"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[40.6795196533203,-102.838851928711],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom","United States"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[40.6795196533203,-102.838851928711],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[45.1917495727539,5.77174997329712],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom","France"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[45.1917495727539,5.77174997329712],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","France"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[51.5235214233398,-0.132312998175621],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals"},{"arc":[[43.2412185668945,-2.8500440120697],[51.1218070983887,10.4006948471069]],"countries":["Spain","Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[-16.499080657959,-68.1337814331055]],"countries":["Spain","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[41.6720504760742,2.2520899772644]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[48.5444183349609,12.1591682434082]],"countries":["Spain","Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[28.0604705810547,-15.4747295379639]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[-16.499080657959,-68.1337814331055]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[41.6720504760742,2.2520899772644]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[48.5444183349609,12.1591682434082]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[28.0604705810547,-15.4747295379639]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[41.6720504760742,2.2520899772644]],"countries":["Bolivia","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[48.5444183349609,12.1591682434082]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[51.1218070983887,10.4006948471069]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[28.0604705810547,-15.4747295379639]],"countries":["Bolivia","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[48.5444183349609,12.1591682434082]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[51.1218070983887,10.4006948471069]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[28.0604705810547,-15.4747295379639]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[48.5444183349609,12.1591682434082],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[48.5444183349609,12.1591682434082],[28.0604705810547,-15.4747295379639]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-53.0833320617676,73.5500030517578],[49.0094413757324,8.41166973114014]],"countries":["Heard Island and McDonald Islands","Germany"],"title":"Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of β-Keto Esters"},{"arc":[[-53.0833320617676,73.5500030517578],[49.8745918273926,8.65526962280273]],"countries":["Heard Island and McDonald Islands","Germany"],"title":"Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of β-Keto Esters"},{"arc":[[49.0094413757324,8.41166973114014],[49.8745918273926,8.65526962280273]],"countries":["Germany"],"title":"Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of β-Keto Esters"},{"arc":[[-85.0169982910156,-167.5],[40.9437103271484,40.2619209289551]],"countries":["Turkey","NOCOUNTRY"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.7387313842773,12.5470895767212]],"countries":["NOCOUNTRY","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[45.8021583557129,126.535797119141]],"countries":["NOCOUNTRY","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","NOCOUNTRY"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.6756706237793,12.5675601959229]],"countries":["NOCOUNTRY","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.7387313842773,12.5470895767212]],"countries":["Turkey","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[45.8021583557129,126.535797119141]],"countries":["Turkey","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[40.7182693481445,46.4133987426758]],"countries":["Turkey","Azerbaijan"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.6756706237793,12.5675601959229]],"countries":["Turkey","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[45.8021583557129,126.535797119141]],"countries":["Denmark","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[55.6756706237793,12.5675601959229]],"countries":["Denmark","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.7182693481445,46.4133987426758],[55.6756706237793,12.5675601959229]],"countries":["Azerbaijan","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[40.9437103271484,40.2619209289551]],"countries":["Turkey","NOCOUNTRY"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.7387313842773,12.5470895767212]],"countries":["NOCOUNTRY","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[45.8021583557129,126.535797119141]],"countries":["NOCOUNTRY","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","NOCOUNTRY"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.6756706237793,12.5675601959229]],"countries":["NOCOUNTRY","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.7387313842773,12.5470895767212]],"countries":["Turkey","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[45.8021583557129,126.535797119141]],"countries":["Turkey","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[40.7182693481445,46.4133987426758]],"countries":["Turkey","Azerbaijan"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.6756706237793,12.5675601959229]],"countries":["Turkey","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[45.8021583557129,126.535797119141]],"countries":["Denmark","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[55.6756706237793,12.5675601959229]],"countries":["Denmark","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.7182693481445,46.4133987426758],[55.6756706237793,12.5675601959229]],"countries":["Azerbaijan","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[47.1806716918945,5.77007007598877],[25.7610397338867,-80.3762817382812]],"countries":["France","United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[47.1806716918945,5.77007007598877],[37.1157264709473,127.150489807129]],"countries":["France","South Korea"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[47.1806716918945,5.77007007598877],[38.3835906982422,-81.7656936645508]],"countries":["United States","France"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[47.1806716918945,5.77007007598877],[39.6851081848145,-83.9281692504883]],"countries":["France","United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[25.7610397338867,-80.3762817382812],[37.1157264709473,127.150489807129]],"countries":["United States","South Korea"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[25.7610397338867,-80.3762817382812],[38.3835906982422,-81.7656936645508]],"countries":["United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[25.7610397338867,-80.3762817382812],[39.6851081848145,-83.9281692504883]],"countries":["United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[37.1157264709473,127.150489807129],[38.3835906982422,-81.7656936645508]],"countries":["United States","South Korea"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[37.1157264709473,127.150489807129],[39.6851081848145,-83.9281692504883]],"countries":["South Korea","United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[38.3835906982422,-81.7656936645508],[39.6851081848145,-83.9281692504883]],"countries":["United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[38.8868255615234,-89.4355163574219],[9.36855030059814,-83.6394882202148]],"countries":["United States","Costa Rica"],"title":"Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV"},{"arc":[[38.8868255615234,-89.4355163574219],[40.0063018798828,-83.0163803100586]],"countries":["United States"],"title":"Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV"},{"arc":[[38.8868255615234,-89.4355163574219],[38.944408416748,-92.3292999267578]],"countries":["United States"],"title":"Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV"},{"arc":[[9.36855030059814,-83.6394882202148],[40.0063018798828,-83.0163803100586]],"countries":["Costa Rica","United States"],"title":"Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV"},{"arc":[[9.36855030059814,-83.6394882202148],[38.944408416748,-92.3292999267578]],"countries":["Costa Rica","United States"],"title":"Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV"},{"arc":[[40.0063018798828,-83.0163803100586],[38.944408416748,-92.3292999267578]],"countries":["United States"],"title":"Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV"},{"arc":[[42.3502082824707,-71.0988693237305],[-33.88618,151.18716]],"countries":["United States","Australia"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[54.5704803466797,-1.23447000980377]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[-23.5594444274902,-46.7238883972168]],"countries":["United States","NOCOUNTRY"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[51.9630088806152,7.61780977249146]],"countries":["United States","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[28.6008148193359,-81.1996078491211]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[54.5704803466797,-1.23447000980377]],"countries":["Australia","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","Australia"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[51.9630088806152,7.61780977249146]],"countries":["Australia","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[28.6008148193359,-81.1996078491211]],"countries":["Australia","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[35.1019592285156,-106.591567993164]],"countries":["Australia","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[53.3718719482422,-3.0949079990387]],"countries":["Australia","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[51.9630088806152,7.61780977249146]],"countries":["United Kingdom","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[28.6008148193359,-81.1996078491211]],"countries":["United Kingdom","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[35.1019592285156,-106.591567993164]],"countries":["United Kingdom","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[53.3718719482422,-3.0949079990387]],"countries":["United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[51.9630088806152,7.61780977249146]],"countries":["NOCOUNTRY","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[28.6008148193359,-81.1996078491211]],"countries":["NOCOUNTRY","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[35.1019592285156,-106.591567993164]],"countries":["NOCOUNTRY","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[53.3718719482422,-3.0949079990387]],"countries":["NOCOUNTRY","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[28.6008148193359,-81.1996078491211]],"countries":["Germany","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[35.1019592285156,-106.591567993164]],"countries":["Germany","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[53.3718719482422,-3.0949079990387]],"countries":["Germany","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[28.6008148193359,-81.1996078491211],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[28.6008148193359,-81.1996078491211],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[35.1019592285156,-106.591567993164],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[42.3502082824707,-71.0988693237305],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[42.3502082824707,-71.0988693237305],[14.3596153259277,-14.4684610366821]],"countries":["United States","Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[40.8081588745117,-73.9636535644531],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[40.8081588745117,-73.9636535644531],[14.3596153259277,-14.4684610366821]],"countries":["United States","Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[28.7162494659424,77.2728576660156],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","India"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[14.3596153259277,-14.4684610366821],[14.3596153259277,-14.4684610366821]],"countries":["Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[41.66333,-91.54439],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[41.66333,-91.54439],[53.1849708557129,-8.146897315979]],"countries":["United States","Ireland"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[41.66333,-91.54439],[42.385311126709,-72.5253524780273]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[41.66333,-91.54439],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[37.7697296142578,-122.466094970703],[53.1849708557129,-8.146897315979]],"countries":["United States","Ireland"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[37.7697296142578,-122.466094970703],[42.385311126709,-72.5253524780273]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[37.7697296142578,-122.466094970703],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[53.1849708557129,-8.146897315979],[42.385311126709,-72.5253524780273]],"countries":["Ireland","United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[53.1849708557129,-8.146897315979],[35.9053153991699,-79.0477142333984]],"countries":["Ireland","United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[42.385311126709,-72.5253524780273],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[51.457706451416,-2.59726095199585],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Management of Kawasaki disease"},{"arc":[[51.457706451416,-2.59726095199585],[53.330680847168,-3.02163004875183]],"countries":["United Kingdom"],"title":"Management of Kawasaki disease"},{"arc":[[51.5002288818359,-0.178939998149872],[53.330680847168,-3.02163004875183]],"countries":["United Kingdom"],"title":"Management of Kawasaki disease"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design"},{"arc":[[41.8275108337402,-71.4047698974609],[-33.9339714050293,18.865119934082]],"countries":["United States","South Africa"],"title":"Migration and health in Southern Africa: 100 years and still circulating"},{"arc":[[40.9437103271484,40.2619209289551],[23.7489929199219,120.971282958984]],"countries":["Turkey","Taiwan"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[40.9437103271484,40.2619209289551],[33.2227516174316,107.54564666748]],"countries":["Turkey","China"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[33.2227516174316,107.54564666748]],"countries":["Taiwan","China"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[37.7697296142578,-122.466094970703],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[37.7697296142578,-122.466094970703],[38.5367012023926,-121.749008178711]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[37.7697296142578,-122.466094970703],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[37.7697296142578,-122.466094970703],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[39.4959106445312,-98.9899826049805],[38.5367012023926,-121.749008178711]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[39.4959106445312,-98.9899826049805],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[39.4959106445312,-98.9899826049805],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[38.5367012023926,-121.749008178711],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[38.5367012023926,-121.749008178711],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[37.7633209228516,-122.458541870117],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections"},{"arc":[[33.1274299621582,-117.165199279785],[32.3287200927734,-90.1755599975586]],"countries":["United States"],"title":"The Molecular Biology of Frog Virus 3 and other Iridoviruses Infecting Cold-Blooded Vertebrates"},{"arc":[[47.3280982971191,-114.292999267578],[-25.1099891662598,30.7521800994873]],"countries":["United States","South Africa"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[40.7182693481445,46.4133987426758]],"countries":["United States","Azerbaijan"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[-31.61016,-60.69643]],"countries":["United States","Argentina"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[55.8721008300781,-4.28659009933472]],"countries":["United States","United Kingdom"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[-25.7523803710938,28.2516193389893]],"countries":["United States","South Africa"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[41.87774,12.49506]],"countries":["United States","Italy"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","South Africa"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[-31.61016,-60.69643]],"countries":["South Africa","Argentina"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[55.8721008300781,-4.28659009933472]],"countries":["South Africa","United Kingdom"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[-25.7523803710938,28.2516193389893]],"countries":["South Africa"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[41.87774,12.49506]],"countries":["South Africa","Italy"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[-31.61016,-60.69643]],"countries":["Azerbaijan","Argentina"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[55.8721008300781,-4.28659009933472]],"countries":["Azerbaijan","United Kingdom"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[-25.7523803710938,28.2516193389893]],"countries":["Azerbaijan","South Africa"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[41.87774,12.49506]],"countries":["Azerbaijan","Italy"],"title":"Access to"},{"arc":[[-31.61016,-60.69643],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom","Argentina"],"title":"Access to"},{"arc":[[-31.61016,-60.69643],[-25.7523803710938,28.2516193389893]],"countries":["Argentina","South Africa"],"title":"Access to"},{"arc":[[-31.61016,-60.69643],[41.87774,12.49506]],"countries":["Argentina","Italy"],"title":"Access to"},{"arc":[[55.8721008300781,-4.28659009933472],[-25.7523803710938,28.2516193389893]],"countries":["United Kingdom","South Africa"],"title":"Access to"},{"arc":[[55.8721008300781,-4.28659009933472],[41.87774,12.49506]],"countries":["United Kingdom","Italy"],"title":"Access to"},{"arc":[[-25.7523803710938,28.2516193389893],[41.87774,12.49506]],"countries":["South Africa","Italy"],"title":"Access to"},{"arc":[[48.7505416870117,30.2246208190918],[47.4847412109375,1.68438005447388]],"countries":["Ukraine","France"],"title":"R A P I D C O M M U N I C A T I O N Investigation into the Role of Potentially Contaminated Feed as a Source of the First-Detected Outbreaks of Porcine Epidemic Diarrhea in Canada"},{"arc":[[48.7505416870117,30.2246208190918],[43.5278816223145,-80.2231063842773]],"countries":["Ukraine","Canada"],"title":"R A P I D C O M M U N I C A T I O N Investigation into the Role of Potentially Contaminated Feed as a Source of the First-Detected Outbreaks of Porcine Epidemic Diarrhea in Canada"},{"arc":[[47.4847412109375,1.68438005447388],[43.5278816223145,-80.2231063842773]],"countries":["France","Canada"],"title":"R A P I D C O M M U N I C A T I O N Investigation into the Role of Potentially Contaminated Feed as a Source of the First-Detected Outbreaks of Porcine Epidemic Diarrhea in Canada"},{"arc":[[55.84738,-4.25425],[47.5488014221191,7.58781003952026]],"countries":["United Kingdom","Switzerland"],"title":"Open Forum Infectious Diseases Open Forum Infectious Diseases ® Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience"},{"arc":[[55.84738,-4.25425],[47.5585289001465,7.58259010314941]],"countries":["United Kingdom","Switzerland"],"title":"Open Forum Infectious Diseases Open Forum Infectious Diseases ® Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience"},{"arc":[[47.5488014221191,7.58781003952026],[47.5585289001465,7.58259010314941]],"countries":["Switzerland"],"title":"Open Forum Infectious Diseases Open Forum Infectious Diseases ® Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience"},{"arc":[[41.7278709411621,44.764778137207],[39.9046897888184,116.407173156738]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[31.0254402160645,121.436302185059]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[39.9046897888184,116.407173156738],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[39.9046897888184,116.407173156738],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[31.0254402160645,121.436302185059],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[42.0247383117676,-93.6445465087891]],"countries":["Georgia","United States"],"title":"High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults"},{"arc":[[41.7278709411621,44.764778137207],[28.7162494659424,77.2728576660156]],"countries":["Georgia","India"],"title":"High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults"},{"arc":[[41.7278709411621,44.764778137207],[51.7589988708496,-1.26400005817413]],"countries":["Georgia","United Kingdom"],"title":"High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults"},{"arc":[[42.0247383117676,-93.6445465087891],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults"},{"arc":[[42.0247383117676,-93.6445465087891],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","United States"],"title":"High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults"},{"arc":[[28.7162494659424,77.2728576660156],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","India"],"title":"High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension"},{"arc":[[41.7278709411621,44.764778137207],[-19.9233207702637,-43.9290504455566]],"countries":["Georgia","Brazil"],"title":") A Multiplex Asymmetric Reverse Transcription-PCR Assay Combined With an Electrochemical DNA Sensor for Simultaneously Detecting and Subtyping Influenza A Multiplex Asymmetric Reverse Transcription-PCR Assay Combined With an Electrochemical DNA Sensor for Simultaneously Detecting and Subtyping Influenza A Viruses"},{"arc":[[41.7278709411621,44.764778137207],[36.5631141662598,103.735809326172]],"countries":["China","Georgia"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[31.2988891601562,121.499168395996]],"countries":["Georgia","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[22.333080291748,114.191223144531]],"countries":["Georgia","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[11.2589302062988,75.7811813354492]],"countries":["Georgia","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[22.2802925109863,114.142951965332]],"countries":["Georgia","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[30.2633018493652,120.122261047363]],"countries":["Georgia","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[11.2589302062988,75.7811813354492]],"countries":["China","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[30.2633018493652,120.122261047363]],"countries":["China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[11.2589302062988,75.7811813354492]],"countries":["China","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[30.2633018493652,120.122261047363]],"countries":["China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.333080291748,114.191223144531],[11.2589302062988,75.7811813354492]],"countries":["Hong Kong SAR","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.333080291748,114.191223144531],[30.2633018493652,120.122261047363]],"countries":["Hong Kong SAR","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[11.2589302062988,75.7811813354492],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[11.2589302062988,75.7811813354492],[30.2633018493652,120.122261047363]],"countries":["India","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.2802925109863,114.142951965332],[30.2633018493652,120.122261047363]],"countries":["Hong Kong SAR","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[39.9046897888184,116.407173156738]],"countries":["Georgia","China"],"title":"Genetic drift of human coronavirus OC43 spike gene during adaptive evolution OPEN"},{"arc":[[41.7278709411621,44.764778137207],[41.7278709411621,44.764778137207]],"countries":["Georgia"],"title":"Genetic drift of human coronavirus OC43 spike gene during adaptive evolution OPEN"},{"arc":[[39.9046897888184,116.407173156738],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"Genetic drift of human coronavirus OC43 spike gene during adaptive evolution OPEN"},{"arc":[[51.4884300231934,-3.17879009246826],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.4884300231934,-3.17879009246826],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.4884300231934,-3.17879009246826],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.5002288818359,-0.178939998149872],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.5002288818359,-0.178939998149872],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[55.9452209472656,-3.18803000450134],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[40.48782,-3.69356],[39.51581,3.21459]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[41.3893013000488,2.15140008926392]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[25.79705,-100.5662]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[51.1218070983887,10.4006948471069]],"countries":["Spain","Germany"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[41.6541900634766,-4.7321400642395]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[11.9707298278809,124.836952209473]],"countries":["Spain","Philippines"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[-12.10353,-77.00568]],"countries":["Spain","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[41.0514984130859,-0.882239997386932]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[28.2905292510986,-16.5567169189453]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[12.464542388916,-83.7508316040039]],"countries":["Spain","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[21.0004692077637,-101.241577148438]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[-32.8430404663086,-60.6971206665039]],"countries":["Spain","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[23.3535003662109,116.68221282959]],"countries":["Spain","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[40.48782,-3.69356],[35.7868995666504,-93.9436416625977]],"countries":["United States","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[41.3893013000488,2.15140008926392]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[25.79705,-100.5662]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[51.1218070983887,10.4006948471069]],"countries":["Germany","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[41.6541900634766,-4.7321400642395]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[11.9707298278809,124.836952209473]],"countries":["Spain","Philippines"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[-12.10353,-77.00568]],"countries":["Spain","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[41.0514984130859,-0.882239997386932]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[28.2905292510986,-16.5567169189453]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[12.464542388916,-83.7508316040039]],"countries":["Spain","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[21.0004692077637,-101.241577148438]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[-32.8430404663086,-60.6971206665039]],"countries":["Spain","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[23.3535003662109,116.68221282959]],"countries":["Spain","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[39.51581,3.21459],[35.7868995666504,-93.9436416625977]],"countries":["United States","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[25.79705,-100.5662]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[51.1218070983887,10.4006948471069]],"countries":["Germany","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[41.6541900634766,-4.7321400642395]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[11.9707298278809,124.836952209473]],"countries":["Spain","Philippines"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[-12.10353,-77.00568]],"countries":["Spain","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[41.0514984130859,-0.882239997386932]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[28.2905292510986,-16.5567169189453]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[12.464542388916,-83.7508316040039]],"countries":["Spain","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[21.0004692077637,-101.241577148438]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[-32.8430404663086,-60.6971206665039]],"countries":["Spain","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[23.3535003662109,116.68221282959]],"countries":["Spain","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.3893013000488,2.15140008926392],[35.7868995666504,-93.9436416625977]],"countries":["United States","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[51.1218070983887,10.4006948471069]],"countries":["Germany","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[41.6541900634766,-4.7321400642395]],"countries":["Mexico","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[11.9707298278809,124.836952209473]],"countries":["Mexico","Philippines"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[-12.10353,-77.00568]],"countries":["Mexico","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[41.0514984130859,-0.882239997386932]],"countries":["Mexico","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[28.2905292510986,-16.5567169189453]],"countries":["Mexico","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[12.464542388916,-83.7508316040039]],"countries":["Mexico","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[21.0004692077637,-101.241577148438]],"countries":["Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[-32.8430404663086,-60.6971206665039]],"countries":["Mexico","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[23.3535003662109,116.68221282959]],"countries":["Mexico","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[25.79705,-100.5662],[35.7868995666504,-93.9436416625977]],"countries":["United States","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[41.6541900634766,-4.7321400642395]],"countries":["Germany","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[11.9707298278809,124.836952209473]],"countries":["Germany","Philippines"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[-12.10353,-77.00568]],"countries":["Germany","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[41.0514984130859,-0.882239997386932]],"countries":["Germany","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[28.2905292510986,-16.5567169189453]],"countries":["Germany","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[12.464542388916,-83.7508316040039]],"countries":["Germany","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[21.0004692077637,-101.241577148438]],"countries":["Germany","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[-32.8430404663086,-60.6971206665039]],"countries":["Germany","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[23.3535003662109,116.68221282959]],"countries":["Germany","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[51.1218070983887,10.4006948471069],[35.7868995666504,-93.9436416625977]],"countries":["United States","Germany"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[11.9707298278809,124.836952209473]],"countries":["Spain","Philippines"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[-12.10353,-77.00568]],"countries":["Spain","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[41.0514984130859,-0.882239997386932]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[28.2905292510986,-16.5567169189453]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[12.464542388916,-83.7508316040039]],"countries":["Spain","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[21.0004692077637,-101.241577148438]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[-32.8430404663086,-60.6971206665039]],"countries":["Spain","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[23.3535003662109,116.68221282959]],"countries":["Spain","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.6541900634766,-4.7321400642395],[35.7868995666504,-93.9436416625977]],"countries":["United States","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[-12.10353,-77.00568]],"countries":["Philippines","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[41.0514984130859,-0.882239997386932]],"countries":["Philippines","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[28.2905292510986,-16.5567169189453]],"countries":["Philippines","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[12.464542388916,-83.7508316040039]],"countries":["Philippines","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[21.0004692077637,-101.241577148438]],"countries":["Philippines","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[-32.8430404663086,-60.6971206665039]],"countries":["Philippines","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[23.3535003662109,116.68221282959]],"countries":["Philippines","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[11.9707298278809,124.836952209473],[35.7868995666504,-93.9436416625977]],"countries":["United States","Philippines"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-12.10353,-77.00568],[41.0514984130859,-0.882239997386932]],"countries":["Peru","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-12.10353,-77.00568],[28.2905292510986,-16.5567169189453]],"countries":["Peru","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-12.10353,-77.00568],[12.464542388916,-83.7508316040039]],"countries":["Peru","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-12.10353,-77.00568],[21.0004692077637,-101.241577148438]],"countries":["Peru","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-12.10353,-77.00568],[-32.8430404663086,-60.6971206665039]],"countries":["Peru","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-12.10353,-77.00568],[23.3535003662109,116.68221282959]],"countries":["Peru","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-12.10353,-77.00568],[35.7868995666504,-93.9436416625977]],"countries":["United States","Peru"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.0514984130859,-0.882239997386932],[28.2905292510986,-16.5567169189453]],"countries":["Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.0514984130859,-0.882239997386932],[12.464542388916,-83.7508316040039]],"countries":["Spain","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.0514984130859,-0.882239997386932],[21.0004692077637,-101.241577148438]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.0514984130859,-0.882239997386932],[-32.8430404663086,-60.6971206665039]],"countries":["Spain","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.0514984130859,-0.882239997386932],[23.3535003662109,116.68221282959]],"countries":["Spain","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.0514984130859,-0.882239997386932],[35.7868995666504,-93.9436416625977]],"countries":["United States","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[28.2905292510986,-16.5567169189453],[12.464542388916,-83.7508316040039]],"countries":["Spain","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[28.2905292510986,-16.5567169189453],[21.0004692077637,-101.241577148438]],"countries":["Spain","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[28.2905292510986,-16.5567169189453],[-32.8430404663086,-60.6971206665039]],"countries":["Spain","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[28.2905292510986,-16.5567169189453],[23.3535003662109,116.68221282959]],"countries":["Spain","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[28.2905292510986,-16.5567169189453],[35.7868995666504,-93.9436416625977]],"countries":["United States","Spain"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[12.464542388916,-83.7508316040039],[21.0004692077637,-101.241577148438]],"countries":["Nicaragua","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[12.464542388916,-83.7508316040039],[-32.8430404663086,-60.6971206665039]],"countries":["Nicaragua","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[12.464542388916,-83.7508316040039],[23.3535003662109,116.68221282959]],"countries":["Nicaragua","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[12.464542388916,-83.7508316040039],[35.7868995666504,-93.9436416625977]],"countries":["United States","Nicaragua"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[21.0004692077637,-101.241577148438],[-32.8430404663086,-60.6971206665039]],"countries":["Mexico","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[21.0004692077637,-101.241577148438],[23.3535003662109,116.68221282959]],"countries":["Mexico","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[21.0004692077637,-101.241577148438],[35.7868995666504,-93.9436416625977]],"countries":["United States","Mexico"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-32.8430404663086,-60.6971206665039],[23.3535003662109,116.68221282959]],"countries":["Argentina","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[-32.8430404663086,-60.6971206665039],[35.7868995666504,-93.9436416625977]],"countries":["United States","Argentina"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[23.3535003662109,116.68221282959],[35.7868995666504,-93.9436416625977]],"countries":["United States","China"],"title":"Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"arc":[[41.5059089660645,-81.6090927124023],[41.5047302246094,-81.6907424926758]],"countries":["United States"],"title":"Network-based Drug Repurposing for Human Coronavirus"},{"arc":[[47.4847412109375,1.68438005447388],[51.2169990539551,4.40000009536743]],"countries":["Belgium","France"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus"},{"arc":[[47.4847412109375,1.68438005447388],[52.0896492004395,5.11434984207153]],"countries":["Netherlands","France"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus"},{"arc":[[47.4847412109375,1.68438005447388],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","France"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus"},{"arc":[[51.2169990539551,4.40000009536743],[52.0896492004395,5.11434984207153]],"countries":["Belgium","Netherlands"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus"},{"arc":[[51.2169990539551,4.40000009536743],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Belgium"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus"},{"arc":[[52.0896492004395,5.11434984207153],[52.3687591552734,4.89012002944946]],"countries":["Netherlands"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus"},{"arc":[[42.4763488769531,-7.98753976821899],[30.0418796539307,80.311149597168]],"countries":["Spain","India"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Spain"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[31.4627456665039,-99.3330459594727]],"countries":["United States","Spain"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[43.6221504211426,7.0402398109436]],"countries":["Spain","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[48.7307891845703,2.17218995094299]],"countries":["Spain","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[49.787841796875,9.93556022644043]],"countries":["Spain","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","India"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[31.4627456665039,-99.3330459594727]],"countries":["United States","India"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[43.6221504211426,7.0402398109436]],"countries":["India","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[48.7307891845703,2.17218995094299]],"countries":["India","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[49.787841796875,9.93556022644043]],"countries":["India","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[31.4627456665039,-99.3330459594727]],"countries":["United States","Azerbaijan"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[43.6221504211426,7.0402398109436]],"countries":["Azerbaijan","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[48.7307891845703,2.17218995094299]],"countries":["Azerbaijan","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[49.787841796875,9.93556022644043]],"countries":["Azerbaijan","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[31.4627456665039,-99.3330459594727],[43.6221504211426,7.0402398109436]],"countries":["United States","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[31.4627456665039,-99.3330459594727],[48.7307891845703,2.17218995094299]],"countries":["United States","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[31.4627456665039,-99.3330459594727],[49.787841796875,9.93556022644043]],"countries":["United States","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[43.6221504211426,7.0402398109436],[48.7307891845703,2.17218995094299]],"countries":["France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[43.6221504211426,7.0402398109436],[49.787841796875,9.93556022644043]],"countries":["France","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[48.7307891845703,2.17218995094299],[49.787841796875,9.93556022644043]],"countries":["France","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[45.9471015930176,3.14088010787964],[43.6108589172363,3.87612009048462]],"countries":["France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[45.9471015930176,3.14088010787964],[33.789680480957,-84.3255462646484]],"countries":["France","United States"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[45.9471015930176,3.14088010787964],[53.1598205566406,45.2158508300781]],"countries":["France","Russia"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[45.9471015930176,3.14088010787964],[48.843879699707,2.35513997077942]],"countries":["France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[45.9471015930176,3.14088010787964],[33.9571990966797,-83.3740615844727]],"countries":["United States","France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[43.6108589172363,3.87612009048462],[33.789680480957,-84.3255462646484]],"countries":["France","United States"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[43.6108589172363,3.87612009048462],[53.1598205566406,45.2158508300781]],"countries":["France","Russia"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[43.6108589172363,3.87612009048462],[48.843879699707,2.35513997077942]],"countries":["France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[43.6108589172363,3.87612009048462],[33.9571990966797,-83.3740615844727]],"countries":["United States","France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[33.789680480957,-84.3255462646484],[53.1598205566406,45.2158508300781]],"countries":["Russia","United States"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[33.789680480957,-84.3255462646484],[48.843879699707,2.35513997077942]],"countries":["United States","France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[33.789680480957,-84.3255462646484],[33.9571990966797,-83.3740615844727]],"countries":["United States"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[53.1598205566406,45.2158508300781],[48.843879699707,2.35513997077942]],"countries":["Russia","France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[53.1598205566406,45.2158508300781],[33.9571990966797,-83.3740615844727]],"countries":["United States","Russia"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[48.843879699707,2.35513997077942],[33.9571990966797,-83.3740615844727]],"countries":["United States","France"],"title":"Interdisciplinarity and Infectious Diseases: An Ebola Case Study"},{"arc":[[36.5631141662598,103.735809326172],[41.118278503418,85.1935272216797]],"countries":["China"],"title":"Complex dynamics in an SIS epidemic model induced by nonlinear incidence"},{"arc":[[26.7023582458496,-80.0865325927734],[31.2988891601562,121.499168395996]],"countries":["China","United States"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[26.7023582458496,-80.0865325927734],[27.7355003356934,111.619239807129]],"countries":["United States","China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[26.7023582458496,-80.0865325927734],[28.2277793884277,112.938858032227]],"countries":["United States","China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[26.7023582458496,-80.0865325927734],[30.5363693237305,114.365432739258]],"countries":["United States","China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[31.2988891601562,121.499168395996],[27.7355003356934,111.619239807129]],"countries":["China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[31.2988891601562,121.499168395996],[28.2277793884277,112.938858032227]],"countries":["China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[31.2988891601562,121.499168395996],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[27.7355003356934,111.619239807129],[28.2277793884277,112.938858032227]],"countries":["China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[27.7355003356934,111.619239807129],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[28.2277793884277,112.938858032227],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Title: Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study"},{"arc":[[26.7023582458496,-80.0865325927734],[23.2024116516113,113.38606262207]],"countries":["China","United States"],"title":"Analysis of the sex ratio of reported gonorrhoea incidence in Shenzhen, China"},{"arc":[[44.9948196411133,-93.41455078125],[28.8037395477295,79.2010192871094]],"countries":["United States","India"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[0.537028014659882,37.8567771911621]],"countries":["United States","Kenya"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[52.598876953125,-1.46688103675842]],"countries":["United States","United Kingdom"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[39.8202781677246,-105.649436950684]],"countries":["United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[36.708869934082,-119.556427001953]],"countries":["United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[0.537028014659882,37.8567771911621]],"countries":["India","Kenya"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[52.598876953125,-1.46688103675842]],"countries":["India","United Kingdom"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[39.8202781677246,-105.649436950684]],"countries":["India","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[36.708869934082,-119.556427001953]],"countries":["India","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[0.537028014659882,37.8567771911621],[52.598876953125,-1.46688103675842]],"countries":["Kenya","United Kingdom"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[0.537028014659882,37.8567771911621],[39.8202781677246,-105.649436950684]],"countries":["Kenya","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[0.537028014659882,37.8567771911621],[36.708869934082,-119.556427001953]],"countries":["Kenya","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[52.598876953125,-1.46688103675842],[39.8202781677246,-105.649436950684]],"countries":["United Kingdom","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[52.598876953125,-1.46688103675842],[36.708869934082,-119.556427001953]],"countries":["United Kingdom","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[39.8202781677246,-105.649436950684],[36.708869934082,-119.556427001953]],"countries":["United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[51.1218070983887,10.4006948471069],[47.3191909790039,5.06463003158569]],"countries":["Germany","France"],"title":"Robitaille et al. 1 DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection"},{"arc":[[-1.63194000720978,13.5797300338745],[50.7338905334473,7.10222196578979]],"countries":["Gabon","Germany"],"title":"Identification of an Unclassified Paramyxovirus in Coleura afra: A Potential Case of Host Specificity"},{"arc":[[51.1218070983887,10.4006948471069],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"Imported Episodic Rabies Increases Patient Demand for and Physician Delivery of Antirabies Prophylaxis"},{"arc":[[51.1218070983887,10.4006948471069],[51.9100685119629,4.46534013748169]],"countries":["Germany","Netherlands"],"title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein"},{"arc":[[51.1218070983887,10.4006948471069],[52.3461112976074,-1.13979995250702]],"countries":["Germany","United Kingdom"],"title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein"},{"arc":[[51.1218070983887,10.4006948471069],[52.08896,5.1784]],"countries":["Germany","Netherlands"],"title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein"},{"arc":[[51.9100685119629,4.46534013748169],[51.9100685119629,4.46534013748169]],"countries":["Netherlands"],"title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein"},{"arc":[[51.9100685119629,4.46534013748169],[52.3461112976074,-1.13979995250702]],"countries":["Netherlands","United Kingdom"],"title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein"},{"arc":[[51.9100685119629,4.46534013748169],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein"},{"arc":[[52.3461112976074,-1.13979995250702],[52.08896,5.1784]],"countries":["United Kingdom","Netherlands"],"title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein"},{"arc":[[54.6490783691406,-8.43280029296875],[39.0048141479492,-77.0975341796875]],"countries":["Ireland","United States"],"title":"Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018"},{"arc":[[54.6490783691406,-8.43280029296875],[44.9734497070312,-93.2378997802734]],"countries":["Ireland","United States"],"title":"Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018"},{"arc":[[39.0048141479492,-77.0975341796875],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018"},{"arc":[[42.8499984741211,-7.08333301544189],[35.7442817687988,127.166305541992]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[36.7971878051758,127.704856872559]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[36.662978,126.755133]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Spain"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[31.3634490966797,75.5509414672852]],"countries":["Spain","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[33.511875,126.5585]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Spain"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[35.386514,129.051233]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[35.5382690429688,129.313323974609]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[42.9547386169434,-78.8192367553711]],"countries":["United States","Spain"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[36.7971878051758,127.704856872559]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[36.662978,126.755133]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[33.511875,126.5585]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[36.662978,126.755133]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[33.511875,126.5585]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[36.662978,126.755133]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[33.511875,126.5585]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[31.3634490966797,75.5509414672852]],"countries":["United Kingdom","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[33.511875,126.5585]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[40.9437103271484,40.2619209289551]],"countries":["United Kingdom","Turkey"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[35.386514,129.051233]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[35.5382690429688,129.313323974609]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[42.9547386169434,-78.8192367553711]],"countries":["United Kingdom","United States"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[33.511875,126.5585]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[35.386514,129.051233]],"countries":["India","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[35.5382690429688,129.313323974609]],"countries":["India","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[42.9547386169434,-78.8192367553711]],"countries":["United States","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[35.386514,129.051233]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[35.5382690429688,129.313323974609]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[42.9547386169434,-78.8192367553711]],"countries":["Turkey","United States"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.386514,129.051233],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.386514,129.051233],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.386514,129.051233],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.5382690429688,129.313323974609],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.5382690429688,129.313323974609],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.9547386169434,-78.8192367553711],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[30.4009304046631,78.0787124633789],[51.4681205749512,0.0636989995837212]],"countries":["India","United Kingdom"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[35.876606,126.8157]],"countries":["India","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[36.5631141662598,103.735809326172]],"countries":["China","India"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[22.6201400756836,120.31226348877]],"countries":["India","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[23.7489929199219,120.971282958984]],"countries":["Taiwan","India"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[35.876606,126.8157]],"countries":["United Kingdom","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[36.5631141662598,103.735809326172]],"countries":["China","United Kingdom"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[22.6201400756836,120.31226348877]],"countries":["United Kingdom","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[23.7489929199219,120.971282958984]],"countries":["Taiwan","United Kingdom"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[35.876606,126.8157],[36.5631141662598,103.735809326172]],"countries":["China","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[35.876606,126.8157],[22.6201400756836,120.31226348877]],"countries":["South Korea","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[35.876606,126.8157],[23.7489929199219,120.971282958984]],"countries":["Taiwan","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[36.5631141662598,103.735809326172],[22.6201400756836,120.31226348877]],"countries":["China","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[36.5631141662598,103.735809326172],[23.7489929199219,120.971282958984]],"countries":["China","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[22.6201400756836,120.31226348877],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[35.876606,126.8157]],"countries":["United Kingdom","South Korea"],"title":"PERK Signal-Modulated Protein Translation Promotes the Survivability of Dengue 2 Virus-Infected Mosquito Cells and Extends Viral Replication"},{"arc":[[35.876606,126.8157],[51.4559898376465,-0.24176000058651]],"countries":["South Korea","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[35.876606,126.8157],[22.2802925109863,114.142951965332]],"countries":["South Korea","Hong Kong SAR"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[51.4559898376465,-0.24176000058651],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[36.3686943054199,127.346206665039],[33.2227516174316,107.54564666748]],"countries":["South Korea","China"],"title":"Utilization of and Direct Expenditure for Emergency Medical Care in Taiwan: A Population-based Descriptive Study"},{"arc":[[36.3686943054199,127.346206665039],[24.9925498962402,121.307838439941]],"countries":["South Korea","Taiwan"],"title":"Utilization of and Direct Expenditure for Emergency Medical Care in Taiwan: A Population-based Descriptive Study"},{"arc":[[33.2227516174316,107.54564666748],[24.9925498962402,121.307838439941]],"countries":["China","Taiwan"],"title":"Utilization of and Direct Expenditure for Emergency Medical Care in Taiwan: A Population-based Descriptive Study"},{"arc":[[52.5251808166504,13.3792200088501],[65.3224716186523,25.3776607513428]],"countries":["Germany","Finland"],"title":"Virology Journal Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections"},{"arc":[[52.5251808166504,13.3792200088501],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"Virology Journal Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections"},{"arc":[[65.3224716186523,25.3776607513428],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Finland"],"title":"Virology Journal Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections"},{"arc":[[-12.3747396469116,130.874435424805],[-37.7949981689453,144.949722290039]],"countries":["Australia"],"title":"hƉƉĞƌ ĂŝƌǁĂǇ |ŝƌƵƐĞƐ ĂŶĚ ďĂĐƚĞƌŝĂ ĚĞƚĞĐƟŽŶ ŝŶ ĐůŝŶŝĐĂů ƉŶĞƵŵŽŶŝĂ ŝŶ Ă ƉŽƉƵůĂƟŽŶ ǁŝƚŚ ŚŝŐŚ ŶĂƐĂů ĐŽůŽŶŝƐĂƟŽŶ ĚŽ ŶŽƚ ƌĞůĂƚĞ ƚŽ ĐůŝŶŝĐĂů ƐŝŐŶƐ"},{"arc":[[-12.3747396469116,130.874435424805],[-33.8895797729492,151.18212890625]],"countries":["Australia"],"title":"hƉƉĞƌ ĂŝƌǁĂǇ |ŝƌƵƐĞƐ ĂŶĚ ďĂĐƚĞƌŝĂ ĚĞƚĞĐƟŽŶ ŝŶ ĐůŝŶŝĐĂů ƉŶĞƵŵŽŶŝĂ ŝŶ Ă ƉŽƉƵůĂƟŽŶ ǁŝƚŚ ŚŝŐŚ ŶĂƐĂů ĐŽůŽŶŝƐĂƟŽŶ ĚŽ ŶŽƚ ƌĞůĂƚĞ ƚŽ ĐůŝŶŝĐĂů ƐŝŐŶƐ"},{"arc":[[-37.7949981689453,144.949722290039],[-33.8895797729492,151.18212890625]],"countries":["Australia"],"title":"hƉƉĞƌ ĂŝƌǁĂǇ |ŝƌƵƐĞƐ ĂŶĚ ďĂĐƚĞƌŝĂ ĚĞƚĞĐƟŽŶ ŝŶ ĐůŝŶŝĐĂů ƉŶĞƵŵŽŶŝĂ ŝŶ Ă ƉŽƉƵůĂƟŽŶ ǁŝƚŚ ŚŝŐŚ ŶĂƐĂů ĐŽůŽŶŝƐĂƟŽŶ ĚŽ ŶŽƚ ƌĞůĂƚĞ ƚŽ ĐůŝŶŝĐĂů ƐŝŐŶƐ"},{"arc":[[42.9547386169434,-78.8192367553711],[22.3419208526611,91.8058929443359]],"countries":["United States","Bangladesh"],"title":"Assessment of transport stress on cattle travelling a long distance (≈648 km), from Jessore (Indian border) to Chittagong, Bangladesh"},{"arc":[[42.9547386169434,-78.8192367553711],[42.4089393615723,-71.1182174682617]],"countries":["United States"],"title":"Assessment of transport stress on cattle travelling a long distance (≈648 km), from Jessore (Indian border) to Chittagong, Bangladesh"},{"arc":[[22.3419208526611,91.8058929443359],[42.4089393615723,-71.1182174682617]],"countries":["Bangladesh","United States"],"title":"Assessment of transport stress on cattle travelling a long distance (≈648 km), from Jessore (Indian border) to Chittagong, Bangladesh"},{"arc":[[30.5701999664307,104.064758300781],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[30.5701999664307,104.064758300781],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[30.5701999664307,104.064758300781],[36.6514205932617,116.900840759277]],"countries":["China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[30.5701999664307,104.064758300781],[40.6942749023438,-73.9868011474609]],"countries":["China","United States"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[30.5701999664307,104.064758300781],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[30.5701999664307,104.064758300781],[42.2762107849121,-83.7407531738281]],"countries":["United States","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.2802925109863,114.142951965332],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.2802925109863,114.142951965332],[36.6514205932617,116.900840759277]],"countries":["Hong Kong SAR","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.2802925109863,114.142951965332],[40.6942749023438,-73.9868011474609]],"countries":["Hong Kong SAR","United States"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.2802925109863,114.142951965332],[31.2148895263672,121.564643859863]],"countries":["Hong Kong SAR","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.2802925109863,114.142951965332],[42.2762107849121,-83.7407531738281]],"countries":["United States","Hong Kong SAR"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.333080291748,114.191223144531],[36.6514205932617,116.900840759277]],"countries":["Hong Kong SAR","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.333080291748,114.191223144531],[40.6942749023438,-73.9868011474609]],"countries":["Hong Kong SAR","United States"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.333080291748,114.191223144531],[31.2148895263672,121.564643859863]],"countries":["Hong Kong SAR","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[22.333080291748,114.191223144531],[42.2762107849121,-83.7407531738281]],"countries":["United States","Hong Kong SAR"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[36.6514205932617,116.900840759277],[40.6942749023438,-73.9868011474609]],"countries":["China","United States"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[36.6514205932617,116.900840759277],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[36.6514205932617,116.900840759277],[42.2762107849121,-83.7407531738281]],"countries":["United States","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[40.6942749023438,-73.9868011474609],[31.2148895263672,121.564643859863]],"countries":["United States","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[40.6942749023438,-73.9868011474609],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[31.2148895263672,121.564643859863],[42.2762107849121,-83.7407531738281]],"countries":["United States","China"],"title":"-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)"},{"arc":[[29.7095108032227,-95.3981781005859],[-37.7035598754883,145.180358886719]],"countries":["United States","Australia"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[29.7095108032227,-95.3981781005859],[22.6201400756836,120.31226348877]],"countries":["United States","Taiwan"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[-37.7035598754883,145.180358886719],[22.6201400756836,120.31226348877]],"countries":["Australia","Taiwan"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[41.7219505310059,-87.6093215942383],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"A Novel Approach to Clustering Genome Sequences Using Inter-nucleotide Covariance"},{"arc":[[42.3374290466309,-71.1058197021484],[-27.4479598999023,153.016067504883]],"countries":["United States","Australia"],"title":"Using internet search queries for infectious disease surveillance: screening diseases for suitability"},{"arc":[[29.9536991119385,-90.077751159668],[45.5003509521484,-122.686950683594]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[29.9536991119385,-90.077751159668],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[29.9536991119385,-90.077751159668],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[29.9536991119385,-90.077751159668],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[45.5003509521484,-122.686950683594],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[45.5003509521484,-122.686950683594],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[45.5003509521484,-122.686950683594],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[37.8056831359863,-122.268104553223],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[37.8056831359863,-122.268104553223],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[39.0048141479492,-77.0975341796875],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[31.2988891601562,121.499168395996],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[31.2988891601562,121.499168395996],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[31.2988891601562,121.499168395996],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[37.7697296142578,-122.466094970703],[31.2988891601562,121.499168395996]],"countries":["United States","China"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[37.7697296142578,-122.466094970703],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[37.7697296142578,-122.466094970703],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[36.5631141662598,103.735809326172],[28.7162494659424,77.2728576660156]],"countries":["China","India"],"title":"Acute Respiratory Distress Syndrome Induced by a Swine 2009 H1N1 Variant in Mice"},{"arc":[[36.5631141662598,103.735809326172],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[36.5631141662598,103.735809326172],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[23.2024116516113,113.38606262207],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[23.2024116516113,113.38606262207],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[36.5631141662598,103.735809326172],[37.7697296142578,-122.466094970703]],"countries":["China","United States"],"title":"Structural basis for the regulatory function of a complex zinc-binding domain in a replicative arterivirus helicase resembling a nonsense-mediated mRNA decay helicase"},{"arc":[[36.5631141662598,103.735809326172],[52.1658325195312,4.47749996185303]],"countries":["China","Netherlands"],"title":"Structural basis for the regulatory function of a complex zinc-binding domain in a replicative arterivirus helicase resembling a nonsense-mediated mRNA decay helicase"},{"arc":[[36.5631141662598,103.735809326172],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Structural basis for the regulatory function of a complex zinc-binding domain in a replicative arterivirus helicase resembling a nonsense-mediated mRNA decay helicase"},{"arc":[[37.7697296142578,-122.466094970703],[52.1658325195312,4.47749996185303]],"countries":["United States","Netherlands"],"title":"Structural basis for the regulatory function of a complex zinc-binding domain in a replicative arterivirus helicase resembling a nonsense-mediated mRNA decay helicase"},{"arc":[[37.7697296142578,-122.466094970703],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Structural basis for the regulatory function of a complex zinc-binding domain in a replicative arterivirus helicase resembling a nonsense-mediated mRNA decay helicase"},{"arc":[[52.1658325195312,4.47749996185303],[40.0059814453125,116.326812744141]],"countries":["Netherlands","China"],"title":"Structural basis for the regulatory function of a complex zinc-binding domain in a replicative arterivirus helicase resembling a nonsense-mediated mRNA decay helicase"},{"arc":[[36.5631141662598,103.735809326172],[33.8806037902832,113.619728088379]],"countries":["China"],"title":"Complete Genome Sequence of Porcine Epidemic Diarrhea Virus from an Outbreak in a Vaccinated Farm in Shandong, China"},{"arc":[[36.5631141662598,103.735809326172],[19.2065467834473,109.768585205078]],"countries":["China"],"title":"Tropical Medicine and Infectious Disease Endemic Melioidosis in Southern China: Past and Present"},{"arc":[[36.5631141662598,103.735809326172],[23.1312255859375,113.347915649414]],"countries":["China"],"title":"Tropical Medicine and Infectious Disease Endemic Melioidosis in Southern China: Past and Present"},{"arc":[[19.2065467834473,109.768585205078],[23.1312255859375,113.347915649414]],"countries":["China"],"title":"Tropical Medicine and Infectious Disease Endemic Melioidosis in Southern China: Past and Present"},{"arc":[[36.5631141662598,103.735809326172],[37.7697296142578,-122.466094970703]],"countries":["China","United States"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[23.1312255859375,113.347915649414]],"countries":["China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[32.0483512878418,118.79808807373]],"countries":["China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[37.7697296142578,-122.466094970703],[23.1312255859375,113.347915649414]],"countries":["United States","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[37.7697296142578,-122.466094970703],[32.0483512878418,118.79808807373]],"countries":["United States","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[23.1312255859375,113.347915649414],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[23.1312255859375,113.347915649414],[32.0483512878418,118.79808807373]],"countries":["China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[40.9437103271484,40.2619209289551],[32.0483512878418,118.79808807373]],"countries":["Turkey","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[39.0048141479492,-77.0975341796875]],"countries":["China","United States"],"title":"MMDB: annotating protein sequences with Entrez's 3D-structure database"},{"arc":[[36.5631141662598,103.735809326172],[30.5927600860596,114.305252075195]],"countries":["China"],"title":"MMDB: annotating protein sequences with Entrez's 3D-structure database"},{"arc":[[39.0048141479492,-77.0975341796875],[30.5927600860596,114.305252075195]],"countries":["China","United States"],"title":"MMDB: annotating protein sequences with Entrez's 3D-structure database"},{"arc":[[36.5631141662598,103.735809326172],[38.8350486755371,-77.3112411499023]],"countries":["China","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[36.5631141662598,103.735809326172],[23.9117393493652,120.687438964844]],"countries":["China","Taiwan"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[36.5631141662598,103.735809326172],[41.8842506408691,-87.6324462890625]],"countries":["China","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[38.8350486755371,-77.3112411499023],[23.9117393493652,120.687438964844]],"countries":["United States","Taiwan"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[38.8350486755371,-77.3112411499023],[41.8842506408691,-87.6324462890625]],"countries":["United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[23.9117393493652,120.687438964844],[41.8842506408691,-87.6324462890625]],"countries":["Taiwan","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[52.4751586914062,-1.8967000246048],[28.7162494659424,77.2728576660156]],"countries":["United Kingdom","India"],"title":"Characterization of Human Coronavirus Etiology in Chinese Adults with Acute Upper Respiratory Tract Infection by Real-Time RT-PCR Assays"},{"arc":[[52.4751586914062,-1.8967000246048],[27.9949207305908,120.69938659668]],"countries":["United Kingdom","China"],"title":"Characterization of Human Coronavirus Etiology in Chinese Adults with Acute Upper Respiratory Tract Infection by Real-Time RT-PCR Assays"},{"arc":[[28.7162494659424,77.2728576660156],[27.9949207305908,120.69938659668]],"countries":["China","India"],"title":"Characterization of Human Coronavirus Etiology in Chinese Adults with Acute Upper Respiratory Tract Infection by Real-Time RT-PCR Assays"},{"arc":[[40.9437103271484,40.2619209289551],[37.7697296142578,-122.466094970703]],"countries":["Turkey","United States"],"title":"An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism"},{"arc":[[37.7697296142578,-122.466094970703],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism"},{"arc":[[40.9437103271484,40.2619209289551],[52.9340705871582,-1.20404005050659]],"countries":["Turkey","United Kingdom"],"title":"Global miRNA expression profiling of domestic cat livers following acute Toxoplasma gondii infection"},{"arc":[[40.9437103271484,40.2619209289551],[32.9907302856445,112.528511047363]],"countries":["Turkey","China"],"title":"The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain"},{"arc":[[32.9907302856445,112.528511047363],[32.9907302856445,112.528511047363]],"countries":["China"],"title":"The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain"},{"arc":[[40.9437103271484,40.2619209289551],[45.8021583557129,126.535797119141]],"countries":["Turkey","China"],"title":"Significant Interference with Porcine Epidemic Diarrhea Virus Pandemic and Classical Strain Replication in Small-Intestine Epithelial Cells Using an shRNA Expression Vector"},{"arc":[[40.9437103271484,40.2619209289551],[44.0889167785645,113.921737670898]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[30.2741508483887,120.155151367188]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[44.0889167785645,113.921737670898],[30.6250877380371,102.697288513184]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[44.0889167785645,113.921737670898],[30.2741508483887,120.155151367188]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[30.6250877380371,102.697288513184],[30.2741508483887,120.155151367188]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[32.9907302856445,112.528511047363]],"countries":["Turkey","China"],"title":"viruses Regulation of Stress Responses and Translational Control by Coronavirus"},{"arc":[[40.9437103271484,40.2619209289551],[36.0000915527344,-78.9306488037109]],"countries":["Turkey","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[29.7095108032227,-95.3981781005859]],"countries":["Turkey","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[32.9907302856445,112.528511047363]],"countries":["Turkey","China"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[42.0617485046387,-87.6770706176758]],"countries":["Turkey","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[36.0000915527344,-78.9306488037109],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[36.0000915527344,-78.9306488037109],[32.9907302856445,112.528511047363]],"countries":["United States","China"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[36.0000915527344,-78.9306488037109],[42.0617485046387,-87.6770706176758]],"countries":["United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[29.7095108032227,-95.3981781005859],[32.9907302856445,112.528511047363]],"countries":["United States","China"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[29.7095108032227,-95.3981781005859],[42.0617485046387,-87.6770706176758]],"countries":["United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[32.9907302856445,112.528511047363],[42.0617485046387,-87.6770706176758]],"countries":["China","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[9.36855030059814,-83.6394882202148]],"countries":["Turkey","Costa Rica"],"title":"Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population"},{"arc":[[40.9437103271484,40.2619209289551],[39.0010192365134,-77.0841755726199]],"countries":["Turkey","United States"],"title":"Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population"},{"arc":[[9.36855030059814,-83.6394882202148],[39.0010192365134,-77.0841755726199]],"countries":["Costa Rica","United States"],"title":"Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"viruses Review From SARS to MERS, Thrusting Coronaviruses into the Spotlight"},{"arc":[[39.9046897888184,116.407173156738],[45.8021583557129,126.535797119141]],"countries":["China"],"title":"Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice"},{"arc":[[39.9046897888184,116.407173156738],[44.3065299987793,86.0789337158203]],"countries":["China"],"title":"Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells"},{"arc":[[39.9046897888184,116.407173156738],[43.8378410339355,126.549438476562]],"countries":["China"],"title":"Molecular Characterization and Phylogenetic Analysis of New Variants of the Porcine Epidemic Diarrhea Virus in Gansu, China in 2012"},{"arc":[[39.9046897888184,116.407173156738],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Molecular Characterization and Phylogenetic Analysis of New Variants of the Porcine Epidemic Diarrhea Virus in Gansu, China in 2012"},{"arc":[[43.8378410339355,126.549438476562],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Molecular Characterization and Phylogenetic Analysis of New Variants of the Porcine Epidemic Diarrhea Virus in Gansu, China in 2012"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Modeling Heterogeneity in Direct Infectious Disease Transmission in a Compartmental Model"},{"arc":[[37.7697296142578,-122.466094970703],[54.6490783691406,-8.43280029296875]],"countries":["United States","Ireland"],"title":"Modeling Heterogeneity in Direct Infectious Disease Transmission in a Compartmental Model"},{"arc":[[37.7697296142578,-122.466094970703],[60.1698989868164,24.9490509033203]],"countries":["United States","Finland"],"title":"Bid-deficient fish delay grass carp reovirus (GCRV) replication and attenuate GCRV-triggered apoptosis"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Adenoviral vector-based strategies against infectious disease and cancer"},{"arc":[[37.7697296142578,-122.466094970703],[17.33934,78.413]],"countries":["United States","India"],"title":"Surveillance for respiratory infectious diseases caused by 6 common viruses in a recruit training site in the Northern region of China"},{"arc":[[37.7697296142578,-122.466094970703],[36.5631141662598,103.735809326172]],"countries":["China","United States"],"title":"Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3 OPEN"},{"arc":[[37.7697296142578,-122.466094970703],[41.5059089660645,-81.6090927124023]],"countries":["United States"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[50.5807495117188,8.67675018310547]],"countries":["United States","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[39.1381492614746,117.150108337402]],"countries":["United States","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[25.8856201171875,116.02709197998]],"countries":["United States","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[39.2892150878906,117.349395751953]],"countries":["United States","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[53.8391494750977,10.7079601287842]],"countries":["United States","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[51.7589988708496,-1.26400005817413]],"countries":["United States","United Kingdom"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[41.5059089660645,-81.6090927124023],[50.5807495117188,8.67675018310547]],"countries":["United States","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[41.5059089660645,-81.6090927124023],[39.1381492614746,117.150108337402]],"countries":["United States","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[41.5059089660645,-81.6090927124023],[25.8856201171875,116.02709197998]],"countries":["United States","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[41.5059089660645,-81.6090927124023],[39.2892150878906,117.349395751953]],"countries":["China","United States"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[41.5059089660645,-81.6090927124023],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[41.5059089660645,-81.6090927124023],[53.8391494750977,10.7079601287842]],"countries":["United States","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[41.5059089660645,-81.6090927124023],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","United States"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[50.5807495117188,8.67675018310547],[39.1381492614746,117.150108337402]],"countries":["Germany","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[50.5807495117188,8.67675018310547],[25.8856201171875,116.02709197998]],"countries":["Germany","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[50.5807495117188,8.67675018310547],[39.2892150878906,117.349395751953]],"countries":["China","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[50.5807495117188,8.67675018310547],[40.0059814453125,116.326812744141]],"countries":["Germany","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[50.5807495117188,8.67675018310547],[53.8391494750977,10.7079601287842]],"countries":["Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[50.5807495117188,8.67675018310547],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.1381492614746,117.150108337402],[25.8856201171875,116.02709197998]],"countries":["China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.1381492614746,117.150108337402],[39.2892150878906,117.349395751953]],"countries":["China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.1381492614746,117.150108337402],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.1381492614746,117.150108337402],[53.8391494750977,10.7079601287842]],"countries":["China","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.1381492614746,117.150108337402],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[25.8856201171875,116.02709197998],[39.2892150878906,117.349395751953]],"countries":["China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[25.8856201171875,116.02709197998],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[25.8856201171875,116.02709197998],[53.8391494750977,10.7079601287842]],"countries":["China","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[25.8856201171875,116.02709197998],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.2892150878906,117.349395751953],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.2892150878906,117.349395751953],[53.8391494750977,10.7079601287842]],"countries":["China","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[39.2892150878906,117.349395751953],[51.7589988708496,-1.26400005817413]],"countries":["China","United Kingdom"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[40.0059814453125,116.326812744141],[53.8391494750977,10.7079601287842]],"countries":["China","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[40.0059814453125,116.326812744141],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","China"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[53.8391494750977,10.7079601287842],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Germany"],"title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases"},{"arc":[[37.7697296142578,-122.466094970703],[32.0583801269531,118.79647064209]],"countries":["United States","China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[37.7697296142578,-122.466094970703],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[37.7697296142578,-122.466094970703],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[32.0583801269531,118.79647064209],[39.0048141479492,-77.0975341796875]],"countries":["China","United States"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[32.0583801269531,118.79647064209],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[39.0048141479492,-77.0975341796875],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[37.7697296142578,-122.466094970703],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[37.7697296142578,-122.466094970703],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[37.7697296142578,-122.466094970703],[22.5732707977295,88.3621826171875]],"countries":["United States","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[28.7162494659424,77.2728576660156],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[28.7162494659424,77.2728576660156],[22.5732707977295,88.3621826171875]],"countries":["India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[22.2802925109863,114.142951965332],[22.5732707977295,88.3621826171875]],"countries":["Hong Kong SAR","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[37.7697296142578,-122.466094970703],[31.5884895324707,120.357612609863]],"countries":["United States","China"],"title":"Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)"},{"arc":[[37.7697296142578,-122.466094970703],[29.5647106170654,106.550727844238]],"countries":["United States","China"],"title":"Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)"},{"arc":[[31.5884895324707,120.357612609863],[29.5647106170654,106.550727844238]],"countries":["China"],"title":"Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)"},{"arc":[[37.7697296142578,-122.466094970703],[39.9925537109375,116.310485839844]],"countries":["United States","China"],"title":"Evaluation of Public Health Emergency Management in China: A Systematic Review"},{"arc":[[37.7697296142578,-122.466094970703],[30.6250877380371,102.697288513184]],"countries":["United States","China"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[37.7697296142578,-122.466094970703],[44.3972511291504,-69.5694427490234]],"countries":["United States"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[30.6250877380371,102.697288513184],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[37.7697296142578,-122.466094970703],[31.2988891601562,121.499168395996]],"countries":["United States","China"],"title":"A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV"},{"arc":[[37.7697296142578,-122.466094970703],[21.1991405487061,81.2897262573242]],"countries":["United States","India"],"title":"A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[21.1991405487061,81.2897262573242]],"countries":["China","India"],"title":"A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV"},{"arc":[[37.7697296142578,-122.466094970703],[26.029390335083,118.138877868652]],"countries":["United States","China"],"title":"Article 1843-L (2019) Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6"},{"arc":[[37.7697296142578,-122.466094970703],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Article 1843-L (2019) Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6"},{"arc":[[26.029390335083,118.138877868652],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Article 1843-L (2019) Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine"},{"arc":[[37.7697296142578,-122.466094970703],[30.5927600860596,114.305252075195]],"countries":["United States","China"],"title":"Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine"},{"arc":[[40.9437103271484,40.2619209289551],[30.5927600860596,114.305252075195]],"countries":["Turkey","China"],"title":"Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine"},{"arc":[[37.7697296142578,-122.466094970703],[32.0583801269531,118.79647064209]],"countries":["United States","China"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[37.7697296142578,-122.466094970703],[38.9997596740723,-77.0832443237305]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[37.7697296142578,-122.466094970703],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[37.7697296142578,-122.466094970703],[35.140251159668,-90.0300979614258]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[32.0583801269531,118.79647064209],[38.9997596740723,-77.0832443237305]],"countries":["China","United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[32.0583801269531,118.79647064209],[39.4959106445312,-98.9899826049805]],"countries":["China","United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[32.0583801269531,118.79647064209],[35.140251159668,-90.0300979614258]],"countries":["China","United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[38.9997596740723,-77.0832443237305],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[38.9997596740723,-77.0832443237305],[35.140251159668,-90.0300979614258]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[39.4959106445312,-98.9899826049805],[35.140251159668,-90.0300979614258]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Citation: Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression"},{"arc":[[37.7697296142578,-122.466094970703],[39.2892150878906,117.349395751953]],"countries":["United States","China"],"title":"Citation: Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression"},{"arc":[[40.9437103271484,40.2619209289551],[39.2892150878906,117.349395751953]],"countries":["Turkey","China"],"title":"Citation: Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression"},{"arc":[[35.9628207555179,-88.9393164950906],[9.36855030059814,-83.6394882202148]],"countries":["United States","Costa Rica"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[35.9628207555179,-88.9393164950906],[41.7278709411621,44.764778137207]],"countries":["Georgia","United States"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[9.36855030059814,-83.6394882202148],[41.7278709411621,44.764778137207]],"countries":["Georgia","Costa Rica"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[22.2802925109863,114.142951965332],[22.3796997070312,114.201698303223]],"countries":["Hong Kong SAR"],"title":"Immunofluorescence Assay for Serologic Diagnosis of SARS"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Immunofluorescence Assay for Serologic Diagnosis of SARS"},{"arc":[[22.3796997070312,114.201698303223],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Immunofluorescence Assay for Serologic Diagnosis of SARS"},{"arc":[[35.7442817687988,127.166305541992],[35.7442817687988,127.166305541992]],"countries":["South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[35.7442817687988,127.166305541992],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[35.7442817687988,127.166305541992],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[36.4511566162109,127.861145019531],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[29.5647106170654,106.550727844238],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China"},{"arc":[[29.5647106170654,106.550727844238],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China"},{"arc":[[39.9925537109375,116.310485839844],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China"},{"arc":[[34.8679008483887,126.990997314453],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Development of Lectin-Linked Immunomagnetic Separation for the Detection of Hepatitis A Virus"},{"arc":[[34.8679008483887,126.990997314453],[37.498367,126.675769]],"countries":["South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[34.8679008483887,126.990997314453],[42.6500015258789,-7.33330011367798]],"countries":["Spain","South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[34.8679008483887,126.990997314453],[29.7095108032227,-95.3981781005859]],"countries":["United States","South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[34.8679008483887,126.990997314453],[39.73878,-75.06354]],"countries":["South Korea","United States"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[34.8679008483887,126.990997314453],[37.374783,127.131108]],"countries":["South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[37.498367,126.675769],[42.6500015258789,-7.33330011367798]],"countries":["Spain","South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[37.498367,126.675769],[29.7095108032227,-95.3981781005859]],"countries":["United States","South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[37.498367,126.675769],[39.73878,-75.06354]],"countries":["South Korea","United States"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[37.498367,126.675769],[37.374783,127.131108]],"countries":["South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[42.6500015258789,-7.33330011367798],[29.7095108032227,-95.3981781005859]],"countries":["United States","Spain"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[42.6500015258789,-7.33330011367798],[39.73878,-75.06354]],"countries":["Spain","United States"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[42.6500015258789,-7.33330011367798],[37.374783,127.131108]],"countries":["Spain","South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[29.7095108032227,-95.3981781005859],[39.73878,-75.06354]],"countries":["United States"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[29.7095108032227,-95.3981781005859],[37.374783,127.131108]],"countries":["United States","South Korea"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[39.73878,-75.06354],[37.374783,127.131108]],"countries":["South Korea","United States"],"title":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea"},{"arc":[[48.8221206665039,2.33101010322571],[29.649730682373,-82.3411331176758]],"countries":["France","United States"],"title":"Complete Genome Sequence of Human Coronavirus Strain 229E Isolated from Plasma Collected from a Haitian Child in 2016"},{"arc":[[42.9547386169434,-78.8192367553711],[41.6625213623047,-91.536506652832]],"countries":["United States"],"title":"Negative Immunomodulatory Effects of Type 2 Porcine Reproductive and Respiratory Syndrome Virus-Induced Interleukin-1 Receptor Antagonist on Porcine Innate and Adaptive Immune Functions"},{"arc":[[36.662978,126.755133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.662978,126.755133],[36.755867,126.30135]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.662978,126.755133],[38.069639,128.173325]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.662978,126.755133],[33.4749794006348,126.530693054199]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[36.755867,126.30135]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[38.069639,128.173325]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[33.4749794006348,126.530693054199]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.755867,126.30135],[38.069639,128.173325]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.755867,126.30135],[33.4749794006348,126.530693054199]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[38.069639,128.173325],[33.4749794006348,126.530693054199]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[35.856219,126.988803],[36.662978,126.755133]],"countries":["South Korea"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[35.856219,126.988803],[26.8637504577637,78.9172210693359]],"countries":["South Korea","India"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[35.856219,126.988803],[46.9460830688477,7.43722105026245]],"countries":["South Korea","Switzerland"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[36.662978,126.755133],[26.8637504577637,78.9172210693359]],"countries":["South Korea","India"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[36.662978,126.755133],[46.9460830688477,7.43722105026245]],"countries":["South Korea","Switzerland"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[26.8637504577637,78.9172210693359],[46.9460830688477,7.43722105026245]],"countries":["Switzerland","India"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[36.7909545898438,126.799468994141],[36.662978,126.755133]],"countries":["South Korea"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.7909545898438,126.799468994141],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.7909545898438,126.799468994141],[35.985864,128.914808]],"countries":["South Korea"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.662978,126.755133],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.662978,126.755133],[35.985864,128.914808]],"countries":["South Korea"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[31.3634490966797,75.5509414672852],[35.985864,128.914808]],"countries":["South Korea","India"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.662978,126.755133],[35.0564117431641,127.960624694824]],"countries":["South Korea"],"title":"Healthcare worker infected with Middle East respiratory syndrome during cardiopulmonary resuscitation in Korea, 2015 심폐소생술 시행 중 MERS-CoV에 감염된 의료인 사례"},{"arc":[[39.1410217285156,-84.5021362304688],[-25.4304790496826,-49.2845115661621]],"countries":["United States","Brazil"],"title":"Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province, China: an observational study utilizing crowdsourced data"},{"arc":[[40.7145500183105,-74.0071411132812],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Icariin promotes osteogenic differentiation of BMSCs by upregulating BMAL1 expression via BMP signaling"},{"arc":[[40.7145500183105,-74.0071411132812],[38.8238296508789,-77.0224227905273]],"countries":["United States"],"title":"Icariin promotes osteogenic differentiation of BMSCs by upregulating BMAL1 expression via BMP signaling"},{"arc":[[40.9437103271484,40.2619209289551],[38.8238296508789,-77.0224227905273]],"countries":["Turkey","United States"],"title":"Icariin promotes osteogenic differentiation of BMSCs by upregulating BMAL1 expression via BMP signaling"},{"arc":[[22.3337936154897,114.179224932647],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Hong Kong-China"],"title":"Molecular Evolution of MERS Coronavirus: Dromedaries as a Recent Intermediate Host or Long-Time Animal Reservoir?"},{"arc":[[41.5047302246094,-81.6907424926758],[51.1218070983887,10.4006948471069]],"countries":["Germany","United States"],"title":"Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L"},{"arc":[[41.5047302246094,-81.6907424926758],[41.5059089660645,-81.6090927124023]],"countries":["United States"],"title":"RNase L restricts the mobility of engineered retrotransposons in cultured human cells"},{"arc":[[41.8346481323242,-90.2125396728516],[53.9260635375977,-9.3884744644165]],"countries":["United States","Ireland"],"title":"Citation: Molecular Therapy-Nucleic Acids (2013) 2, e133"},{"arc":[[41.8346481323242,-90.2125396728516],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","United States"],"title":"Citation: Molecular Therapy-Nucleic Acids (2013) 2, e133"},{"arc":[[53.9260635375977,-9.3884744644165],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Ireland"],"title":"Citation: Molecular Therapy-Nucleic Acids (2013) 2, e133"},{"arc":[[30.7602596282959,47.6596298217773],[33.5566825866699,23.774206161499]],"countries":["Iraq","NOCOUNTRY"],"title":"Detection of Plant DNA in the Bronchoalveolar Lavage of Patients with Ventilator-Associated Pneumonia"},{"arc":[[38.8465995788574,-104.824287414551],[43.7031517028809,-72.2894134521484]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[38.8465995788574,-104.824287414551],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[38.8465995788574,-104.824287414551],[47.6035690307617,-122.329452514648]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[38.8465995788574,-104.824287414551],[37.5514907836914,-77.4517974853516]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[43.7031517028809,-72.2894134521484],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[43.7031517028809,-72.2894134521484],[47.6035690307617,-122.329452514648]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[43.7031517028809,-72.2894134521484],[37.5514907836914,-77.4517974853516]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[44.9948196411133,-93.41455078125],[47.6035690307617,-122.329452514648]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[44.9948196411133,-93.41455078125],[37.5514907836914,-77.4517974853516]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[47.6035690307617,-122.329452514648],[37.5514907836914,-77.4517974853516]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[39.6785011291504,-104.966621398926],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[40.4118385314941,-104.692291259766]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[40.4118385314941,-104.692291259766]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[43.9649963378906,-112.343688964844],[40.4118385314941,-104.692291259766]],"countries":["NOCOUNTRY","United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[37.6757011413574,-121.758560180664]],"countries":["United States"],"title":"Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants"},{"arc":[[39.6785011291504,-104.966621398926],[22.4931182861328,79.7270126342773]],"countries":["United States","India"],"title":"viruses Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine"},{"arc":[[39.6785011291504,-104.966621398926],[43.1265411376953,-77.6315383911133]],"countries":["United States"],"title":"viruses Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine"},{"arc":[[22.4931182861328,79.7270126342773],[43.1265411376953,-77.6315383911133]],"countries":["India","United States"],"title":"viruses Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine"},{"arc":[[40.8081588745117,-73.9636535644531],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[40.8081588745117,-73.9636535644531],[1.29041004180908,103.852111816406]],"countries":["United States","Singapore"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[40.8081588745117,-73.9636535644531],[1.27851998806,103.83464050293]],"countries":["United States","Singapore"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[40.8081588745117,-73.9636535644531],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","United States"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[35.7868995666504,-93.9436416625977],[1.29041004180908,103.852111816406]],"countries":["United States","Singapore"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[35.7868995666504,-93.9436416625977],[1.27851998806,103.83464050293]],"countries":["United States","Singapore"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[35.7868995666504,-93.9436416625977],[52.3687591552734,4.89012002944946]],"countries":["United States","Netherlands"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[1.29041004180908,103.852111816406],[1.27851998806,103.83464050293]],"countries":["Singapore"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[1.29041004180908,103.852111816406],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Singapore"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[1.27851998806,103.83464050293],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Singapore"],"title":"BMC Infectious Diseases Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003"},{"arc":[[40.8081588745117,-73.9636535644531],[40.8075561523438,-73.9640808105469]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8081588745117,-73.9636535644531],[42.9370803833008,-75.6106948852539]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8075561523438,-73.9640808105469],[42.9370803833008,-75.6106948852539]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8081588745117,-73.9636535644531],[33.2227516174316,107.54564666748]],"countries":["United States","China"],"title":"The N-terminal domains of FLASH and Lsm11 form a 2:1 heterotrimer for histone pre-mRNA 3'-end processing"},{"arc":[[40.8081588745117,-73.9636535644531],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"The N-terminal domains of FLASH and Lsm11 form a 2:1 heterotrimer for histone pre-mRNA 3'-end processing"},{"arc":[[33.2227516174316,107.54564666748],[35.9053153991699,-79.0477142333984]],"countries":["China","United States"],"title":"The N-terminal domains of FLASH and Lsm11 form a 2:1 heterotrimer for histone pre-mRNA 3'-end processing"},{"arc":[[40.8075561523438,-73.9640808105469],[7.50905990600586,16.0927104949951]],"countries":["United States","Central African Republic"],"title":"336 | Influenza Other Respi Viruses"},{"arc":[[47.4847412109375,1.68438005447388],[1.32175004482269,103.846237182617]],"countries":["France","Singapore"],"title":"Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts"},{"arc":[[40.152660369873,-80.2116928100586],[51.1082496643066,17.0269107818604]],"countries":["United States","Poland"],"title":"Production of Recombinant EAV with Tagged Structural Protein Gp3 to Study Artervirus Minor Protein Localization in Infected Cells"},{"arc":[[51.1218070983887,10.4006948471069],[30.6250877380371,102.697288513184]],"countries":["Germany","China"],"title":"Mannosylated Lipid Nano-emulsions Loaded with Ly- corine-oleic Acid Ionic Complex for Tumor Cell-specific Delivery"},{"arc":[[30.6250877380371,102.697288513184],[30.6250877380371,102.697288513184]],"countries":["China"],"title":"Mannosylated Lipid Nano-emulsions Loaded with Ly- corine-oleic Acid Ionic Complex for Tumor Cell-specific Delivery"},{"arc":[[51.88564,-8.53312],[41.750358581543,-72.6930084228516]],"countries":["Ireland","United States"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[51.88564,-8.53312],[53.3086013793945,-6.22065019607544]],"countries":["Ireland"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[41.750358581543,-72.6930084228516],[53.3086013793945,-6.22065019607544]],"countries":["United States","Ireland"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[42.4463500976562,-76.4826889038086],[30.6250877380371,102.697288513184]],"countries":["United States","China"],"title":"Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71 a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 OPEN ACCESS"},{"arc":[[42.4463500976562,-76.4826889038086],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[42.4463500976562,-76.4826889038086],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","United States"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[42.4463500976562,-76.4826889038086],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[22.333080291748,114.191223144531],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[40.7182693481445,46.4133987426758],[22.2802925109863,114.142951965332]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[52.2457656860352,5.56521511077881],[42.95438,-74.19623]],"countries":["Netherlands","United States"],"title":"Generation of stable monoclonal antibody-producing BCR + human memory B cells by genetic programming Supplementary Figures 1-2 Supplementary Methods Supplementary Reference"},{"arc":[[22.4975490570068,88.3702697753906],[22.5259609222412,88.3634872436523]],"countries":["India"],"title":"Para-Phenylenediamine Induces Apoptotic Death of Melanoma Cells and Reduces Melanoma Tumour Growth in Mice"},{"arc":[[-31.9540615081787,115.863220214844],[35.7868995666504,-93.9436416625977]],"countries":["United States","Australia"],"title":"The Global Outbreak Alert and Response Network"},{"arc":[[44.6344795227051,-63.5939788818359],[13.0170698165894,77.6431198120117]],"countries":["Canada","India"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[43.9649963378906,-112.343688964844]],"countries":["Canada","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[23.3535003662109,116.68221282959]],"countries":["Canada","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[40.72495,8.56011]],"countries":["Canada","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[35.7868995666504,-93.9436416625977]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[49.8096008300781,-97.1333312988281]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[43.9649963378906,-112.343688964844]],"countries":["India","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[23.3535003662109,116.68221282959]],"countries":["India","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[40.72495,8.56011]],"countries":["India","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[35.7868995666504,-93.9436416625977]],"countries":["United States","India"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[49.8096008300781,-97.1333312988281]],"countries":["India","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[52.1374397277832,-106.627517700195]],"countries":["India","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[23.3535003662109,116.68221282959]],"countries":["China","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[40.72495,8.56011]],"countries":["NOCOUNTRY","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[35.7868995666504,-93.9436416625977]],"countries":["United States","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[49.8096008300781,-97.1333312988281]],"countries":["NOCOUNTRY","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[52.1374397277832,-106.627517700195]],"countries":["NOCOUNTRY","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[40.72495,8.56011]],"countries":["China","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[35.7868995666504,-93.9436416625977]],"countries":["United States","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[49.8096008300781,-97.1333312988281]],"countries":["China","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[52.1374397277832,-106.627517700195]],"countries":["China","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[35.7868995666504,-93.9436416625977]],"countries":["United States","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[49.8096008300781,-97.1333312988281]],"countries":["Italy","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[52.1374397277832,-106.627517700195]],"countries":["Italy","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[35.7868995666504,-93.9436416625977],[49.8096008300781,-97.1333312988281]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[35.7868995666504,-93.9436416625977],[52.1374397277832,-106.627517700195]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[49.8096008300781,-97.1333312988281],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[16.0479698181152,108.210708618164],[33.5566825866699,23.774206161499]],"countries":["Vietnam","NOCOUNTRY"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[16.0479698181152,108.210708618164],[16.1676921844482,107.839050292969]],"countries":["Vietnam"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[16.0479698181152,108.210708618164],[-12.9141798019409,-38.3351287841797]],"countries":["Vietnam","Brazil"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[33.5566825866699,23.774206161499],[33.5566825866699,23.774206161499]],"countries":["NOCOUNTRY"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[33.5566825866699,23.774206161499],[16.1676921844482,107.839050292969]],"countries":["NOCOUNTRY","Vietnam"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[33.5566825866699,23.774206161499],[-12.9141798019409,-38.3351287841797]],"countries":["NOCOUNTRY","Brazil"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[16.1676921844482,107.839050292969],[16.1676921844482,107.839050292969]],"countries":["Vietnam"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[16.1676921844482,107.839050292969],[-12.9141798019409,-38.3351287841797]],"countries":["Vietnam","Brazil"],"title":"Prospective case-control analysis of the aetiologies of acute undifferentiated fever in Vietnam"},{"arc":[[-37.8466987609863,145.120620727539],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[-37.8466987609863,145.120620727539],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[40.9437103271484,40.2619209289551],[-37.797981262207,144.959045410156]],"countries":["Turkey","Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[45.6480598449707,-76.3253326416016],[32.9052963256836,-117.243560791016]],"countries":["Canada","United States"],"title":"Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases -evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore"},{"arc":[[45.6480598449707,-76.3253326416016],[1.29718005657196,103.77774810791]],"countries":["Canada","Singapore"],"title":"Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases -evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore"},{"arc":[[32.9052963256836,-117.243560791016],[1.29718005657196,103.77774810791]],"countries":["Singapore","United States"],"title":"Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases -evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore"},{"arc":[[39.9407119750977,116.43531036377],[39.2892150878906,117.349395751953]],"countries":["China"],"title":"Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review"},{"arc":[[39.9407119750977,116.43531036377],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review"},{"arc":[[39.2892150878906,117.349395751953],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review"},{"arc":[[46.9460830688477,7.43722105026245],[44.8185195922852,5.94749021530151]],"countries":["Switzerland","France"],"title":"Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study"},{"arc":[[46.9460830688477,7.43722105026245],[32.9052963256836,-117.243560791016]],"countries":["Switzerland","United States"],"title":"Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study"},{"arc":[[46.9460830688477,7.43722105026245],[36.4687042236328,118.517120361328]],"countries":["Switzerland","China"],"title":"Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study"},{"arc":[[44.8185195922852,5.94749021530151],[32.9052963256836,-117.243560791016]],"countries":["United States","France"],"title":"Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study"},{"arc":[[44.8185195922852,5.94749021530151],[36.4687042236328,118.517120361328]],"countries":["France","China"],"title":"Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study"},{"arc":[[32.9052963256836,-117.243560791016],[36.4687042236328,118.517120361328]],"countries":["United States","China"],"title":"Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study"},{"arc":[[36.0000915527344,-78.9306488037109],[22.3796997070312,114.201698303223]],"countries":["United States","Hong Kong SAR"],"title":"A Mini Review of the Zoonotic Threat Potential of influenza viruses, Coronaviruses, Adenoviruses, and enteroviruses"},{"arc":[[36.0000915527344,-78.9306488037109],[1.27851998806,103.83464050293]],"countries":["United States","Singapore"],"title":"Open Forum Infectious Diseases Bioaerosol Sampling in Clinical Settings: A Promising, Noninvasive Approach for Detecting Respiratory Viruses"},{"arc":[[36.0000915527344,-78.9306488037109],[41.9302787780762,12.4297218322754]],"countries":["United States","Italy"],"title":"Open Forum Infectious Diseases Bioaerosol Sampling in Clinical Settings: A Promising, Noninvasive Approach for Detecting Respiratory Viruses"},{"arc":[[1.27851998806,103.83464050293],[41.9302787780762,12.4297218322754]],"countries":["Singapore","Italy"],"title":"Open Forum Infectious Diseases Bioaerosol Sampling in Clinical Settings: A Promising, Noninvasive Approach for Detecting Respiratory Viruses"},{"arc":[[42.7586784362793,-82.483512878418],[23.8029747009277,108.794311523438]],"countries":["China","United States"],"title":"Non-periodic outbreaks of recurrent epidemics and its network modelling OPEN"},{"arc":[[42.7586784362793,-82.483512878418],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Non-periodic outbreaks of recurrent epidemics and its network modelling OPEN"},{"arc":[[23.8029747009277,108.794311523438],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Non-periodic outbreaks of recurrent epidemics and its network modelling OPEN"},{"arc":[[40.9215507507324,-81.105842590332],[41.6771812438965,123.463096618652]],"countries":["China","United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[40.9215507507324,-81.105842590332],[8.51776,76.94091]],"countries":["United States","India"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[40.9215507507324,-81.105842590332],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[41.6771812438965,123.463096618652],[8.51776,76.94091]],"countries":["China","India"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[41.6771812438965,123.463096618652],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[8.51776,76.94091],[44.9734497070312,-93.2378997802734]],"countries":["India","United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[48.8330574035645,2.36277794837952],[43.6319427490234,3.86388897895813]],"countries":["France"],"title":"ARTICLE Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities"},{"arc":[[48.8330574035645,2.36277794837952],[48.8769454956055,2.35916709899902]],"countries":["France"],"title":"ARTICLE Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities"},{"arc":[[43.6319427490234,3.86388897895813],[48.8769454956055,2.35916709899902]],"countries":["France"],"title":"ARTICLE Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities"},{"arc":[[55.9543800354004,-3.20144009590149],[55.9219360351562,-3.13511395454407]],"countries":["United Kingdom"],"title":"Association between viral seasonality and meteorological factors"},{"arc":[[55.9543800354004,-3.20144009590149],[55.9622459411621,-3.23477005958557]],"countries":["United Kingdom"],"title":"Association between viral seasonality and meteorological factors"},{"arc":[[55.9219360351562,-3.13511395454407],[55.9622459411621,-3.23477005958557]],"countries":["United Kingdom"],"title":"Association between viral seasonality and meteorological factors"},{"arc":[[4.58086013793945,-74.4432830810547],[0.335489988327026,32.5687217712402]],"countries":["Colombia","Uganda"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[4.58086013793945,-74.4432830810547],[45.5065994262695,-73.5779571533203]],"countries":["Colombia","Canada"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[0.335489988327026,32.5687217712402],[45.5065994262695,-73.5779571533203]],"countries":["Uganda","Canada"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[53.3506660461426,7.15311288833618],[41.9015502929688,12.5122203826904]],"countries":["Germany","Italy"],"title":"IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS"},{"arc":[[33.789680480957,-84.3255462646484],[33.7483100891113,-84.39111328125]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[33.7713203430176,-84.3944091796875]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[33.7713203430176,-84.3944091796875]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7713203430176,-84.3944091796875],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7713203430176,-84.3944091796875],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7713203430176,-84.3944091796875],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[-37.7035598754883,145.180358886719],[39.4959106445312,-98.9899826049805]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[-37.7035598754883,145.180358886719],[43.0754890441895,-89.4199829101562]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[39.4959106445312,-98.9899826049805],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Recombinant vector vaccines and within-host evolution 1"},{"arc":[[33.789680480957,-84.3255462646484],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"Case Investigations of Infectious Diseases Occurring in Workplaces, United States, 2006-2015 A Tale of Two Kitchens, Meals, and Microbes"},{"arc":[[33.789680480957,-84.3255462646484],[40.1836891174316,-80.2459411621094]],"countries":["United States"],"title":"Case Investigations of Infectious Diseases Occurring in Workplaces, United States, 2006-2015 A Tale of Two Kitchens, Meals, and Microbes"},{"arc":[[28.7162494659424,77.2728576660156],[40.1836891174316,-80.2459411621094]],"countries":["India","United States"],"title":"Case Investigations of Infectious Diseases Occurring in Workplaces, United States, 2006-2015 A Tale of Two Kitchens, Meals, and Microbes"},{"arc":[[33.7933692932129,-84.3221282958984],[38.5272941589355,-121.766967773438]],"countries":["United States"],"title":"The Search for a Practical Approach to Emerging Diseases: The Case of Severe Acute Respiratory Syndrome (SARS)"},{"arc":[[33.7933692932129,-84.3221282958984],[45.4602432250977,9.19415855407715]],"countries":["United States","Italy"],"title":"The Search for a Practical Approach to Emerging Diseases: The Case of Severe Acute Respiratory Syndrome (SARS)"},{"arc":[[38.5272941589355,-121.766967773438],[45.4602432250977,9.19415855407715]],"countries":["Italy","United States"],"title":"The Search for a Practical Approach to Emerging Diseases: The Case of Severe Acute Respiratory Syndrome (SARS)"},{"arc":[[33.7483100891113,-84.39111328125],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[0.537028014659882,37.8567771911621]],"countries":["United States","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[40.9437103271484,40.2619209289551],[0.537028014659882,37.8567771911621]],"countries":["Turkey","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[40.9437103271484,40.2619209289551],[39.4959106445312,-98.9899826049805]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[39.4959106445312,-98.9899826049805]],"countries":["United States","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[42.9547386169434,-78.8192367553711],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Online Resource Supplemental Material 1 Acta Neuropathologica Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms"},{"arc":[[51.9100685119629,4.46534013748169],[51.9100685119629,4.46534013748169]],"countries":["Netherlands"],"title":"Functional Genomics Highlights Differential Induction of Antiviral Pathways in the Lungs of SARS-CoV-Infected Macaques"},{"arc":[[51.9100685119629,4.46534013748169],[47.6565093994141,-122.312088012695]],"countries":["Netherlands","United States"],"title":"Functional Genomics Highlights Differential Induction of Antiviral Pathways in the Lungs of SARS-CoV-Infected Macaques"},{"arc":[[51.9100685119629,4.46534013748169],[50.5807495117188,8.67675018310547]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[55.6972007751465,37.5378494262695]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[41.9982795715332,-87.6571731567383]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[50.7338905334473,7.10222196578979]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[38.987850189209,-76.9389038085938]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[51.4414596557617,-0.947839975357056]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[52.1658325195312,4.47749996185303]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[55.6972007751465,37.5378494262695]],"countries":["Germany","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[41.9982795715332,-87.6571731567383]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[38.987850189209,-76.9389038085938]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[51.4414596557617,-0.947839975357056]],"countries":["Germany","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[52.08896,5.1784]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[55.6972007751465,37.5378494262695]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[41.9982795715332,-87.6571731567383]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[50.7338905334473,7.10222196578979]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[38.987850189209,-76.9389038085938]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[51.4414596557617,-0.947839975357056]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[41.9982795715332,-87.6571731567383]],"countries":["Russia","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[50.7338905334473,7.10222196578979]],"countries":["Russia","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[38.987850189209,-76.9389038085938]],"countries":["Russia","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[51.4414596557617,-0.947839975357056]],"countries":["Russia","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[52.08896,5.1784]],"countries":["Russia","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[38.987850189209,-76.9389038085938]],"countries":["United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[51.4414596557617,-0.947839975357056]],"countries":["United States","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[52.08896,5.1784]],"countries":["United States","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[38.987850189209,-76.9389038085938]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[51.4414596557617,-0.947839975357056]],"countries":["Germany","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[52.08896,5.1784]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[51.4414596557617,-0.947839975357056]],"countries":["United States","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[52.08896,5.1784]],"countries":["United States","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.4414596557617,-0.947839975357056],[52.08896,5.1784]],"countries":["United Kingdom","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[27.7711906433105,-82.6387634277344]],"countries":["Netherlands","United States"],"title":"Cryptococcus gattii VGIIb-like Variant in White-Tailed Deer, Nova Scotia, Canada"},{"arc":[[51.9100685119629,4.46534013748169],[51.9100685119629,4.46534013748169]],"countries":["Netherlands"],"title":"Seoul Virus Tropism and Pathology in Naturally Infected Feeder Rats"},{"arc":[[51.9100685119629,4.46534013748169],[28.7162494659424,77.2728576660156]],"countries":["Netherlands","India"],"title":"Seoul Virus Tropism and Pathology in Naturally Infected Feeder Rats"},{"arc":[[51.9100685119629,4.46534013748169],[29.3106803894043,-94.7768173217773]],"countries":["Netherlands","United States"],"title":"Seoul Virus Tropism and Pathology in Naturally Infected Feeder Rats"},{"arc":[[28.7162494659424,77.2728576660156],[29.3106803894043,-94.7768173217773]],"countries":["India","United States"],"title":"Seoul Virus Tropism and Pathology in Naturally Infected Feeder Rats"},{"arc":[[51.9100685119629,4.46534013748169],[-27.6047096252441,151.929931640625]],"countries":["Netherlands","Australia"],"title":"SARS Risk Perception, Knowledge, Precautions, and Information Sources, the Netherlands"},{"arc":[[51.1218070983887,10.4006948471069],[-22.881010055542,-43.352668762207]],"countries":["Germany","Brazil"],"title":"The introduction of dengue follows transportation infrastructure changes in the state of Acre, Brazil: A network-based analysis"},{"arc":[[51.1218070983887,10.4006948471069],[-20.3852100372314,-43.5036888122559]],"countries":["Germany","Brazil"],"title":"The introduction of dengue follows transportation infrastructure changes in the state of Acre, Brazil: A network-based analysis"},{"arc":[[-22.881010055542,-43.352668762207],[-22.881010055542,-43.352668762207]],"countries":["Brazil"],"title":"The introduction of dengue follows transportation infrastructure changes in the state of Acre, Brazil: A network-based analysis"},{"arc":[[-22.881010055542,-43.352668762207],[-20.3852100372314,-43.5036888122559]],"countries":["Brazil"],"title":"The introduction of dengue follows transportation infrastructure changes in the state of Acre, Brazil: A network-based analysis"},{"arc":[[37.7000007629395,141],[54.6906204223633,25.2698001861572]],"countries":["Japan","Lithuania"],"title":"Structural bioinformatics SKEMPI 2.0: an updated benchmark of changes in protein-protein binding energy, kinetics and thermodynamics upon mutation"},{"arc":[[42.9547386169434,-78.8192367553711],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles"},{"arc":[[40.9437103271484,40.2619209289551],[46.6430816650391,1.2641099691391]],"countries":["Turkey","France"],"title":"Public Health Emergency of International Concern (PHEIC) has Declared Twice in 2014; Polio and Ebola at the Top"},{"arc":[[-16.6903705596924,-49.2583808898926],[-15.7782897949219,-47.9290885925293]],"countries":["Brazil"],"title":"Molecular and serological surveys of canine distemper virus: A meta-analysis of cross- sectional studies"},{"arc":[[-5.80592012405396,-35.2105407714844],[-23.5594444274902,-46.7238883972168]],"countries":["Brazil","NOCOUNTRY"],"title":"Chloroquine Inhibits Dengue Virus Type 2 Replication in Vero Cells but Not in C6/36 Cells"},{"arc":[[46.7657318115234,-112.696098327637],[32.1037902832031,76.4724884033203]],"countries":["United States","India"],"title":"Seasonal recurrence of cowpox virus outbreaks in captive cheetahs (Acinonyx jubatus)"},{"arc":[[46.7657318115234,-112.696098327637],[8.59595775604248,29.9919891357422]],"countries":["United States","South Sudan"],"title":"Seasonal recurrence of cowpox virus outbreaks in captive cheetahs (Acinonyx jubatus)"},{"arc":[[32.1037902832031,76.4724884033203],[8.59595775604248,29.9919891357422]],"countries":["India","South Sudan"],"title":"Seasonal recurrence of cowpox virus outbreaks in captive cheetahs (Acinonyx jubatus)"},{"arc":[[-35.0198211669922,138.568862915039],[-34.9212799072266,138.603546142578]],"countries":["Australia"],"title":"Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8 + T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways"},{"arc":[[-35.0198211669922,138.568862915039],[-27.6047096252441,151.929931640625]],"countries":["Australia"],"title":"Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8 + T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways"},{"arc":[[-34.9212799072266,138.603546142578],[-27.6047096252441,151.929931640625]],"countries":["Australia"],"title":"Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8 + T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways"},{"arc":[[45.4600639343262,9.19467735290527],[41.9090461730957,12.5119895935059]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[45.4600639343262,9.19467735290527],[45.467960357666,9.1817798614502]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[45.4600639343262,9.19467735290527],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[41.9090461730957,12.5119895935059],[45.467960357666,9.1817798614502]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[41.9090461730957,12.5119895935059],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[45.467960357666,9.1817798614502],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[50.9214782714844,6.3621997833252],[50.7775192260742,6.07814979553223]],"countries":["Germany"],"title":"The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP- ribosylhydrolases OPEN"},{"arc":[[41.7278709411621,44.764778137207],[41.6771812438965,123.463096618652]],"countries":["Georgia","China"],"title":"Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures"},{"arc":[[38.0572509765625,-97.9326782226562],[39.527660369873,-119.813529968262]],"countries":["United States"],"title":"Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity Title: FSHD-like transgenic mouse models of varying severity"},{"arc":[[39.4157409667969,-77.4120330810547],[38.8873481750488,-77.0951919555664]],"countries":["United States"],"title":"Structural complexity of Dengue virus untranslated regions: cis-acting RNA motifs and pseudoknot interactions modulating functionality of the viral genome"},{"arc":[[39.4157409667969,-77.4120330810547],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Structural complexity of Dengue virus untranslated regions: cis-acting RNA motifs and pseudoknot interactions modulating functionality of the viral genome"},{"arc":[[38.8873481750488,-77.0951919555664],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Structural complexity of Dengue virus untranslated regions: cis-acting RNA motifs and pseudoknot interactions modulating functionality of the viral genome"},{"arc":[[50.8360481262207,4.3706259727478],[50.8360481262207,4.3706259727478]],"countries":["Belgium"],"title":"The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road"},{"arc":[[44.2833099365234,12.3498802185059],[47.999195098877,7.84813022613525]],"countries":["Italy","Germany"],"title":"USP18 -a multifunctional component in the interferon response"},{"arc":[[40.7182693481445,46.4133987426758],[38.0361785888672,-78.5016174316406]],"countries":["Azerbaijan","United States"],"title":"Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications"},{"arc":[[35.7868995666504,-93.9436416625977],[31.0254402160645,121.436302185059]],"countries":["United States","China"],"title":"Single Chain Fragment Variable (scFv) Antibodies Targeting the Spike Protein of Porcine Epidemic Diarrhea Virus Provide Protection against Viral Infection in Piglets"},{"arc":[[31.2988891601562,121.499168395996],[54.0102615356445,-2.78708004951477]],"countries":["China","United Kingdom"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[54.0102615356445,-2.78708004951477],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[31.2988891601562,121.499168395996],[51.5204315185547,-0.130309998989105]],"countries":["China","United Kingdom"],"title":"Estimating the infection and case fatality ratio for COVID-19 using age-adjusted data from the outbreak on the Diamond Princess cruise ship"},{"arc":[[31.2988891601562,121.499168395996],[40.6830215454102,-76.2544097900391]],"countries":["China","United States"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.2988891601562,121.499168395996],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.2988891601562,121.499168395996],[51.9635810852051,7.61390018463135]],"countries":["China","Germany"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[40.6830215454102,-76.2544097900391],[31.0254402160645,121.436302185059]],"countries":["China","United States"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[40.6830215454102,-76.2544097900391],[51.9635810852051,7.61390018463135]],"countries":["United States","Germany"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.0254402160645,121.436302185059],[51.9635810852051,7.61390018463135]],"countries":["China","Germany"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.2988891601562,121.499168395996],[36.5042343139648,138.984161376953]],"countries":["China","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[24.9809303283691,93.8902435302734]],"countries":["China","India"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[35.4666900634766,139.621841430664]],"countries":["China","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[36.5042343139648,138.984161376953],[24.9809303283691,93.8902435302734]],"countries":["Japan","India"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[36.5042343139648,138.984161376953],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[36.5042343139648,138.984161376953],[35.4666900634766,139.621841430664]],"countries":["Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[24.9809303283691,93.8902435302734],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[24.9809303283691,93.8902435302734],[35.4666900634766,139.621841430664]],"countries":["India","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[40.9437103271484,40.2619209289551],[35.4666900634766,139.621841430664]],"countries":["Turkey","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[35.4666900634766,139.621841430664],[35.4666900634766,139.621841430664]],"countries":["Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[32.0583801269531,118.79647064209]],"countries":["China"],"title":"Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models"},{"arc":[[31.2988891601562,121.499168395996],[32.1895904541016,119.425003051758]],"countries":["China"],"title":"Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models"},{"arc":[[32.0583801269531,118.79647064209],[32.1895904541016,119.425003051758]],"countries":["China"],"title":"Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models"},{"arc":[[31.2988891601562,121.499168395996],[45.8021583557129,126.535797119141]],"countries":["China"],"title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[39.3045501708984,115.0048828125]],"countries":["China"],"title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[40.7145500183105,-74.0071411132812]],"countries":["China","United States"],"title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV"},{"arc":[[45.8021583557129,126.535797119141],[39.3045501708984,115.0048828125]],"countries":["China"],"title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV"},{"arc":[[45.8021583557129,126.535797119141],[40.7145500183105,-74.0071411132812]],"countries":["United States","China"],"title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV"},{"arc":[[39.3045501708984,115.0048828125],[40.7145500183105,-74.0071411132812]],"countries":["China","United States"],"title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV"},{"arc":[[26.029390335083,118.138877868652],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[26.029390335083,118.138877868652],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[31.0254402160645,121.436302185059],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[-22.881010055542,-43.352668762207],[51.1218070983887,10.4006948471069]],"countries":["Germany","Brazil"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[-22.881010055542,-43.352668762207],[18.8973274230957,-70.4999237060547]],"countries":["Brazil","Dominican Republic"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[-22.881010055542,-43.352668762207],[-22.881010055542,-43.352668762207]],"countries":["Brazil"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[51.1218070983887,10.4006948471069],[18.8973274230957,-70.4999237060547]],"countries":["Germany","Dominican Republic"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[51.1218070983887,10.4006948471069],[-22.881010055542,-43.352668762207]],"countries":["Germany","Brazil"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[18.8973274230957,-70.4999237060547],[51.1218070983887,10.4006948471069]],"countries":["Germany","Dominican Republic"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[18.8973274230957,-70.4999237060547],[-22.881010055542,-43.352668762207]],"countries":["Brazil","Dominican Republic"],"title":"H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis"},{"arc":[[-22.881010055542,-43.352668762207],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Brazil"],"title":",3-Diphenyl-4,5-dihydro-1H-pyrazol-5- one"},{"arc":[[45.2616806030273,4.67889022827148],[36.755867,126.30135]],"countries":["France","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[45.2616806030273,4.67889022827148],[14.477560043335,120.89826965332]],"countries":["Philippines","France"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[45.2616806030273,4.67889022827148],[36.532703,127.252875]],"countries":["France","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[36.755867,126.30135],[14.477560043335,120.89826965332]],"countries":["Philippines","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[36.755867,126.30135],[36.532703,127.252875]],"countries":["South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[14.477560043335,120.89826965332],[36.532703,127.252875]],"countries":["Philippines","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[45.4953117370605,15.5533599853516],[36.5042343139648,138.984161376953]],"countries":["Croatia","Japan"],"title":"The Emerging Role of Rhinoviruses in Lower Respiratory Tract Infections in Children -Clinical and Molecular Epidemiological Study From Croatia"},{"arc":[[45.4953117370605,15.5533599853516],[45.8072395324707,15.9675703048706]],"countries":["Croatia"],"title":"The Emerging Role of Rhinoviruses in Lower Respiratory Tract Infections in Children -Clinical and Molecular Epidemiological Study From Croatia"},{"arc":[[36.5042343139648,138.984161376953],[45.8072395324707,15.9675703048706]],"countries":["Croatia","Japan"],"title":"The Emerging Role of Rhinoviruses in Lower Respiratory Tract Infections in Children -Clinical and Molecular Epidemiological Study From Croatia"},{"arc":[[1.29041004180908,103.852111816406],[-35.40233,-71.63531]],"countries":["Singapore","Chile"],"title":"Strategies for Success. Viral Infections and Membraneless Organelles"},{"arc":[[1.29041004180908,103.852111816406],[27.6073627471924,111.713684082031]],"countries":["China","Singapore"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[1.29041004180908,103.852111816406],[45.188892364502,-91.2747573852539]],"countries":["Singapore","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[1.29041004180908,103.852111816406],[29.649730682373,-82.3411331176758]],"countries":["Singapore","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[27.6073627471924,111.713684082031],[45.188892364502,-91.2747573852539]],"countries":["China","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[27.6073627471924,111.713684082031],[29.649730682373,-82.3411331176758]],"countries":["China","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[45.188892364502,-91.2747573852539],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[38.8350486755371,-77.3112411499023],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"Genome and Bioinformatic Analysis of a HAdV-B14p1 Virus Isolated from a Baby with Pneumonia in Beijing, China"},{"arc":[[38.9076614379883,-77.0716094970703],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[51.5204315185547,-0.130309998989105]],"countries":["United States","United Kingdom"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[33.779167175293,-84.3869476318359]],"countries":["United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[9.5854320526123,8.09356498718262]],"countries":["United States","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[51.5204315185547,-0.130309998989105]],"countries":["United States","United Kingdom"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[33.779167175293,-84.3869476318359]],"countries":["United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[9.5854320526123,8.09356498718262]],"countries":["United States","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[51.5204315185547,-0.130309998989105],[33.779167175293,-84.3869476318359]],"countries":["United Kingdom","United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[51.5204315185547,-0.130309998989105],[9.5854320526123,8.09356498718262]],"countries":["United Kingdom","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[51.5204315185547,-0.130309998989105],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[33.779167175293,-84.3869476318359],[9.5854320526123,8.09356498718262]],"countries":["United States","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[33.779167175293,-84.3869476318359],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[9.5854320526123,8.09356498718262],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[32.6483306884766,-83.4445571899414],[35.3076782226562,-93.8832092285156]],"countries":["United States"],"title":"Complete Genome Sequence of Avian Coronavirus Strain GA08 (GI-27 Lineage)"},{"arc":[[32.6483306884766,-83.4445571899414],[53.4570770263672,27.2214450836182]],"countries":["United States","Belarus"],"title":"Complete Genome Sequence of Avian Coronavirus Strain GA08 (GI-27 Lineage)"},{"arc":[[35.3076782226562,-93.8832092285156],[53.4570770263672,27.2214450836182]],"countries":["United States","Belarus"],"title":"Complete Genome Sequence of Avian Coronavirus Strain GA08 (GI-27 Lineage)"},{"arc":[[36.0004425048828,-78.9623413085938],[52.2593307495117,-109.820449829102]],"countries":["United States","Canada"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[50.8101806640625,8.77422046661377]],"countries":["United States","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[50.7775192260742,6.07814979553223]],"countries":["United States","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[52.3722686767578,9.73814964294434]],"countries":["United States","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[52.2593307495117,-109.820449829102],[50.8101806640625,8.77422046661377]],"countries":["Canada","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[52.2593307495117,-109.820449829102],[50.7775192260742,6.07814979553223]],"countries":["Canada","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[52.2593307495117,-109.820449829102],[52.3722686767578,9.73814964294434]],"countries":["Germany","Canada"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.8101806640625,8.77422046661377],[50.8101806640625,8.77422046661377]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.8101806640625,8.77422046661377],[50.7775192260742,6.07814979553223]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.8101806640625,8.77422046661377],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.7775192260742,6.07814979553223],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[36.0004425048828,-78.9623413085938]],"countries":["United States"],"title":"Interferon-Induced Transmembrane Protein- Mediated Inhibition of Host Cell Entry of Ebolaviruses"},{"arc":[[36.0004425048828,-78.9623413085938],[43.383487701416,142.571090698242]],"countries":["United States","Japan"],"title":"Interferon-Induced Transmembrane Protein- Mediated Inhibition of Host Cell Entry of Ebolaviruses"},{"arc":[[36.0004425048828,-78.9623413085938],[52.2593307495117,-109.820449829102]],"countries":["United States","Canada"],"title":"Interferon-Induced Transmembrane Protein- Mediated Inhibition of Host Cell Entry of Ebolaviruses"},{"arc":[[36.0004425048828,-78.9623413085938],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Interferon-Induced Transmembrane Protein- Mediated Inhibition of Host Cell Entry of Ebolaviruses"},{"arc":[[43.383487701416,142.571090698242],[52.2593307495117,-109.820449829102]],"countries":["Japan","Canada"],"title":"Interferon-Induced Transmembrane Protein- Mediated Inhibition of Host Cell Entry of Ebolaviruses"},{"arc":[[43.383487701416,142.571090698242],[37.8056831359863,-122.268104553223]],"countries":["Japan","United States"],"title":"Interferon-Induced Transmembrane Protein- Mediated Inhibition of Host Cell Entry of Ebolaviruses"},{"arc":[[52.2593307495117,-109.820449829102],[37.8056831359863,-122.268104553223]],"countries":["Canada","United States"],"title":"Interferon-Induced Transmembrane Protein- Mediated Inhibition of Host Cell Entry of Ebolaviruses"},{"arc":[[36.0004425048828,-78.9623413085938],[52.2593307495117,-109.820449829102]],"countries":["United States","Canada"],"title":"Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay"},{"arc":[[51.0556297302246,3.72855997085571],[50.877628326416,4.70719003677368]],"countries":["Belgium"],"title":"Genetic Characterization of the Belgian Nephropathogenic Infectious Bronchitis Virus (NIBV) Reference Strain B1648"},{"arc":[[35.4135284423828,136.771347045898],[20.2663593292236,85.8105697631836]],"countries":["Japan","India"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[35.4135284423828,136.771347045898],[34.1732597351074,131.47900390625]],"countries":["Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[20.2663593292236,85.8105697631836],[34.1732597351074,131.47900390625]],"countries":["India","Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[-25.1099891662598,30.7521800994873],[45.7594299316406,4.82885980606079]],"countries":["South Africa","France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[-25.1099891662598,30.7521800994873],[45.7491493225098,4.83716011047363]],"countries":["South Africa","France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[45.7594299316406,4.82885980606079],[45.7491493225098,4.83716011047363]],"countries":["France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[34.0983047485352,-117.269203186035],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Globalization and Health Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States"},{"arc":[[34.0983047485352,-117.269203186035],[29.31842,47.97301]],"countries":["United States","Kuwait"],"title":"Globalization and Health Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States"},{"arc":[[42.373161315918,-71.1181182861328],[29.31842,47.97301]],"countries":["United States","Kuwait"],"title":"Globalization and Health Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States"},{"arc":[[40.9469909667969,-81.4652099609375],[36.4511566162109,127.861145019531]],"countries":["South Korea","United States"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[40.9469909667969,-81.4652099609375],[49.6897506713867,-102.02889251709]],"countries":["United States","Canada"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[40.9469909667969,-81.4652099609375],[32.9052963256836,-117.243560791016]],"countries":["United States"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[40.9469909667969,-81.4652099609375],[37.4599990844727,126.949996948242]],"countries":["United States","South Korea"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[36.4511566162109,127.861145019531],[49.6897506713867,-102.02889251709]],"countries":["South Korea","Canada"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[36.4511566162109,127.861145019531],[32.9052963256836,-117.243560791016]],"countries":["South Korea","United States"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[36.4511566162109,127.861145019531],[37.4599990844727,126.949996948242]],"countries":["South Korea"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[49.6897506713867,-102.02889251709],[32.9052963256836,-117.243560791016]],"countries":["United States","Canada"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[49.6897506713867,-102.02889251709],[37.4599990844727,126.949996948242]],"countries":["Canada","South Korea"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[32.9052963256836,-117.243560791016],[37.4599990844727,126.949996948242]],"countries":["United States","South Korea"],"title":"Complete Genome Sequences of Porcine Deltacoronavirus Strains DH1/2016 and DH2/2016 Isolated in South Korea"},{"arc":[[-27.5583305358887,153.051071166992],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-27.5583305358887,153.051071166992],[1.29041004180908,103.852111816406]],"countries":["Singapore","Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-27.5583305358887,153.051071166992],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-37.7035598754883,145.180358886719],[1.29041004180908,103.852111816406]],"countries":["Australia","Singapore"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-37.7035598754883,145.180358886719],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[1.29041004180908,103.852111816406],[-37.797981262207,144.959045410156]],"countries":["Singapore","Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[23.2024116516113,113.38606262207],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[23.2024116516113,113.38606262207],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[23.2024116516113,113.38606262207],[26.8308792114258,-80.1056594848633]],"countries":["China","United States"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[23.2024116516113,113.38606262207],[3.90665602684021,-73.0762023925781]],"countries":["China","Colombia"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[23.2024116516113,113.38606262207],[30.2633018493652,120.122261047363]],"countries":["China"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[22.333080291748,114.191223144531],[39.9046897888184,116.407173156738]],"countries":["China","Hong Kong SAR"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[22.333080291748,114.191223144531],[26.8308792114258,-80.1056594848633]],"countries":["Hong Kong SAR","United States"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[22.333080291748,114.191223144531],[3.90665602684021,-73.0762023925781]],"countries":["Hong Kong SAR","Colombia"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[22.333080291748,114.191223144531],[30.2633018493652,120.122261047363]],"countries":["Hong Kong SAR","China"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[39.9046897888184,116.407173156738],[26.8308792114258,-80.1056594848633]],"countries":["China","United States"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[39.9046897888184,116.407173156738],[3.90665602684021,-73.0762023925781]],"countries":["China","Colombia"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[39.9046897888184,116.407173156738],[30.2633018493652,120.122261047363]],"countries":["China"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[26.8308792114258,-80.1056594848633],[3.90665602684021,-73.0762023925781]],"countries":["Colombia","United States"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[26.8308792114258,-80.1056594848633],[30.2633018493652,120.122261047363]],"countries":["China","United States"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[3.90665602684021,-73.0762023925781],[30.2633018493652,120.122261047363]],"countries":["Colombia","China"],"title":"Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus"},{"arc":[[23.2024116516113,113.38606262207],[50.837776184082,4.33750009536743]],"countries":["China","Belgium"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.2024116516113,113.38606262207],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.2024116516113,113.38606262207],[39.6668891906738,-75.7527618408203]],"countries":["China","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.2024116516113,113.38606262207],[43.6486892700195,-79.3854370117188]],"countries":["China","Canada"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[50.837776184082,4.33750009536743],[40.0059814453125,116.326812744141]],"countries":["Belgium","China"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[50.837776184082,4.33750009536743],[39.6668891906738,-75.7527618408203]],"countries":["Belgium","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[50.837776184082,4.33750009536743],[43.6486892700195,-79.3854370117188]],"countries":["Canada","Belgium"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[40.0059814453125,116.326812744141],[39.6668891906738,-75.7527618408203]],"countries":["China","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[40.0059814453125,116.326812744141],[43.6486892700195,-79.3854370117188]],"countries":["Canada","China"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[39.6668891906738,-75.7527618408203],[43.6486892700195,-79.3854370117188]],"countries":["Canada","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.8029747009277,108.794311523438],[37.4599990844727,126.949996948242]],"countries":["China","South Korea"],"title":"Molecular Characterization of Major Structural Protein Genes of Avian Coronavirus Infectious Bronchitis Virus Isolates in Southern China"},{"arc":[[23.1290798187256,113.264358520508],[51.1218070983887,10.4006948471069]],"countries":["Germany","China"],"title":"Spontaneous breathing during mechanical ventilation Wrigge and colleagues [4] demonstrated that spontaneous breathing with airway pressure release ventilation promotes Year in review 2005: Critical Care -Respirology: mechanical ventilation, infection, monitoring, and education"},{"arc":[[23.1290798187256,113.264358520508],[43.6486892700195,-79.3854370117188]],"countries":["China","Canada"],"title":"Spontaneous breathing during mechanical ventilation Wrigge and colleagues [4] demonstrated that spontaneous breathing with airway pressure release ventilation promotes Year in review 2005: Critical Care -Respirology: mechanical ventilation, infection, monitoring, and education"},{"arc":[[51.1218070983887,10.4006948471069],[43.6486892700195,-79.3854370117188]],"countries":["Germany","Canada"],"title":"Spontaneous breathing during mechanical ventilation Wrigge and colleagues [4] demonstrated that spontaneous breathing with airway pressure release ventilation promotes Year in review 2005: Critical Care -Respirology: mechanical ventilation, infection, monitoring, and education"},{"arc":[[26.6470203399658,106.630241394043],[23.1312255859375,113.347915649414]],"countries":["China"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[26.6470203399658,106.630241394043],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[26.6470203399658,106.630241394043],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[26.6470203399658,106.630241394043],[28.061149597168,-82.4131469726562]],"countries":["China","United States"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[23.1312255859375,113.347915649414],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[23.1312255859375,113.347915649414],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[23.1312255859375,113.347915649414],[28.061149597168,-82.4131469726562]],"countries":["China","United States"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[31.0254402160645,121.436302185059],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[31.0254402160645,121.436302185059],[28.061149597168,-82.4131469726562]],"countries":["China","United States"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[14.3596153259277,-14.4684610366821],[28.061149597168,-82.4131469726562]],"countries":["Senegal","United States"],"title":"Drug Design, Development and Therapy Dovepress Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study"},{"arc":[[22.5713901519775,88.3903274536133],[22.49587059021,88.3711624145508]],"countries":["India"],"title":"Strategies for vaccine design for corona virus using Immunoinformatics techniques"},{"arc":[[42.9547386169434,-78.8192367553711],[38.68397,-90.3419]],"countries":["United States"],"title":"Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex"},{"arc":[[34.7286605834961,137.739303588867],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[34.7286605834961,137.739303588867],[35.7130813598633,139.445846557617]],"countries":["Japan"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[40.9437103271484,40.2619209289551],[35.7130813598633,139.445846557617]],"countries":["Turkey","Japan"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[38.713264465332,-85.458740234375],[34.0321617126465,-84.581298828125]],"countries":["United States"],"title":"Kinetic Analysis of Bacteriophage Sf6 Binding to Outer Membrane Protein A Using Whole Virions"},{"arc":[[45.8021583557129,126.535797119141],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV"},{"arc":[[45.8021583557129,126.535797119141],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"novel identified hla-a*0201- restricted hantaan Virus glycoprotein cytotoxic T-cell epitopes could effectively induce Protective responses in hla-a2.1/K b Transgenic Mice May associate with the severity of hemorrhagic Fever with renal syndrome"},{"arc":[[45.8021583557129,126.535797119141],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"novel identified hla-a*0201- restricted hantaan Virus glycoprotein cytotoxic T-cell epitopes could effectively induce Protective responses in hla-a2.1/K b Transgenic Mice May associate with the severity of hemorrhagic Fever with renal syndrome"},{"arc":[[41.7278709411621,44.764778137207],[44.9734497070312,-93.2378997802734]],"countries":["Georgia","United States"],"title":"novel identified hla-a*0201- restricted hantaan Virus glycoprotein cytotoxic T-cell epitopes could effectively induce Protective responses in hla-a2.1/K b Transgenic Mice May associate with the severity of hemorrhagic Fever with renal syndrome"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps"},{"arc":[[42.373161315918,-71.1181182861328],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps"},{"arc":[[42.3354797363281,-71.1043930053711],[-69.1330032348633,-63.6669998168945]],"countries":["Argentina","United States"],"title":"TIM-family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-associated Phosphatidylserine"},{"arc":[[42.3354797363281,-71.1043930053711],[28.6001033782959,-81.198616027832]],"countries":["United States"],"title":"A potent human neutralizing antibody Fc- dependently reduces established HBV infections"},{"arc":[[42.3354797363281,-71.1043930053711],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"A potent human neutralizing antibody Fc- dependently reduces established HBV infections"},{"arc":[[28.6001033782959,-81.198616027832],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"A potent human neutralizing antibody Fc- dependently reduces established HBV infections"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19"},{"arc":[[42.373161315918,-71.1181182861328],[37.2173461914062,-80.4220352172852]],"countries":["United States"],"title":"Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19"},{"arc":[[42.373161315918,-71.1181182861328],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Fractional Dosing of Yellow Fever Vaccine to Extend Supply: A Modeling Study"},{"arc":[[50.93091,5.36806],[28.7162494659424,77.2728576660156]],"countries":["Belgium","India"],"title":"Estimating the generation interval for COVID-19 based on symptom onset data"},{"arc":[[49.2629,-123.24671],[37.8056831359863,-122.268104553223]],"countries":["Canada","United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[49.2629,-123.24671],[38.0361785888672,-78.5016174316406]],"countries":["Canada","United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[37.8056831359863,-122.268104553223],[38.0361785888672,-78.5016174316406]],"countries":["United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[39.3045501708984,115.0048828125],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Diarrhea may be underestimated: a missing link in 2019 novel coronavirus"},{"arc":[[39.3045501708984,115.0048828125],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Diarrhea may be underestimated: a missing link in 2019 novel coronavirus"},{"arc":[[39.3045501708984,115.0048828125],[-37.7035598754883,145.180358886719]],"countries":["Australia","China"],"title":"Diarrhea may be underestimated: a missing link in 2019 novel coronavirus"},{"arc":[[22.2802925109863,114.142951965332],[40.0059814453125,116.326812744141]],"countries":["Hong Kong SAR","China"],"title":"Diarrhea may be underestimated: a missing link in 2019 novel coronavirus"},{"arc":[[22.2802925109863,114.142951965332],[-37.7035598754883,145.180358886719]],"countries":["Australia","Hong Kong SAR"],"title":"Diarrhea may be underestimated: a missing link in 2019 novel coronavirus"},{"arc":[[40.0059814453125,116.326812744141],[-37.7035598754883,145.180358886719]],"countries":["Australia","China"],"title":"Diarrhea may be underestimated: a missing link in 2019 novel coronavirus"},{"arc":[[49.4181175231934,8.66556262969971],[49.9887084960938,8.23101043701172]],"countries":["Germany"],"title":"RNA Modifications Modulate Activation of Innate Toll-Like Receptors"},{"arc":[[51.188419342041,6.79547023773193],[14.477560043335,120.89826965332]],"countries":["Philippines","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.188419342041,6.79547023773193],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.188419342041,6.79547023773193],[51.451831817627,7.01107978820801]],"countries":["Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.188419342041,6.79547023773193],[51.4285888671875,6.79955005645752]],"countries":["Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[14.477560043335,120.89826965332],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Philippines"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[14.477560043335,120.89826965332],[51.451831817627,7.01107978820801]],"countries":["Philippines","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[14.477560043335,120.89826965332],[51.4285888671875,6.79955005645752]],"countries":["Philippines","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[52.421459197998,-1.43792998790741],[51.451831817627,7.01107978820801]],"countries":["United Kingdom","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[52.421459197998,-1.43792998790741],[51.4285888671875,6.79955005645752]],"countries":["United Kingdom","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.451831817627,7.01107978820801],[51.4285888671875,6.79955005645752]],"countries":["Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[50.8358001708984,12.9225702285767],[48.150390625,11.5805997848511]],"countries":["Germany"],"title":"EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells- A New Option for the Treatment of B-CLL"},{"arc":[[33.8806037902832,113.619728088379],[39.2988395690918,-76.5941390991211]],"countries":["China","United States"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[33.8806037902832,113.619728088379],[51.446361541748,7.26077508926392]],"countries":["China","Germany"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[33.8806037902832,113.619728088379],[51.451831817627,7.01107978820801]],"countries":["Germany","China"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[33.8806037902832,113.619728088379],[51.4285888671875,6.79955005645752]],"countries":["China","Germany"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[39.2988395690918,-76.5941390991211],[51.446361541748,7.26077508926392]],"countries":["United States","Germany"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[39.2988395690918,-76.5941390991211],[51.451831817627,7.01107978820801]],"countries":["Germany","United States"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[39.2988395690918,-76.5941390991211],[51.4285888671875,6.79955005645752]],"countries":["United States","Germany"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[51.446361541748,7.26077508926392],[51.451831817627,7.01107978820801]],"countries":["Germany"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[51.446361541748,7.26077508926392],[51.4285888671875,6.79955005645752]],"countries":["Germany"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[51.451831817627,7.01107978820801],[51.4285888671875,6.79955005645752]],"countries":["Germany"],"title":"Citation: The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8 + T Cells During an Acute Retroviral Infection"},{"arc":[[55.908260345459,-3.31926989555359],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[51.5204315185547,-0.130309998989105]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5204315185547,-0.130309998989105]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[40.3495407104492,-74.6600875854492]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[40.3495407104492,-74.6600875854492],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[40.3495407104492,-74.6600875854492],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[52.2025413513184,0.119549997150898],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[34.3790397644043,132.469787597656],[35.015510559082,135.770034790039]],"countries":["Japan"],"title":"a section of the journal Frontiers in Microbiology IFN-β-inducing, unusual viral RNA species produced by paramyxovirus infection accumulated into distinct cytoplasmic structures in an RNA-type-dependent manner"},{"arc":[[43.383487701416,142.571090698242],[42.9547386169434,-78.8192367553711]],"countries":["United States","Japan"],"title":"Real time detection of farm-level swine mycobacteriosis outbreak using time series modeling of the number of condemned intestines in abattoirs"},{"arc":[[43.383487701416,142.571090698242],[35.6895027160645,138.68879699707]],"countries":["Japan"],"title":"Clinical Medicine Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)"},{"arc":[[43.383487701416,142.571090698242],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"Effect of thermal control of dry fomites on regulating the survival of human pathogenic bacteria responsible for nosocomial infections"},{"arc":[[22.2953874131903,114.179700358067],[31.0254402160645,121.436302185059]],"countries":["Hong Kong-China","China"],"title":"Two novel HLA-A*0201 T-cell epitopes in avian H5N1 viral nucleoprotein induced specific immune responses in HHD mice"},{"arc":[[22.2953874131903,114.179700358067],[22.3374996185303,114.263000488281]],"countries":["Hong Kong-China","Hong Kong SAR"],"title":"Two novel HLA-A*0201 T-cell epitopes in avian H5N1 viral nucleoprotein induced specific immune responses in HHD mice"},{"arc":[[31.0254402160645,121.436302185059],[22.3374996185303,114.263000488281]],"countries":["China","Hong Kong SAR"],"title":"Two novel HLA-A*0201 T-cell epitopes in avian H5N1 viral nucleoprotein induced specific immune responses in HHD mice"},{"arc":[[22.333080291748,114.191223144531],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"Beliefs and Knowledge about Vaccination against AH1N1pdm09 Infection and Uptake Factors among Chinese Parents"},{"arc":[[22.333080291748,114.191223144531],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data"},{"arc":[[22.333080291748,114.191223144531],[36.5631141662598,103.735809326172]],"countries":["China","Hong Kong SAR"],"title":"Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data"},{"arc":[[36.5631141662598,103.735809326172],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Detection of novel astroviruses in urban brown rats and previously known astroviruses in humans"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Responses to Threat of Influenza A(H7N9) and Support for Live Poultry Markets, Hong Kong, 2013"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Responses to Threat of Influenza A(H7N9) and Support for Live Poultry Markets, Hong Kong, 2013"},{"arc":[[22.333080291748,114.191223144531],[-33.9181594848633,151.228820800781]],"countries":["Hong Kong SAR","Australia"],"title":"A review of medical masks and respirators for use during an influenza pandemic"},{"arc":[[45.7429885864258,4.87936019897461],[51.756290435791,-1.2595100402832]],"countries":["United Kingdom","France"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[45.7429885864258,4.87936019897461],[18.495677947998,103.767715454102]],"countries":["France","Laos"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[45.7429885864258,4.87936019897461],[35.1083641052246,102.941299438477]],"countries":["France","NOCOUNTRY"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[45.7429885864258,4.87936019897461],[26.7811698913574,75.81005859375]],"countries":["France","India"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[51.756290435791,-1.2595100402832],[18.495677947998,103.767715454102]],"countries":["United Kingdom","Laos"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[51.756290435791,-1.2595100402832],[35.1083641052246,102.941299438477]],"countries":["United Kingdom","NOCOUNTRY"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[51.756290435791,-1.2595100402832],[26.7811698913574,75.81005859375]],"countries":["United Kingdom","India"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[18.495677947998,103.767715454102],[35.1083641052246,102.941299438477]],"countries":["Laos","NOCOUNTRY"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[18.495677947998,103.767715454102],[26.7811698913574,75.81005859375]],"countries":["Laos","India"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[35.1083641052246,102.941299438477],[26.7811698913574,75.81005859375]],"countries":["NOCOUNTRY","India"],"title":"\"Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR\": A prospective, community-based cohort study"},{"arc":[[51.5227890014648,-0.136329993605614],[55.947639465332,-3.18207001686096]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[51.5227890014648,-0.136329993605614],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[55.947639465332,-3.18207001686096],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[10.4595603942871,-66.8315963745117],[40.4109497070312,-3.67230010032654]],"countries":["Venezuela","Spain"],"title":"Citation: Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ + T-Cell Receptor and CD19 + Cell Depleted Grafts: High CD56 dim /CD56 bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome"},{"arc":[[27.9197807312012,78.085693359375],[38.6370010375977,-90.2646026611328]],"countries":["India","United States"],"title":"NADPH Oxidase and Guanylate Binding Protein 5 Restrict Survival of Avirulent Type III Strains of Toxoplasma gondii in Naive Macrophages"},{"arc":[[11.0134401321411,76.9366226196289],[37.8056831359863,-122.268104553223]],"countries":["India","United States"],"title":"Carbon Nanocarriers Deliver siRNA to Intact Plant Cells for Efficient Gene"},{"arc":[[11.0134401321411,76.9366226196289],[41.6625213623047,-91.536506652832]],"countries":["India","United States"],"title":"Porcine Deltacoronavirus Nucleocapsid Protein Suppressed IFN-β Production by Interfering Porcine RIG-I dsRNA-Binding and K63-Linked Polyubiquitination"},{"arc":[[40.9437103271484,40.2619209289551],[30.973201751709,112.276123046875]],"countries":["Turkey","China"],"title":"Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile"},{"arc":[[40.9437103271484,40.2619209289551],[30.5363693237305,114.365432739258]],"countries":["Turkey","China"],"title":"Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile"},{"arc":[[40.9437103271484,40.2619209289551],[14.3596153259277,-14.4684610366821]],"countries":["Turkey","Senegal"],"title":"Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile"},{"arc":[[30.973201751709,112.276123046875],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile"},{"arc":[[30.973201751709,112.276123046875],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile"},{"arc":[[30.5363693237305,114.365432739258],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[40.9437103271484,40.2619209289551],[44.9734497070312,-93.2378997802734]],"countries":["Turkey","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[30.6250877380371,102.697288513184],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[-37.7035598754883,145.180358886719],[42.9547386169434,-78.8192367553711]],"countries":["United States","Australia"],"title":"The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer"},{"arc":[[42.9547386169434,-78.8192367553711],[23.7489929199219,120.971282958984]],"countries":["United States","Taiwan"],"title":"Avian Influenza Risk Perception and Preventive Behavior among Traditional Market Workers and Shoppers in Taiwan: Practical Implications for Prevention"},{"arc":[[28.3938446044922,79.4324493408203],[39.2892150878906,117.349395751953]],"countries":["China","India"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[28.3938446044922,79.4324493408203],[32.8771514892578,-117.237426757812]],"countries":["India","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[28.3938446044922,79.4324493408203],[41.3144607543945,-72.9232711791992]],"countries":["India","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[39.2892150878906,117.349395751953],[32.8771514892578,-117.237426757812]],"countries":["China","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[39.2892150878906,117.349395751953],[41.3144607543945,-72.9232711791992]],"countries":["China","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[32.8771514892578,-117.237426757812],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[-27.4977779388428,153.012771606445],[-22.5757026672363,144.535293579102]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[56.4049682617188,8.59008979797363]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[-27.3900699615479,153.023635864258]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[-27.4977779388428,153.012771606445]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[56.4049682617188,8.59008979797363]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[-27.3900699615479,153.023635864258]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[-27.4977779388428,153.012771606445]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[56.4049682617188,8.59008979797363],[-27.3900699615479,153.023635864258]],"countries":["Denmark","Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[56.4049682617188,8.59008979797363],[-27.4977779388428,153.012771606445]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[56.4049682617188,8.59008979797363],[-33.8852996826172,151.188766479492]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.3900699615479,153.023635864258],[-27.4977779388428,153.012771606445]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.3900699615479,153.023635864258],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[51.5002288818359,-0.178939998149872],[37.8056831359863,-122.268104553223]],"countries":["United Kingdom","United States"],"title":"Mouse LSECtin as a model for a human Ebola virus receptor"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Supplementary Text: The spatial resolution of epidemic peaks"},{"arc":[[51.5002288818359,-0.178939998149872],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Frequent Travelers and Rate of Spread of Epidemics"},{"arc":[[51.5002288818359,-0.178939998149872],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom"],"title":"Antiviral Screening of Multiple Compounds against Ebola Virus"},{"arc":[[51.5002288818359,-0.178939998149872],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Antiviral Screening of Multiple Compounds against Ebola Virus"},{"arc":[[52.598876953125,-1.46688103675842],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Antiviral Screening of Multiple Compounds against Ebola Virus"},{"arc":[[51.5002288818359,-0.178939998149872],[39.1860809326172,-96.5832672119141]],"countries":["United Kingdom","United States"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[51.5002288818359,-0.178939998149872],[52.1658325195312,4.47749996185303]],"countries":["United Kingdom","Netherlands"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[51.5002288818359,-0.178939998149872],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[39.1860809326172,-96.5832672119141],[52.1658325195312,4.47749996185303]],"countries":["United States","Netherlands"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[39.1860809326172,-96.5832672119141],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.1658325195312,4.47749996185303],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","Netherlands"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[51.5002288818359,-0.178939998149872],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"Biological targets for isatin and its analogues: Implications for therapy"},{"arc":[[37.498367,126.675769],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Closed-type pre-treatment device for point-of-care testing of sputum OPEN"},{"arc":[[22.9680194854736,88.5302581787109],[22.9680194854736,88.5302581787109]],"countries":["India"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[39.9484710693359,-75.1576614379883]],"countries":["India","United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[40.0039215087891,-105.26683807373]],"countries":["India","United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[39.9530487060547,-75.1940231323242]],"countries":["United States","India"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[39.9484710693359,-75.1576614379883],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[39.9484710693359,-75.1576614379883],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[40.0039215087891,-105.26683807373],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[39.173511505127,-86.5160522460938],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants"},{"arc":[[39.173511505127,-86.5160522460938],[38.2150382995605,-85.7605133056641]],"countries":["United States"],"title":"Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants"},{"arc":[[40.0039215087891,-105.26683807373],[38.2150382995605,-85.7605133056641]],"countries":["United States"],"title":"Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants"},{"arc":[[41.0193405151367,-8.43128967285156],[31.2830429077148,121.502998352051]],"countries":["Portugal","China"],"title":"Predicting Interactions between Virus and Host Proteins Using Repeat Patterns and Composition of Amino Acids"},{"arc":[[22.4931182861328,79.7270126342773],[51.1218070983887,10.4006948471069]],"countries":["Germany","India"],"title":"viruses Reverse Genetic Approaches for the Generation of Recombinant Zika Virus"},{"arc":[[22.4931182861328,79.7270126342773],[43.1265411376953,-77.6315383911133]],"countries":["India","United States"],"title":"viruses Reverse Genetic Approaches for the Generation of Recombinant Zika Virus"},{"arc":[[51.1218070983887,10.4006948471069],[43.1265411376953,-77.6315383911133]],"countries":["Germany","United States"],"title":"viruses Reverse Genetic Approaches for the Generation of Recombinant Zika Virus"},{"arc":[[53.1598205566406,45.2158508300781],[48.8571701049805,2.3413999080658]],"countries":["France","Russia"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[53.1598205566406,45.2158508300781],[65.3224716186523,25.3776607513428]],"countries":["Russia","Finland"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[53.1598205566406,45.2158508300781],[57.1647491455078,-2.10070991516113]],"countries":["Russia","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[53.1598205566406,45.2158508300781],[50.877628326416,4.70719003677368]],"countries":["Russia","Belgium"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[48.8571701049805,2.3413999080658],[65.3224716186523,25.3776607513428]],"countries":["France","Finland"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[48.8571701049805,2.3413999080658],[57.1647491455078,-2.10070991516113]],"countries":["France","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[48.8571701049805,2.3413999080658],[50.877628326416,4.70719003677368]],"countries":["France","Belgium"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[65.3224716186523,25.3776607513428],[57.1647491455078,-2.10070991516113]],"countries":["Finland","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[65.3224716186523,25.3776607513428],[50.877628326416,4.70719003677368]],"countries":["Belgium","Finland"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[57.1647491455078,-2.10070991516113],[50.877628326416,4.70719003677368]],"countries":["Belgium","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[48.5444183349609,12.1591682434082],[44.8367004394531,-0.581070005893707]],"countries":["Germany","France"],"title":"Finding and identifying the viral needle in the metagenomic haystack: trends and challenges"},{"arc":[[40.7182693481445,46.4133987426758],[38.9907493591309,48.5817184448242]],"countries":["Azerbaijan"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[30.7602596282959,47.6596298217773]],"countries":["Azerbaijan","Iraq"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[41.3872909545898,2.16295003890991]],"countries":["Azerbaijan","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[30.7602596282959,47.6596298217773]],"countries":["Iraq","Azerbaijan"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[41.3872909545898,2.16295003890991]],"countries":["Azerbaijan","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[30.7602596282959,47.6596298217773],[41.3872909545898,2.16295003890991]],"countries":["Iraq","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[1.29718005657196,103.77774810791]],"countries":["Azerbaijan","Singapore"],"title":"An updated roadmap for MERS-CoV research and product development: focus on diagnostics Analysis"},{"arc":[[40.7182693481445,46.4133987426758],[22.333080291748,114.191223144531]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus"},{"arc":[[40.7182693481445,46.4133987426758],[22.2802925109863,114.142951965332]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus"},{"arc":[[51.1218070983887,10.4006948471069],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[51.1218070983887,10.4006948471069],[-19.3828773498535,46.6958503723145]],"countries":["Germany","Madagascar"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[51.1218070983887,10.4006948471069],[46.2638092041016,2.3486499786377]],"countries":["Germany","France"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[40.7182693481445,46.4133987426758],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[40.7182693481445,46.4133987426758],[-19.3828773498535,46.6958503723145]],"countries":["Azerbaijan","Madagascar"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[40.7182693481445,46.4133987426758],[46.2638092041016,2.3486499786377]],"countries":["Azerbaijan","France"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[-19.3828773498535,46.6958503723145],[46.2638092041016,2.3486499786377]],"countries":["France","Madagascar"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[51.1218070983887,10.4006948471069],[46.7798385620117,-71.2695007324219]],"countries":["Germany","Canada"],"title":"Design and Validation with Influenza A Virus of an Aerosol Transmission Chamber for Ferrets"},{"arc":[[51.1218070983887,10.4006948471069],[22.3358345031738,-102.292419433594]],"countries":["Germany","Mexico"],"title":"EV-D68 infection in children with asthma exacerbation and pneumonia in Mexico City during 2014 autumn"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Genomic Analyses of Human European Diversity at the Southwestern Edge: Isolation, African Influence and Disease Associations in the Canary Islands"},{"arc":[[51.1218070983887,10.4006948471069],[28.4607791900635,-16.2639007568359]],"countries":["Germany","Spain"],"title":"Genomic Analyses of Human European Diversity at the Southwestern Edge: Isolation, African Influence and Disease Associations in the Canary Islands"},{"arc":[[51.1218070983887,10.4006948471069],[16.44543,-95.01692]],"countries":["Germany","Mexico"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[51.1218070983887,10.4006948471069],[19.3324108123779,-99.1893463134766]],"countries":["Germany","Mexico"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[51.1218070983887,10.4006948471069],[51.378589630127,-2.32512998580933]],"countries":["Germany","United Kingdom"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[16.44543,-95.01692],[51.1218070983887,10.4006948471069]],"countries":["Germany","Mexico"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[16.44543,-95.01692],[19.3324108123779,-99.1893463134766]],"countries":["Mexico"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[16.44543,-95.01692],[51.378589630127,-2.32512998580933]],"countries":["Mexico","United Kingdom"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[19.3324108123779,-99.1893463134766],[51.378589630127,-2.32512998580933]],"countries":["Mexico","United Kingdom"],"title":"Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico"},{"arc":[[34.0983047485352,-117.269203186035],[36.4511566162109,127.861145019531]],"countries":["South Korea","United States"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[34.0983047485352,-117.269203186035],[15.040599822998,120.937843322754]],"countries":["United States","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[34.0983047485352,-117.269203186035],[14.1818799972534,121.225212097168]],"countries":["United States","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[36.4511566162109,127.861145019531],[15.040599822998,120.937843322754]],"countries":["South Korea","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[36.4511566162109,127.861145019531],[14.1818799972534,121.225212097168]],"countries":["South Korea","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[15.040599822998,120.937843322754],[14.1818799972534,121.225212097168]],"countries":["Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[42.0247383117676,-93.6445465087891],[38.5367012023926,-121.749008178711]],"countries":["United States"],"title":"Randomized controlled clinical trial on the effect of oral immunoglobulin supplementation on neonatal dairy calves with diarrhea"},{"arc":[[38.3544387817383,47.6333312988281],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Iran"],"title":"Stochastic dynamics of an epidemics with recurrent spillovers from an endemic reservoir"},{"arc":[[31,35],[37.2551002502441,-119.617523193359]],"countries":["United States","Israel"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[31,35],[60.3831596374512,5.33134984970093]],"countries":["Israel","Norway"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[31,35],[51.9644241333008,7.61332178115845]],"countries":["Israel","Germany"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[31,35],[30.2783069610596,-97.7634506225586]],"countries":["Israel","United States"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[37.2551002502441,-119.617523193359],[60.3831596374512,5.33134984970093]],"countries":["United States","Norway"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[37.2551002502441,-119.617523193359],[51.9644241333008,7.61332178115845]],"countries":["United States","Germany"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[37.2551002502441,-119.617523193359],[30.2783069610596,-97.7634506225586]],"countries":["United States"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[60.3831596374512,5.33134984970093],[51.9644241333008,7.61332178115845]],"countries":["Norway","Germany"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[60.3831596374512,5.33134984970093],[30.2783069610596,-97.7634506225586]],"countries":["United States","Norway"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[51.9644241333008,7.61332178115845],[30.2783069610596,-97.7634506225586]],"countries":["United States","Germany"],"title":"Evolutionary proteomics uncovers ciliary signaling components 1 2"},{"arc":[[44.5259094238281,11.0393409729004],[44.9734497070312,-93.2378997802734]],"countries":["Italy","United States"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[44.5259094238281,11.0393409729004],[44.5259094238281,11.0393409729004]],"countries":["Italy"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[44.9734497070312,-93.2378997802734],[44.5259094238281,11.0393409729004]],"countries":["Italy","United States"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[39.5938415527344,141.363540649414],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"Prescription Surveillance and Polymerase Chain Reaction Testing to Identify Pathogens during Outbreaks of Infection"},{"arc":[[39.5938415527344,141.363540649414],[35.0121231079102,132.523696899414]],"countries":["Japan"],"title":"Prescription Surveillance and Polymerase Chain Reaction Testing to Identify Pathogens during Outbreaks of Infection"},{"arc":[[39.5938415527344,141.363540649414],[37.3264389038086,-121.877601623535]],"countries":["United States","Japan"],"title":"Prescription Surveillance and Polymerase Chain Reaction Testing to Identify Pathogens during Outbreaks of Infection"},{"arc":[[40.9437103271484,40.2619209289551],[35.0121231079102,132.523696899414]],"countries":["Turkey","Japan"],"title":"Prescription Surveillance and Polymerase Chain Reaction Testing to Identify Pathogens during Outbreaks of Infection"},{"arc":[[40.9437103271484,40.2619209289551],[37.3264389038086,-121.877601623535]],"countries":["Turkey","United States"],"title":"Prescription Surveillance and Polymerase Chain Reaction Testing to Identify Pathogens during Outbreaks of Infection"},{"arc":[[35.0121231079102,132.523696899414],[35.0121231079102,132.523696899414]],"countries":["Japan"],"title":"Prescription Surveillance and Polymerase Chain Reaction Testing to Identify Pathogens during Outbreaks of Infection"},{"arc":[[35.0121231079102,132.523696899414],[37.3264389038086,-121.877601623535]],"countries":["United States","Japan"],"title":"Prescription Surveillance and Polymerase Chain Reaction Testing to Identify Pathogens during Outbreaks of Infection"},{"arc":[[50.0608100891113,19.9325695037842],[51.4459609985352,7.26070976257324]],"countries":["Poland","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[50.0608100891113,19.9325695037842],[-33.8479499816895,151.028793334961]],"countries":["Poland","Australia"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[50.0608100891113,19.9325695037842],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Poland"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[50.0608100891113,19.9325695037842],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Poland"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[51.4459609985352,7.26070976257324],[-33.8479499816895,151.028793334961]],"countries":["Australia","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[51.4459609985352,7.26070976257324],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[51.4459609985352,7.26070976257324],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[-33.8479499816895,151.028793334961],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Australia"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[-33.8479499816895,151.028793334961],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Australia"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[52.421459197998,-1.43792998790741],[52.3687591552734,4.89012002944946]],"countries":["United Kingdom","Netherlands"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[-19.3288898468018,146.76057434082],[-27.4452590942383,153.009536743164]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-19.3288898468018,146.76057434082],[-35.2755393981934,149.121124267578]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-19.3288898468018,146.76057434082],[-34.9172286987305,138.60710144043]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-27.4452590942383,153.009536743164],[-35.2755393981934,149.121124267578]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-27.4452590942383,153.009536743164],[-34.9172286987305,138.60710144043]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-35.2755393981934,149.121124267578],[-34.9172286987305,138.60710144043]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[11.2745704650879,75.8362274169922],[39.9484710693359,-75.1576614379883]],"countries":["India","United States"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[11.2745704650879,75.8362274169922],[39.4959106445312,-98.9899826049805]],"countries":["India","United States"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[11.2745704650879,75.8362274169922],[42.8013381958008,-1.65971994400024]],"countries":["India","Spain"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[39.9484710693359,-75.1576614379883],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[39.9484710693359,-75.1576614379883],[42.8013381958008,-1.65971994400024]],"countries":["United States","Spain"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[39.4959106445312,-98.9899826049805],[42.8013381958008,-1.65971994400024]],"countries":["United States","Spain"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[32.9814147949219,119.519096374512],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Complete Genome Sequence of a Recombinant Porcine Epidemic Diarrhea Virus Strain from Eastern China"},{"arc":[[31.0254402160645,121.436302185059],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"EXPERIMENTAL AND THERAPEUTIC MEDICINE Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head"},{"arc":[[43.8378410339355,126.549438476562],[40.0063018798828,-83.0163803100586]],"countries":["China","United States"],"title":"Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice"},{"arc":[[43.8378410339355,126.549438476562],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice"},{"arc":[[40.0063018798828,-83.0163803100586],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice"},{"arc":[[43.8378410339355,126.549438476562],[39.1381492614746,117.150108337402]],"countries":["China"],"title":"First Discovery and Stucture-Activity Relationship Study of Phenanthroquinolizidines as Novel Antiviral Agents against Tobacco Mosaic Virus (TMV)"},{"arc":[[23.1312255859375,113.347915649414],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"Breaking down of healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China"},{"arc":[[23.1312255859375,113.347915649414],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","China"],"title":"Breaking down of healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China"},{"arc":[[14.3596153259277,-14.4684610366821],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Senegal"],"title":"Breaking down of healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China"},{"arc":[[49.9887084960938,8.23101043701172],[49.9887084960938,8.23101043701172]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[49.9887084960938,8.23101043701172],[54.28927,10.88155]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[49.9887084960938,8.23101043701172],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[54.28927,10.88155],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[39.2973403930664,-76.6152191162109],[37.4378814697266,-122.166603088379]],"countries":["United States"],"title":"Population-Based Incidence of Severe Acute Respiratory Virus Infections among Children Aged ,5 Years in Rural"},{"arc":[[39.2973403930664,-76.6152191162109],[38.5466918945312,-121.744567871094]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[38.2007598876953,-122.447616577148]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[38.2007598876953,-122.447616577148]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[6.48379993438721,2.35245990753174]],"countries":["Canada","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[47.3191909790039,5.06463003158569]],"countries":["Canada","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[-19.0004577636719,29.8718376159668]],"countries":["Canada","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[6.48379993438721,2.35245990753174],[47.3191909790039,5.06463003158569]],"countries":["France","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[6.48379993438721,2.35245990753174],[-19.0004577636719,29.8718376159668]],"countries":["Benin","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[47.3191909790039,5.06463003158569],[47.3191909790039,5.06463003158569]],"countries":["France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[47.3191909790039,5.06463003158569],[-19.0004577636719,29.8718376159668]],"countries":["France","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.3291282653809,-76.6179275512695],[37.4378814697266,-122.166603088379]],"countries":["United States"],"title":"Suppression of Drug Resistance in Dengue Virus"},{"arc":[[31.2481803894043,36.7880096435547],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Jordan"],"title":"Presence of Infectious Bronchitis Virus Strain CK/CH/LDL/97I in the Middle East"},{"arc":[[50.5807495117188,8.67675018310547],[50.5807495117188,8.67675018310547]],"countries":["Germany"],"title":"Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis"},{"arc":[[31.5643100738525,130.557098388672],[35.6457710266113,139.746292114258]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[42.9547386169434,-78.8192367553711]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[38.248908996582,140.889892578125]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[50.8984107971191,-1.43060600757599]],"countries":["Japan","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[42.9547386169434,-78.8192367553711]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[38.248908996582,140.889892578125]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[50.8984107971191,-1.43060600757599]],"countries":["Japan","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[38.248908996582,140.889892578125]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[50.8984107971191,-1.43060600757599]],"countries":["United States","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[38.9000015258789,140.682998657227]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[9.36855030059814,-83.6394882202148]],"countries":["United States","Costa Rica"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.248908996582,140.889892578125],[50.8984107971191,-1.43060600757599]],"countries":["Japan","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.248908996582,140.889892578125],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.248908996582,140.889892578125],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[50.8984107971191,-1.43060600757599],[38.9000015258789,140.682998657227]],"countries":["United Kingdom","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[50.8984107971191,-1.43060600757599],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.9000015258789,140.682998657227],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.9000015258789,140.682998657227],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[36.5665092468262,136.659423828125],[29.7095108032227,-95.3981781005859]],"countries":["United States","Japan"],"title":"Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus"},{"arc":[[36.5665092468262,136.659423828125],[33.2432403564453,130.29280090332]],"countries":["Japan"],"title":"Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus"},{"arc":[[36.5665092468262,136.659423828125],[35.7081146240234,139.767456054688]],"countries":["Japan"],"title":"Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus"},{"arc":[[29.7095108032227,-95.3981781005859],[33.2432403564453,130.29280090332]],"countries":["United States","Japan"],"title":"Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus"},{"arc":[[29.7095108032227,-95.3981781005859],[35.7081146240234,139.767456054688]],"countries":["United States","Japan"],"title":"Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus"},{"arc":[[33.2432403564453,130.29280090332],[35.7081146240234,139.767456054688]],"countries":["Japan"],"title":"Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus"},{"arc":[[39.1860809326172,-96.5832672119141],[32.0583801269531,118.79647064209]],"countries":["China","United States"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[39.1860809326172,-96.5832672119141],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[32.0583801269531,118.79647064209],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[39.1860809326172,-96.5832672119141],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses Are Bat Influenza A-like Viruses Different from Classical IAVs?"},{"arc":[[39.1860809326172,-96.5832672119141],[47.999195098877,7.84813022613525]],"countries":["United States","Germany"],"title":"Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses Are Bat Influenza A-like Viruses Different from Classical IAVs?"},{"arc":[[39.1860809326172,-96.5832672119141],[38.0390396118164,-84.5066909790039]],"countries":["United States"],"title":"Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses Are Bat Influenza A-like Viruses Different from Classical IAVs?"},{"arc":[[39.4959106445312,-98.9899826049805],[47.999195098877,7.84813022613525]],"countries":["United States","Germany"],"title":"Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses Are Bat Influenza A-like Viruses Different from Classical IAVs?"},{"arc":[[39.4959106445312,-98.9899826049805],[38.0390396118164,-84.5066909790039]],"countries":["United States"],"title":"Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses Are Bat Influenza A-like Viruses Different from Classical IAVs?"},{"arc":[[47.999195098877,7.84813022613525],[38.0390396118164,-84.5066909790039]],"countries":["Germany","United States"],"title":"Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses Are Bat Influenza A-like Viruses Different from Classical IAVs?"},{"arc":[[32.9700012207031,130.679992675781],[34.9831085205078,138.392242431641]],"countries":["Japan"],"title":"molecules Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies"},{"arc":[[32.9700012207031,130.679992675781],[38.2499389648438,140.334671020508]],"countries":["Japan"],"title":"molecules Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies"},{"arc":[[34.9831085205078,138.392242431641],[38.2499389648438,140.334671020508]],"countries":["Japan"],"title":"molecules Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies"},{"arc":[[34.0223503112793,-118.291114807129],[50.3743896484375,-4.13887977600098]],"countries":["United States","United Kingdom"],"title":"International Journal of Health Geographics Musings on privacy issues in health research involving disaggregate geographic data about individuals"},{"arc":[[59.3478507995605,18.0294704437256],[1.29718005657196,103.77774810791]],"countries":["Singapore","Sweden"],"title":"Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10"},{"arc":[[59.3478507995605,18.0294704437256],[44.954719543457,-93.2659912109375]],"countries":["Sweden","United States"],"title":"Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10"},{"arc":[[1.29718005657196,103.77774810791],[44.954719543457,-93.2659912109375]],"countries":["Singapore","United States"],"title":"Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10"},{"arc":[[59.3478507995605,18.0294704437256],[59.3478507995605,18.0294704437256]],"countries":["Sweden"],"title":"Viral Findings in Adult Hematological Patients with Neutropenia"},{"arc":[[59.3478507995605,18.0294704437256],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Sweden"],"title":"Viral Findings in Adult Hematological Patients with Neutropenia"},{"arc":[[55.8003005981445,49.108268737793],[55.8003005981445,49.108268737793]],"countries":["Russia"],"title":"Article 747 ORIGINAL RESEARCH"},{"arc":[[28.8037395477295,79.2010192871094],[0.537028014659882,37.8567771911621]],"countries":["India","Kenya"],"title":"comparison of respiratory pathogen yields from nasopharyngeal/oropharyngeal swabs and sputum specimens collected from hospitalized adults in rural Western Kenya"},{"arc":[[28.8037395477295,79.2010192871094],[55.7673683166504,12.5074501037598]],"countries":["India","Denmark"],"title":"comparison of respiratory pathogen yields from nasopharyngeal/oropharyngeal swabs and sputum specimens collected from hospitalized adults in rural Western Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[55.7673683166504,12.5074501037598]],"countries":["Kenya","Denmark"],"title":"comparison of respiratory pathogen yields from nasopharyngeal/oropharyngeal swabs and sputum specimens collected from hospitalized adults in rural Western Kenya"},{"arc":[[39.5981788635254,-105.98900604248],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[42.7923316955566,-77.3426208496094]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[45.3814086914062,-71.9311065673828]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[43.0089416503906,-81.2617721557617]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[42.7923316955566,-77.3426208496094]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[45.3814086914062,-71.9311065673828]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[43.0089416503906,-81.2617721557617]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[42.7923316955566,-77.3426208496094],[45.3814086914062,-71.9311065673828]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[42.7923316955566,-77.3426208496094],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[42.7923316955566,-77.3426208496094],[43.0089416503906,-81.2617721557617]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[45.3814086914062,-71.9311065673828],[44.9734497070312,-93.2378997802734]],"countries":["Canada","United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[45.3814086914062,-71.9311065673828],[43.0089416503906,-81.2617721557617]],"countries":["Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[44.9734497070312,-93.2378997802734],[43.0089416503906,-81.2617721557617]],"countries":["Canada","United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[21.667760848999,39.1527290344238],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Respiratory Tract Viral Infections and Coinfections Identified by AnyplexC II RV16 Detection Kit in Pediatric Patients at a Riyadh Tertiary Care Hospital"},{"arc":[[21.4919700622559,39.2515716552734],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[21.4919700622559,39.2515716552734],[-33.8027992248535,150.991256713867]],"countries":["Saudi Arabia","Australia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[21.4919700622559,39.2515716552734],[-33.8852996826172,151.188766479492]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[21.4919700622559,39.2515716552734],[18.2514591217041,42.4844818115234]],"countries":["Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[24.7343902587891,46.6319313049316],[-33.8027992248535,150.991256713867]],"countries":["Saudi Arabia","Australia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[24.7343902587891,46.6319313049316],[-33.8852996826172,151.188766479492]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[24.7343902587891,46.6319313049316],[18.2514591217041,42.4844818115234]],"countries":["Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[-33.8027992248535,150.991256713867],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[-33.8027992248535,150.991256713867],[18.2514591217041,42.4844818115234]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[-33.8852996826172,151.188766479492],[18.2514591217041,42.4844818115234]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[13.0170698165894,77.6431198120117],[34.23014,-77.88233]],"countries":["India","United States"],"title":"Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4- mediated induction of IRAK-M and PPARγ"},{"arc":[[24.7343902587891,46.6319313049316],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[24.7343902587891,46.6319313049316],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Saudi Arabia"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[24.7343902587891,46.6319313049316],[40.8453598022461,14.2576427459717]],"countries":["Saudi Arabia","Italy"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[40.9437103271484,40.2619209289551],[40.8453598022461,14.2576427459717]],"countries":["Turkey","Italy"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[42.9547386169434,-78.8192367553711],[35.7081146240234,139.767456054688]],"countries":["United States","Japan"],"title":"Alteration of somatostatin receptor 2 expression in canine mammary gland tumor"},{"arc":[[42.9547386169434,-78.8192367553711],[36.4511566162109,127.861145019531]],"countries":["United States","South Korea"],"title":"Risk Perception, Preventive Behaviors, and Vaccination Coverage in the Korean Population during the 2009- 2010 Pandemic Influenza A (H1N1): Comparison between High-Risk Group and Non-High-Risk Group"},{"arc":[[42.9547386169434,-78.8192367553711],[36.611458,127.325192]],"countries":["United States","South Korea"],"title":"Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning"},{"arc":[[36.4511566162109,127.861145019531],[38.0390396118164,-84.5066909790039]],"countries":["South Korea","United States"],"title":"2 convergent Research center for emerging Virus infection"},{"arc":[[45.6341972351074,-115.931625366211],[35.5382690429688,129.313323974609]],"countries":["United States","South Korea"],"title":"Detection rate and clinical impact of respiratory viruses in children with Kawasaki disease"},{"arc":[[50.877628326416,4.70719003677368],[50.877628326416,4.70719003677368]],"countries":["Belgium"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[50.877628326416,4.70719003677368],[53.9120407104492,15.1994600296021]],"countries":["Belgium","Poland"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[53.9120407104492,15.1994600296021],[50.877628326416,4.70719003677368]],"countries":["Belgium","Poland"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[24.87965965271,102.833221435547],[24.9724082946777,101.487899780273]],"countries":["China"],"title":"Correction: Xie, H.; et al. 3D QSAR Studies, Pharmacophore Modeling and Virtual Screening on a Series of Steroidal Aromatase"},{"arc":[[29.31842,47.97301],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Kuwait"],"title":"E- The Prevalence of Human Bocavirus, Human Coronavirus-NL63, Human Metapneumovirus, Human Polyomavirus KI and WU in Respiratory Tract Infections in Kuwait"},{"arc":[[35.015510559082,135.770034790039],[21.1394691467285,79.0602798461914]],"countries":["India","Japan"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[35.015510559082,135.770034790039],[29.649730682373,-82.3411331176758]],"countries":["Japan","United States"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[21.1394691467285,79.0602798461914],[21.1394691467285,79.0602798461914]],"countries":["India"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[21.1394691467285,79.0602798461914],[29.649730682373,-82.3411331176758]],"countries":["India","United States"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[43.8378410339355,126.549438476562],[48.6535606384277,-0.836489975452423]],"countries":["China","France"],"title":"Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle"},{"arc":[[43.8378410339355,126.549438476562],[41.7409400939941,-111.814712524414]],"countries":["China","United States"],"title":"Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle"},{"arc":[[48.6535606384277,-0.836489975452423],[41.7409400939941,-111.814712524414]],"countries":["France","United States"],"title":"Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle"},{"arc":[[33.6278381347656,130.422973632812],[35.7081146240234,139.767456054688]],"countries":["Japan"],"title":"Title: Ascertainment rate of novel coronavirus disease (COVID- 1 19) in Japan 2 Running title: Ascertainment in Japan 3 Correspondence to"},{"arc":[[54.0102615356445,-2.78708004951477],[51.4570693969727,-2.60121011734009]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[54.0102615356445,-2.78708004951477],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[51.4570693969727,-2.60121011734009],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[37.6757011413574,-121.758560180664],[37.6757011413574,-121.758560180664]],"countries":["United States"],"title":"Sendai virus intra-host population dynamics and host immunocompetence influence viral virulence during in vivo passage"},{"arc":[[37.6757011413574,-121.758560180664],[-27.4977779388428,153.012771606445]],"countries":["Australia","United States"],"title":"Sendai virus intra-host population dynamics and host immunocompetence influence viral virulence during in vivo passage"},{"arc":[[52.159309387207,4.48662710189819],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"The Nature of Protein Domain Evolution: Shaping the Interaction Network"},{"arc":[[52.159309387207,4.48662710189819],[30.0160102844238,31.4056301116943]],"countries":["Netherlands","Egypt"],"title":"The Nature of Protein Domain Evolution: Shaping the Interaction Network"},{"arc":[[52.1658325195312,4.47749996185303],[30.0160102844238,31.4056301116943]],"countries":["Netherlands","Egypt"],"title":"The Nature of Protein Domain Evolution: Shaping the Interaction Network"},{"arc":[[52.1658325195312,4.47749996185303],[48.2128105163574,16.3610992431641]],"countries":["Austria","Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[52.1658325195312,4.47749996185303],[51.300220489502,-0.645680010318756]],"countries":["Netherlands","United Kingdom"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[52.1658325195312,4.47749996185303],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[48.2128105163574,16.3610992431641],[51.300220489502,-0.645680010318756]],"countries":["Austria","United Kingdom"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[48.2128105163574,16.3610992431641],[52.08896,5.1784]],"countries":["Austria","Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[51.300220489502,-0.645680010318756],[52.08896,5.1784]],"countries":["United Kingdom","Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[36.6533355712891,137.981689453125],[-37.7035598754883,145.180358886719]],"countries":["Australia","Japan"],"title":"Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014"},{"arc":[[36.6533355712891,137.981689453125],[33.9102592468262,132.183929443359]],"countries":["Japan"],"title":"Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014"},{"arc":[[-37.7035598754883,145.180358886719],[33.9102592468262,132.183929443359]],"countries":["Australia","Japan"],"title":"Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014"},{"arc":[[53.4088287353516,-2.97017002105713],[-13.3602857589722,34.2930488586426]],"countries":["United Kingdom","Malawi"],"title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus Europe PMC Funders Group"},{"arc":[[53.4088287353516,-2.97017002105713],[52.0896492004395,5.11434984207153]],"countries":["Netherlands","United Kingdom"],"title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus Europe PMC Funders Group"},{"arc":[[53.4088287353516,-2.97017002105713],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","United Kingdom"],"title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus Europe PMC Funders Group"},{"arc":[[-13.3602857589722,34.2930488586426],[52.0896492004395,5.11434984207153]],"countries":["Netherlands","Malawi"],"title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus Europe PMC Funders Group"},{"arc":[[-13.3602857589722,34.2930488586426],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","Malawi"],"title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus Europe PMC Funders Group"},{"arc":[[52.0896492004395,5.11434984207153],[-23.5594444274902,-46.7238883972168]],"countries":["Netherlands","NOCOUNTRY"],"title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus Europe PMC Funders Group"},{"arc":[[30.4157905578613,-91.1773529052734],[-27.4977779388428,153.012771606445]],"countries":["Australia","United States"],"title":"Type 1 Interferons and NK Cells Limit Murine Cytomegalovirus Escape from the Lymph Node Subcapsular Sinus"},{"arc":[[41.9982795715332,-87.6571731567383],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing"},{"arc":[[41.9982795715332,-87.6571731567383],[41.8707962036133,-87.6496658325195]],"countries":["United States"],"title":"Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing"},{"arc":[[39.4959106445312,-98.9899826049805],[41.8707962036133,-87.6496658325195]],"countries":["United States"],"title":"Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing"},{"arc":[[49.1416664123535,2.63333296775818],[17.0776653289795,-61.7987098693848]],"countries":["Antigua and Barbuda","France"],"title":"Originalien und Übersichten Disinfection of aircraft Appropriate disinfectants and standard operating procedures for highly infectious diseases"},{"arc":[[49.1416664123535,2.63333296775818],[39.9166984558105,3.08330011367798]],"countries":["France","Spain"],"title":"Originalien und Übersichten Disinfection of aircraft Appropriate disinfectants and standard operating procedures for highly infectious diseases"},{"arc":[[17.0776653289795,-61.7987098693848],[39.9166984558105,3.08330011367798]],"countries":["Antigua and Barbuda","Spain"],"title":"Originalien und Übersichten Disinfection of aircraft Appropriate disinfectants and standard operating procedures for highly infectious diseases"},{"arc":[[-21.1429405212402,149.183715820312],[23.7489929199219,120.971282958984]],"countries":["Taiwan","Australia"],"title":"BMC Medical Genetics Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"arc":[[-21.1429405212402,149.183715820312],[25.0373706817627,121.563552856445]],"countries":["Australia","Taiwan"],"title":"BMC Medical Genetics Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"arc":[[23.7489929199219,120.971282958984],[25.0373706817627,121.563552856445]],"countries":["Taiwan"],"title":"BMC Medical Genetics Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"arc":[[42.9547386169434,-78.8192367553711],[31.4627456665039,-99.3330459594727]],"countries":["United States"],"title":"Article 1197 1 Original research Citation: Darling TL, Sherwood LJ and Hayhurst A (2017) Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging"},{"arc":[[0.335489988327026,32.5687217712402],[31.2148895263672,121.564643859863]],"countries":["Uganda","China"],"title":"Evaluating Subcriticality during the Ebola Epidemic in West Africa"},{"arc":[[0.335489988327026,32.5687217712402],[37.7633209228516,-122.458541870117]],"countries":["Uganda","United States"],"title":"Evaluating Subcriticality during the Ebola Epidemic in West Africa"},{"arc":[[31.2148895263672,121.564643859863],[37.7633209228516,-122.458541870117]],"countries":["China","United States"],"title":"Evaluating Subcriticality during the Ebola Epidemic in West Africa"},{"arc":[[37.7633209228516,-122.458541870117],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Evaluating Subcriticality during the Ebola Epidemic in West Africa"},{"arc":[[44.6669807434082,-90.1736297607422],[51.5086784362793,-0.143889993429184]],"countries":["United States","United Kingdom"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[33.4540901184082,-88.7920227050781]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[49.9682197570801,6.49822998046875]],"countries":["United States","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[33.4540901184082,-88.7920227050781]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[49.9682197570801,6.49822998046875]],"countries":["United Kingdom","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[30.6127891540527,-96.339599609375]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[37.7633209228516,-122.458541870117]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[29.649730682373,-82.3411331176758]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[49.9682197570801,6.49822998046875]],"countries":["United States","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[30.6127891540527,-96.339599609375]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[37.7633209228516,-122.458541870117]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[29.649730682373,-82.3411331176758]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[30.6127891540527,-96.339599609375],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[30.6127891540527,-96.339599609375],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[37.7633209228516,-122.458541870117],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[53.9260635375977,-9.3884744644165],[38.987850189209,-76.9389038085938]],"countries":["Ireland","United States"],"title":"Designing and building oncolytic viruses"},{"arc":[[43.2623291015625,-79.915641784668],[38.987850189209,-76.9389038085938]],"countries":["Canada","United States"],"title":"viruses Bats and Coronaviruses"},{"arc":[[43.2623291015625,-79.915641784668],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"viruses Bats and Coronaviruses"},{"arc":[[38.987850189209,-76.9389038085938],[52.1374397277832,-106.627517700195]],"countries":["United States","Canada"],"title":"viruses Bats and Coronaviruses"},{"arc":[[38.3835906982422,-81.7656936645508],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[38.3835906982422,-81.7656936645508],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[38.3835906982422,-81.7656936645508],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[39.9530487060547,-75.1940231323242],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[39.9530487060547,-75.1940231323242],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[30.2787208557129,-97.7324523925781],[43.6486892700195,-79.3854370117188]],"countries":["Canada","United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[39.1381492614746,117.150108337402],[39.1381492614746,117.150108337402]],"countries":["China"],"title":"National Natural Science Foundation of China 81273331 (to R. Xiang) and National Natural Science Foundation of China 81270774"},{"arc":[[39.1381492614746,117.150108337402],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"National Natural Science Foundation of China 81273331 (to R. Xiang) and National Natural Science Foundation of China 81270774"},{"arc":[[53.5561904907227,10.0217695236206],[42.2768669128418,-71.7623977661133]],"countries":["Germany","United States"],"title":"Private specificities of CD8 T cell responses control patterns of heterologous immunity"},{"arc":[[42.7294616699219,-84.4804077148438],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective ΦX174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[42.7294616699219,-84.4804077148438],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective ΦX174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[40.0039215087891,-105.26683807373],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective ΦX174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[33.6622200012207,-112.186401367188],[18.5224609375,73.8294067382812]],"countries":["United States","India"],"title":"Peptide Vaccine: Progress and Challenges"},{"arc":[[40.9437103271484,40.2619209289551],[31.9044609069824,34.8084716796875]],"countries":["Turkey","Israel"],"title":"A systematic view on influenza induced host shutoff"},{"arc":[[40.9437103271484,40.2619209289551],[32.5642623901367,54.3036727905273]],"countries":["Turkey","Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[40.9437103271484,40.2619209289551],[35.6887702941895,51.4150314331055]],"countries":["Turkey","Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[32.5642623901367,54.3036727905273],[35.6887702941895,51.4150314331055]],"countries":["Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[35.6887702941895,51.4150314331055],[35.6887702941895,51.4150314331055]],"countries":["Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[-27.4965896606445,153.012985229492],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-27.4965896606445,153.012985229492],[-37.7994003295898,144.957412719727]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-37.797981262207,144.959045410156],[-37.7994003295898,144.957412719727]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[45.6646690368652,-111.042823791504],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Delivery of IL-35 by Lactococcus lactis Ameliorates Collagen-Induced Arthritis in Mice"},{"arc":[[40.7900657653809,-73.9532470703125],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Patient Contact Recall after SARS Exposure"},{"arc":[[-32.0647506713867,115.838226318359],[39.1395683288574,-84.5051727294922]],"countries":["Australia","United States"],"title":"Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies"},{"arc":[[-32.0647506713867,115.838226318359],[-31.986400604248,115.818786621094]],"countries":["Australia"],"title":"Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies"},{"arc":[[-32.0647506713867,115.838226318359],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies"},{"arc":[[39.1395683288574,-84.5051727294922],[-31.986400604248,115.818786621094]],"countries":["United States","Australia"],"title":"Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies"},{"arc":[[39.1395683288574,-84.5051727294922],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies"},{"arc":[[-31.986400604248,115.818786621094],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies"},{"arc":[[32.7603302001953,129.866546630859],[34.0592918395996,134.557968139648]],"countries":["Japan"],"title":"CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B"},{"arc":[[32.7603302001953,129.866546630859],[27.3640460968018,127.89427947998]],"countries":["Japan","NOCOUNTRY"],"title":"CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B"},{"arc":[[34.0592918395996,134.557968139648],[27.3640460968018,127.89427947998]],"countries":["Japan","NOCOUNTRY"],"title":"CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B"},{"arc":[[32.0583801269531,118.79647064209],[33.9571990966797,-83.3740615844727]],"countries":["United States","China"],"title":"Identification of Nuclear Localization Signals in the ORF2 Protein of Porcine Circovirus Type 3"},{"arc":[[32.0583801269531,118.79647064209],[32.3935813903809,119.412689208984]],"countries":["China"],"title":"Identification of Nuclear Localization Signals in the ORF2 Protein of Porcine Circovirus Type 3"},{"arc":[[33.9571990966797,-83.3740615844727],[32.3935813903809,119.412689208984]],"countries":["United States","China"],"title":"Identification of Nuclear Localization Signals in the ORF2 Protein of Porcine Circovirus Type 3"},{"arc":[[32.0583801269531,118.79647064209],[32.0561103820801,118.775001525879]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0583801269531,118.79647064209],[43.8378410339355,126.549438476562]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0583801269531,118.79647064209],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0583801269531,118.79647064209],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0561103820801,118.775001525879],[43.8378410339355,126.549438476562]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0561103820801,118.775001525879],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0561103820801,118.775001525879],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[43.8378410339355,126.549438476562],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[43.8378410339355,126.549438476562],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[42.3402290344238,-71.0890197753906],[30.5363693237305,114.365432739258]],"countries":["United States","China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0583801269531,118.79647064209],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"A new Schiff base coordinated copper(II) compound induces apoptosis and inhibits tumor growth in gastric cancer"},{"arc":[[39.1381492614746,117.150108337402],[14.165060043335,121.215789794922]],"countries":["China","Philippines"],"title":"DNA segment of African Swine Fever Virus 1 first detected in hard ticks from sheep and bovine"},{"arc":[[32.9907302856445,112.528511047363],[1.27851998806,103.83464050293]],"countries":["China","Singapore"],"title":"Supporting Information Incorporating uracil and 5-halouracils into short peptide nucleic acids for enhanced recognition of A-U pairs in dsRNAs"},{"arc":[[-37.7035598754883,145.180358886719],[35.7081146240234,139.767456054688]],"countries":["Australia","Japan"],"title":"Immortalization and Characterization of Porcine Macrophages that had Been transduced with Lentiviral Vectors encoding the sV40 Large t Antigen and Porcine telomerase Reverse transcriptase"},{"arc":[[21.1394691467285,79.0602798461914],[-69.1330032348633,-63.6669998168945]],"countries":["Argentina","India"],"title":"mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3"},{"arc":[[46.9460830688477,7.43722105026245],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Switzerland"],"title":"Evolution and Structural Organization of the C Proteins of Paramyxovirinae"},{"arc":[[46.9460830688477,7.43722105026245],[25.0373706817627,121.563552856445]],"countries":["Switzerland","Taiwan"],"title":"Hospice utilization during the SARS outbreak in Taiwan"},{"arc":[[30.3002605438232,108.037666320801],[23.7489929199219,120.971282958984]],"countries":["Taiwan","China"],"title":"The Infection of Chicken Tracheal Epithelial Cells with a H6N1 Avian Influenza Virus"},{"arc":[[42.3360176086426,-71.0685958862305],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates"},{"arc":[[42.3360176086426,-71.0685958862305],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates"},{"arc":[[42.3360176086426,-71.0685958862305],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates"},{"arc":[[43.9649963378906,-112.343688964844],[39.4959106445312,-98.9899826049805]],"countries":["United States","NOCOUNTRY"],"title":"Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates"},{"arc":[[43.9649963378906,-112.343688964844],[29.3106803894043,-94.7768173217773]],"countries":["NOCOUNTRY","United States"],"title":"Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates"},{"arc":[[39.4959106445312,-98.9899826049805],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates"},{"arc":[[28.7162494659424,77.2728576660156],[52.598876953125,-1.46688103675842]],"countries":["India","United Kingdom"],"title":"Challenges of the Unknown: Clinical Application of Microbial Metagenomics"},{"arc":[[45.3010215759277,8.85933017730713],[37.9732398986816,15.6630697250366]],"countries":["Italy"],"title":"Interferon-a Improves Phosphoantigen-Induced Vc9Vd2 T-Cells Interferon-c Production during Chronic HCV Infection"},{"arc":[[28.7162494659424,77.2728576660156],[6.48379993438721,2.35245990753174]],"countries":["India","Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[28.7162494659424,77.2728576660156],[9.35044002532959,2.61926007270813]],"countries":["India","Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[6.48379993438721,2.35245990753174],[6.48379993438721,2.35245990753174]],"countries":["Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[6.48379993438721,2.35245990753174],[9.35044002532959,2.61926007270813]],"countries":["Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[28.7162494659424,77.2728576660156],[-33.9181594848633,151.228820800781]],"countries":["India","Australia"],"title":"Viral and bacterial upper respiratory tract infection in hospital health care workers over time and association with symptoms"},{"arc":[[40.9437103271484,40.2619209289551],[-69.1330032348633,-63.6669998168945]],"countries":["Turkey","Argentina"],"title":"Supplementary Information Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection"},{"arc":[[40.9437103271484,40.2619209289551],[35.4666900634766,139.621841430664]],"countries":["Turkey","Japan"],"title":"Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia"},{"arc":[[40.9437103271484,40.2619209289551],[52.2355995178223,21.0103702545166]],"countries":["Turkey","Poland"],"title":"Influenza vaccines and vaccinations in Poland -past, present and future"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFNa Responses by Plasmacytoid Dendritic Cells"},{"arc":[[39.0048141479492,-77.0975341796875],[38.2150382995605,-85.7605133056641]],"countries":["United States"],"title":"viruses Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.0048141479492,-77.0975341796875],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.0048141479492,-77.0975341796875],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.0048141479492,-77.0975341796875],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.4959106445312,-98.9899826049805],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.4959106445312,-98.9899826049805],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[35.9053153991699,-79.0477142333984],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[35.9053153991699,-79.0477142333984],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature"},{"arc":[[25.0373706817627,121.563552856445],[25.0373706817627,121.563552856445]],"countries":["Taiwan"],"title":"How to Reduce the Latent Social Risk of Disease: The Determinants of Vaccination against Rabies in Taiwan"},{"arc":[[25.0373706817627,121.563552856445],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"How to Reduce the Latent Social Risk of Disease: The Determinants of Vaccination against Rabies in Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan 1"},{"arc":[[23.7489929199219,120.971282958984],[21.2993793487549,-157.820159912109]],"countries":["Taiwan","United States"],"title":"Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan 1"},{"arc":[[23.7489929199219,120.971282958984],[25.0119304656982,121.465621948242]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[23.7489929199219,120.971282958984],[24.1632404327393,120.648208618164]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[25.0119304656982,121.465621948242],[24.1632404327393,120.648208618164]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[32.9052963256836,-117.243560791016],[1.29718005657196,103.77774810791]],"countries":["Singapore","United States"],"title":"Title: Public preferences for interventions to prevent emerging infectious disease threats: a discrete choice experiment -supplementary material Authors (family names underlined)"},{"arc":[[53.2772102355957,-9.06151008605957],[-33.9606513977051,18.4602298736572]],"countries":["Ireland","South Africa"],"title":"Virology Journal Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission"},{"arc":[[53.2772102355957,-9.06151008605957],[-33.9339714050293,18.865119934082]],"countries":["Ireland","South Africa"],"title":"Virology Journal Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission"},{"arc":[[-33.9606513977051,18.4602298736572],[-33.9339714050293,18.865119934082]],"countries":["South Africa"],"title":"Virology Journal Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission"},{"arc":[[1.29718005657196,103.77774810791],[1.32175004482269,103.846237182617]],"countries":["Singapore"],"title":"How HIV patients construct liveable identities in a shame based culture: the case of Singapore"},{"arc":[[-37.7035598754883,145.180358886719],[51.1082496643066,17.0269107818604]],"countries":["Australia","Poland"],"title":"Whole genome characterisation of quail deltacoronavirus detected in Poland"},{"arc":[[54.6490783691406,-8.43280029296875],[42.8098297119141,-88.3805541992188]],"countries":["Ireland","United States"],"title":"Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity"},{"arc":[[54.6490783691406,-8.43280029296875],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","Ireland"],"title":"Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity"},{"arc":[[42.8098297119141,-88.3805541992188],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity"},{"arc":[[55.1693992614746,-114.511054992676],[-69.1330032348633,-63.6669998168945]],"countries":["Canada","Argentina"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[55.1693992614746,-114.511054992676],[50.877628326416,4.70719003677368]],"countries":["Canada","Belgium"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[-69.1330032348633,-63.6669998168945],[50.877628326416,4.70719003677368]],"countries":["Argentina","Belgium"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[40.7145500183105,-74.0071411132812],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"MERS Coronavirus: An Emerging Zoonotic Virus"},{"arc":[[39.0048141479492,-77.0975341796875],[48.9997100830078,12.0921401977539]],"countries":["United States","Germany"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[39.0048141479492,-77.0975341796875],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[39.0048141479492,-77.0975341796875],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[39.0048141479492,-77.0975341796875],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[48.9997100830078,12.0921401977539],[40.0039215087891,-105.26683807373]],"countries":["Germany","United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[48.9997100830078,12.0921401977539],[42.2762107849121,-83.7407531738281]],"countries":["United States","Germany"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[48.9997100830078,12.0921401977539],[38.6370010375977,-90.2646026611328]],"countries":["Germany","United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[40.0039215087891,-105.26683807373],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[40.0039215087891,-105.26683807373],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[42.2762107849121,-83.7407531738281],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[36.6533355712891,137.981689453125],[37.8056831359863,-122.268104553223]],"countries":["Japan","United States"],"title":"Epidemiological evaluation of cat health at a first-response animal shelter in Fukushima, following the Great East Japan Earthquakes of 2011"},{"arc":[[36.5631141662598,103.735809326172],[39.6304817199707,118.18058013916]],"countries":["China"],"title":"Expression and role of HEPIS in breast cancer"},{"arc":[[36.5631141662598,103.735809326172],[47.587085723877,14.1412858963013]],"countries":["China","Austria"],"title":"Expression and role of HEPIS in breast cancer"},{"arc":[[39.6304817199707,118.18058013916],[47.587085723877,14.1412858963013]],"countries":["Austria","China"],"title":"Expression and role of HEPIS in breast cancer"},{"arc":[[42.3402290344238,-71.0890197753906],[46.7798385620117,-71.2695007324219]],"countries":["Canada","United States"],"title":"Beyond R 0 : the importance of contact tracing when predicting epidemics"},{"arc":[[42.3402290344238,-71.0890197753906],[44.4754409790039,-73.2006301879883]],"countries":["United States"],"title":"Beyond R 0 : the importance of contact tracing when predicting epidemics"},{"arc":[[42.3402290344238,-71.0890197753906],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Beyond R 0 : the importance of contact tracing when predicting epidemics"},{"arc":[[46.7798385620117,-71.2695007324219],[44.4754409790039,-73.2006301879883]],"countries":["Canada","United States"],"title":"Beyond R 0 : the importance of contact tracing when predicting epidemics"},{"arc":[[46.7798385620117,-71.2695007324219],[47.6565093994141,-122.312088012695]],"countries":["Canada","United States"],"title":"Beyond R 0 : the importance of contact tracing when predicting epidemics"},{"arc":[[44.4754409790039,-73.2006301879883],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Beyond R 0 : the importance of contact tracing when predicting epidemics"},{"arc":[[42.0617485046387,-87.6770706176758],[41.8953018188477,-87.6160507202148]],"countries":["United States"],"title":"Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System"},{"arc":[[40.6830215454102,-76.2544097900391],[63.401252746582,10.4083375930786]],"countries":["United States","Norway"],"title":"Detection of Spliced mRNA from Human Bocavirus 1 in Clinical Samples from Children with Respiratory Tract Infections"},{"arc":[[48.5850410461426,7.73642015457153],[46.5425682067871,24.5580005645752]],"countries":["France","Romania"],"title":"Simulation-based Training as Perceived by Young Anesthesiology and Intensive Care Residents"},{"arc":[[40.0063018798828,-83.0163803100586],[40.807071685791,-77.8588790893555]],"countries":["United States"],"title":"To Go or Stay: The Development, Benefit, and Detriment of Tissue-Resident Memory CD8 T Cells during Central Nervous System Viral Infections"},{"arc":[[45.5003509521484,-122.686950683594],[38.6365394592285,-90.2294082641602]],"countries":["United States"],"title":"BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1 (-/-) Mice from Monkeypoxvirus Lethal Challenge"},{"arc":[[45.5003509521484,-122.686950683594],[25.7258,-80.2708]],"countries":["United States"],"title":"BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1 (-/-) Mice from Monkeypoxvirus Lethal Challenge"},{"arc":[[38.6365394592285,-90.2294082641602],[25.7258,-80.2708]],"countries":["United States"],"title":"BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1 (-/-) Mice from Monkeypoxvirus Lethal Challenge"},{"arc":[[59.9375801086426,10.7218799591064],[59.9375801086426,10.7218799591064]],"countries":["Norway"],"title":"TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity"},{"arc":[[51.7589988708496,-1.26400005817413],[-37.7035598754883,145.180358886719]],"countries":["Australia","United Kingdom"],"title":"An early report from newly established laboratory- based influenza surveillance in Lao PDR"},{"arc":[[46.3432235717773,-119.276336669922],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[46.3432235717773,-119.276336669922],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[46.3432235717773,-119.276336669922],[34.39375,-87.11915]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[46.3432235717773,-119.276336669922],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[39.4959106445312,-98.9899826049805],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[39.4959106445312,-98.9899826049805],[34.39375,-87.11915]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[39.4959106445312,-98.9899826049805],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[35.9053153991699,-79.0477142333984],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[35.9053153991699,-79.0477142333984],[34.39375,-87.11915]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[35.9053153991699,-79.0477142333984],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[34.39375,-87.11915],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Mucin 4 Protects Female Mice from Coronavirus Pathogenesis"},{"arc":[[40.7182693481445,46.4133987426758],[41.9015502929688,12.5122203826904]],"countries":["Azerbaijan","Italy"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[-20.2309799194336,57.6789588928223]],"countries":["Azerbaijan","Mauritius"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[51.7525901794434,-1.25320994853973]],"countries":["Azerbaijan","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[55.9452209472656,-3.18803000450134]],"countries":["Azerbaijan","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[50.9342384338379,-1.39631998538971]],"countries":["Azerbaijan","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[-20.2309799194336,57.6789588928223]],"countries":["Italy","Mauritius"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[51.7525901794434,-1.25320994853973]],"countries":["Italy","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[55.9452209472656,-3.18803000450134]],"countries":["Italy","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[50.9342384338379,-1.39631998538971]],"countries":["Italy","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[-20.2309799194336,57.6789588928223],[51.7525901794434,-1.25320994853973]],"countries":["Mauritius","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[-20.2309799194336,57.6789588928223],[55.9452209472656,-3.18803000450134]],"countries":["Mauritius","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[-20.2309799194336,57.6789588928223],[50.9342384338379,-1.39631998538971]],"countries":["Mauritius","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[51.7525901794434,-1.25320994853973],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[51.7525901794434,-1.25320994853973],[50.9342384338379,-1.39631998538971]],"countries":["United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[55.9452209472656,-3.18803000450134],[50.9342384338379,-1.39631998538971]],"countries":["United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[39.9925537109375,116.310485839844],[42.2762107849121,-83.7407531738281]],"countries":["China","United States"],"title":"Is Generalized Maternal Optimism or Pessimism During Pregnancy Associated with Unplanned Cesarean Section Deliveries in China?"},{"arc":[[39.9925537109375,116.310485839844],[35.9053153991699,-79.0477142333984]],"countries":["China","United States"],"title":"Is Generalized Maternal Optimism or Pessimism During Pregnancy Associated with Unplanned Cesarean Section Deliveries in China?"},{"arc":[[42.2762107849121,-83.7407531738281],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Is Generalized Maternal Optimism or Pessimism During Pregnancy Associated with Unplanned Cesarean Section Deliveries in China?"},{"arc":[[50.8101806640625,8.77422046661377],[52.08896,5.1784]],"countries":["Germany","Netherlands"],"title":"The 2 nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin- neuraminidase-receptor balance"},{"arc":[[52.4094696044922,16.9382801055908],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Poland"],"title":"Fatal respiratory distress syndrome due to coronavirus infection in a child with severe combined immunodeficiency"},{"arc":[[40.3495407104492,-74.6600875854492],[51.1218070983887,10.4006948471069]],"countries":["Germany","United States"],"title":"Long-term trends in seasonality of mortality in urban Madagascar: the role of the epidemiological transition"},{"arc":[[62.5360412597656,-96.3883514404297],[-33.9339714050293,18.865119934082]],"countries":["Canada","South Africa"],"title":"royalsocietypublishing.org/journal/rsos Emerging infectious diseases and biological invasions: a call for a One Health collaboration in science and management"},{"arc":[[52.598876953125,-1.46688103675842],[50.2111282348633,-5.48226022720337]],"countries":["United Kingdom"],"title":"Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species"},{"arc":[[52.598876953125,-1.46688103675842],[50.9340896606445,-1.43508005142212]],"countries":["United Kingdom"],"title":"Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species"},{"arc":[[50.2111282348633,-5.48226022720337],[50.9340896606445,-1.43508005142212]],"countries":["United Kingdom"],"title":"Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species"},{"arc":[[36.2617607116699,50.0107688903809],[36.2617607116699,50.0107688903809]],"countries":["Iran"],"title":"Obvious and Hidden Anxiety and the Related Factors in Operating Room Nurses Employed in General Hospital, Qazvin, Iran: A Cross-Sectional Study"},{"arc":[[-34.8838005065918,138.533294677734],[52.4488296508789,-1.93190002441406]],"countries":["Australia","United Kingdom"],"title":"Cystatin D (CST5): An ultra- early inflammatory biomarker of traumatic brain injury OPEN"},{"arc":[[39.527660369873,-119.813529968262],[39.5476913452148,-119.82103729248]],"countries":["United States"],"title":"G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV"},{"arc":[[39.527660369873,-119.813529968262],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV"},{"arc":[[39.5476913452148,-119.82103729248],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV"},{"arc":[[8.59595775604248,29.9919891357422],[49.4165115356445,8.67146015167236]],"countries":["Germany","South Sudan"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[8.59595775604248,29.9919891357422],[49.787841796875,9.93556022644043]],"countries":["South Sudan","Germany"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[49.4165115356445,8.67146015167236],[49.787841796875,9.93556022644043]],"countries":["Germany"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[43.9649963378906,-112.343688964844],[52.1374397277832,-106.627517700195]],"countries":["NOCOUNTRY","Canada"],"title":"Interferon Regulatory Factor 3-Mediated Signaling Limits Middle-East Respiratory Syndrome (MERS) Coronavirus Propagation in Cells from an Insectivorous Bat"},{"arc":[[-37.7949981689453,144.949722290039],[-27.4939594268799,153.00617980957]],"countries":["Australia"],"title":"Genotypic diversity, circulation patterns, and co-detections among rhinoviruses in Queensland, 2001"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element"},{"arc":[[40.9437103271484,40.2619209289551],[52.08896,5.1784]],"countries":["Turkey","Netherlands"],"title":"Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element"},{"arc":[[37.8056831359863,-122.268104553223],[52.08896,5.1784]],"countries":["United States","Netherlands"],"title":"Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element"},{"arc":[[40.7392616271973,-74.1751403808594],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells"},{"arc":[[36.1910514831543,44.0121383666992],[41.6843185424805,14.5951976776123]],"countries":["Iraq","Italy"],"title":"cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!"},{"arc":[[36.1910514831543,44.0121383666992],[45.186767578125,9.15610694885254]],"countries":["Iraq","Italy"],"title":"cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!"},{"arc":[[41.6843185424805,14.5951976776123],[45.186767578125,9.15610694885254]],"countries":["Italy"],"title":"cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!"},{"arc":[[42.8768310546875,-8.54432010650635],[52.38591,-1.55807]],"countries":["Spain","United Kingdom"],"title":"Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection"},{"arc":[[-69.1330032348633,-63.6669998168945],[55.4762802124023,-133.153335571289]],"countries":["Argentina","United States"],"title":"Cloning whole bacterial genomes in yeast"},{"arc":[[41.7278709411621,44.764778137207],[30.2783069610596,-97.7634506225586]],"countries":["Georgia","United States"],"title":"Knowledge Levels and Training Needs of Disaster Medicine among Health Professionals, Medical Students, and Local Residents in Shanghai, China"},{"arc":[[37.374783,127.131108],[37.4599990844727,126.949996948242]],"countries":["South Korea"],"title":"Comparison of viral infection in healthcare- associated pneumonia (HCAP) and community-acquired pneumonia (CAP)"},{"arc":[[37.4599990844727,126.949996948242],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015"},{"arc":[[36.4687042236328,118.517120361328],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"Comparative Transcriptomic Analysis of Immune-Related Gene Expression in Duck Embryo Fibroblasts Following Duck Tembusu Virus Infection"},{"arc":[[31.2378044128418,121.373092651367],[27.9949207305908,120.69938659668]],"countries":["China"],"title":"BMC Infectious Diseases Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007"},{"arc":[[27.9949207305908,120.69938659668],[27.9949207305908,120.69938659668]],"countries":["China"],"title":"BMC Infectious Diseases Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007"},{"arc":[[31.2148895263672,121.564643859863],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"Evidence of Recombination and Genetic Diversity in Human Rhinoviruses in Children with Acute Respiratory Infection"},{"arc":[[31.2148895263672,121.564643859863],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Evidence of Recombination and Genetic Diversity in Human Rhinoviruses in Children with Acute Respiratory Infection"},{"arc":[[41.7278709411621,44.764778137207],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Georgia"],"title":"Evidence of Recombination and Genetic Diversity in Human Rhinoviruses in Children with Acute Respiratory Infection"},{"arc":[[37.5721130371094,112.295066833496],[23.3010749816895,77.4245910644531]],"countries":["China","India"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[37.5721130371094,112.295066833496],[42.2762107849121,-83.7407531738281]],"countries":["China","United States"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[23.3010749816895,77.4245910644531],[23.3010749816895,77.4245910644531]],"countries":["India"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[23.3010749816895,77.4245910644531],[42.2762107849121,-83.7407531738281]],"countries":["United States","India"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[30.6250877380371,102.697288513184],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"Host Cell Vimentin Restrains Toxoplasma gondii Invasion and Phosphorylation of Vimentin is Partially Regulated by Interaction with TgROP18"},{"arc":[[1.29041004180908,103.852111816406],[58.3811416625977,26.7203407287598]],"countries":["Singapore","Estonia"],"title":"Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses"},{"arc":[[44.3972511291504,-69.5694427490234],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Media effects on suicide methods: A case study on Hong Kong 1998-2005"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Human Enterovirus Nonstructural Protein 2C ATPase Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone"},{"arc":[[53.8074073791504,-1.52102303504944],[41.3849182128906,2.18700003623962]],"countries":["Spain","United Kingdom"],"title":"The Tudor SND1 protein is an m 6 A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus"},{"arc":[[53.8074073791504,-1.52102303504944],[53.8072814941406,-1.55228996276855]],"countries":["United Kingdom"],"title":"The Tudor SND1 protein is an m 6 A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus"},{"arc":[[53.8074073791504,-1.52102303504944],[53.3810195922852,-1.48909997940063]],"countries":["United Kingdom"],"title":"The Tudor SND1 protein is an m 6 A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus"},{"arc":[[41.3849182128906,2.18700003623962],[53.8072814941406,-1.55228996276855]],"countries":["Spain","United Kingdom"],"title":"The Tudor SND1 protein is an m 6 A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus"},{"arc":[[41.3849182128906,2.18700003623962],[53.3810195922852,-1.48909997940063]],"countries":["Spain","United Kingdom"],"title":"The Tudor SND1 protein is an m 6 A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus"},{"arc":[[53.8072814941406,-1.55228996276855],[53.3810195922852,-1.48909997940063]],"countries":["United Kingdom"],"title":"The Tudor SND1 protein is an m 6 A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus"},{"arc":[[-37.8073997497559,144.97380065918],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Virology Journal Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses"},{"arc":[[-37.8073997497559,144.97380065918],[-33.8144989013672,150.984664916992]],"countries":["Australia"],"title":"Virology Journal Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses"},{"arc":[[-37.797981262207,144.959045410156],[-33.8144989013672,150.984664916992]],"countries":["Australia"],"title":"Virology Journal Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses"},{"arc":[[43.0004272460938,-78.7892456054688],[40.9142990112305,-73.1162109375]],"countries":["United States"],"title":"Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry"},{"arc":[[14.3596153259277,-14.4684610366821],[44.9734497070312,-93.2378997802734]],"countries":["Senegal","United States"],"title":"Citation: Zebrafish TRIM25 Promotes Innate Immune Response to RGNNV Infection by Targeting 2CARD and RD Regions of RIG-I for K63-Linked Ubiquitination"},{"arc":[[53.1947784423828,-114.199516296387],[43.6486892700195,-79.3854370117188]],"countries":["Canada"],"title":"BMC Medical Ethics On pandemics and the duty to care: whose duty? who cares?"},{"arc":[[51.6088218688965,-3.98343992233276],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Distinct spread of DNA and RNA viruses among mammals amid prominent role of domestic species"},{"arc":[[25.0373706817627,121.563552856445],[25.0373706817627,121.563552856445]],"countries":["Taiwan"],"title":"Developing 21 st century accreditation standards for teaching hospitals: the Taiwan experience"},{"arc":[[32.0805549621582,34.7900009155273],[32.1146583557129,34.8014183044434]],"countries":["Israel"],"title":"Removal of Hepatitis C Virus-Infected Cells by a Zymogenized Bacterial Toxin"},{"arc":[[30.6127891540527,-96.339599609375],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Terpene metabolic engineering via nuclear or chloroplast genomes profoundly and globally impacts off-target pathways through metabolite signalling"},{"arc":[[-35.2755393981934,149.121124267578],[35.7868995666504,-93.9436416625977]],"countries":["United States","Australia"],"title":"Exploring a Proposed WHO Method to Determine Thresholds for Seasonal Influenza Surveillance"},{"arc":[[22.2802925109863,114.142951965332],[51.4285888671875,6.79955005645752]],"countries":["Hong Kong SAR","Germany"],"title":"IL-27 promotes the expansion of self-renewing CD8 + T cells in persistent viral infection"},{"arc":[[51.514720916748,-0.124721996486187],[43.6486892700195,-79.3854370117188]],"countries":["United Kingdom","Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[51.514720916748,-0.124721996486187],[53.0078887939453,-70.9957275390625]],"countries":["United Kingdom","Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[43.6486892700195,-79.3854370117188],[53.0078887939453,-70.9957275390625]],"countries":["Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[40.0063018798828,-83.0163803100586],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions"},{"arc":[[51.300220489502,-0.645680010318756],[49.4165115356445,8.67146015167236]],"countries":["Germany","United Kingdom"],"title":"Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases"},{"arc":[[-69.1330032348633,-63.6669998168945],[37.8056831359863,-122.268104553223]],"countries":["Argentina","United States"],"title":"Adaptation in protein fitness landscapes is facilitated by indirect paths"},{"arc":[[-36.8504104614258,174.768936157227],[-36.8499984741211,174.770004272461]],"countries":["New Zealand"],"title":"Safety of Tdap vaccine in pregnant women: an observational study"},{"arc":[[-36.8504104614258,174.768936157227],[-45.8632011413574,170.51643371582]],"countries":["New Zealand"],"title":"Safety of Tdap vaccine in pregnant women: an observational study"},{"arc":[[-36.8499984741211,174.770004272461],[-45.8632011413574,170.51643371582]],"countries":["New Zealand"],"title":"Safety of Tdap vaccine in pregnant women: an observational study"},{"arc":[[22.2802925109863,114.142951965332],[50.7338905334473,7.10222196578979]],"countries":["Hong Kong SAR","Germany"],"title":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"arc":[[22.2802925109863,114.142951965332],[24.4795093536377,118.089477539062]],"countries":["Hong Kong SAR","China"],"title":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"arc":[[50.7338905334473,7.10222196578979],[24.4795093536377,118.089477539062]],"countries":["China","Germany"],"title":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"arc":[[22.2802925109863,114.142951965332],[39.2523498535156,-76.709716796875]],"countries":["Hong Kong SAR","United States"],"title":"CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes"},{"arc":[[53.4706993103027,-2.23559999465942],[36.708869934082,-119.556427001953]],"countries":["United Kingdom","United States"],"title":"The Utility of Data Transformation for Alignment, De Novo Assembly and Classification of Short Read Virus Sequences"},{"arc":[[52.9340705871582,-1.20404005050659],[-33.8852996826172,151.188766479492]],"countries":["Australia","United Kingdom"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[52.9340705871582,-1.20404005050659],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[-33.8852996826172,151.188766479492],[52.9340705871582,-1.20404005050659]],"countries":["Australia","United Kingdom"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[-33.8852996826172,151.188766479492],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[30.2783069610596,-97.7634506225586],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Direct nucleic acid analysis of mosquitoes for high fidelity species identification and 1 detection of Wolbachia using a cellphone 2 3"},{"arc":[[30.2783069610596,-97.7634506225586],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"Direct nucleic acid analysis of mosquitoes for high fidelity species identification and 1 detection of Wolbachia using a cellphone 2 3"},{"arc":[[30.2787208557129,-97.7324523925781],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"Direct nucleic acid analysis of mosquitoes for high fidelity species identification and 1 detection of Wolbachia using a cellphone 2 3"},{"arc":[[32.9843292236328,-96.7494430541992],[30.2633018493652,120.122261047363]],"countries":["China","United States"],"title":"The lifecycle of the Ebola virus in host cells"},{"arc":[[35.7081146240234,139.767456054688],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom","Japan"],"title":"viruses Imaging, Tracking and Computational Analyses of Virus Entry and Egress with the Cytoskeleton"},{"arc":[[35.7081146240234,139.767456054688],[47.38234,8.54819]],"countries":["Switzerland","Japan"],"title":"viruses Imaging, Tracking and Computational Analyses of Virus Entry and Egress with the Cytoskeleton"},{"arc":[[51.5235214233398,-0.132312998175621],[47.38234,8.54819]],"countries":["Switzerland","United Kingdom"],"title":"viruses Imaging, Tracking and Computational Analyses of Virus Entry and Egress with the Cytoskeleton"},{"arc":[[35.7868995666504,-93.9436416625977],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[-33.9339714050293,18.865119934082]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[-33.9339714050293,18.865119934082]],"countries":["South Africa","United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[39.9530487060547,-75.1940231323242],[-33.9339714050293,18.865119934082]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[39.9530487060547,-75.1940231323242],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[-33.9339714050293,18.865119934082],[35.7868995666504,-93.9436416625977]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[44.353458404541,-78.2959671020508],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"White-nose syndrome is associated with increased replication of a naturally persisting coronaviruses in bats"},{"arc":[[44.353458404541,-78.2959671020508],[49.890308380127,-97.1528778076172]],"countries":["Canada"],"title":"White-nose syndrome is associated with increased replication of a naturally persisting coronaviruses in bats"},{"arc":[[52.1374397277832,-106.627517700195],[49.890308380127,-97.1528778076172]],"countries":["Canada"],"title":"White-nose syndrome is associated with increased replication of a naturally persisting coronaviruses in bats"},{"arc":[[29.9353504180908,-90.123176574707],[29.9353504180908,-90.123176574707]],"countries":["United States"],"title":"Virology Journal Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma"},{"arc":[[-34.9022216796875,-56.1768188476562],[-34.9022216796875,-56.1768188476562]],"countries":["Uruguay"],"title":"Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3- Grabbing Non-integrin inducing T cell anergy OPEN"},{"arc":[[-34.9022216796875,-56.1768188476562],[52.3348197937012,4.86644983291626]],"countries":["Uruguay","Netherlands"],"title":"Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3- Grabbing Non-integrin inducing T cell anergy OPEN"},{"arc":[[51.1218070983887,10.4006948471069],[40.62796,-8.65243]],"countries":["Germany","Portugal"],"title":"Snapshot of Viral Infections in Wild Carnivores Reveals Ubiquity of Parvovirus and Susceptibility of Egyptian Mongoose to Feline Panleukopenia Virus"},{"arc":[[51.1218070983887,10.4006948471069],[38.7528991699219,-9.1576099395752]],"countries":["Germany","Portugal"],"title":"Snapshot of Viral Infections in Wild Carnivores Reveals Ubiquity of Parvovirus and Susceptibility of Egyptian Mongoose to Feline Panleukopenia Virus"},{"arc":[[40.62796,-8.65243],[38.7528991699219,-9.1576099395752]],"countries":["Portugal"],"title":"Snapshot of Viral Infections in Wild Carnivores Reveals Ubiquity of Parvovirus and Susceptibility of Egyptian Mongoose to Feline Panleukopenia Virus"},{"arc":[[39.4959106445312,-98.9899826049805],[52.08896,5.1784]],"countries":["United States","Netherlands"],"title":"Dissection of the Influenza A Virus Endocytic Routes Reveals Macropinocytosis as an Alternative Entry Pathway"},{"arc":[[41.6386985778809,-0.898090004920959],[39.008129119873,-75.4674682617188]],"countries":["United States","Spain"],"title":"NOTE Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings"},{"arc":[[38.7528991699219,-9.1576099395752],[50.7338905334473,7.10222196578979]],"countries":["Portugal","Germany"],"title":"Marilones A-C, phthalides from the sponge-derived fungus Stachylidium sp"},{"arc":[[-23.33411,-51.21125],[-18.9082107543945,-48.264461517334]],"countries":["Brazil"],"title":"EPIDEMIOLOGICAL ASPECTS OF ASTROVIRUS AND CORONAVIRUS IN POULTS IN THE SOUTH EASTERN REGION OF BRAZIL"},{"arc":[[45.467960357666,9.1817798614502],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Open Access SHORT REPORT Collection by trained pediatricians or parents of mid-turbinate nasal flocked swabs for the detection of influenza viruses in childhood"},{"arc":[[41.6149482727051,0.627550005912781],[33.9571990966797,-83.3740615844727]],"countries":["United States","Spain"],"title":"Key Gaps in the Knowledge of the Porcine Respiratory Reproductive Syndrome Virus (PRRSV)"},{"arc":[[39.008129119873,-75.4674682617188],[48.3334579467773,7.43678998947144]],"countries":["United States","France"],"title":"molecules Aminobenzosuberone Scaffold as a Modular Chemical Tool for the Inhibition of Therapeutically Relevant M1 Aminopeptidases"},{"arc":[[48.5444183349609,12.1591682434082],[40.6412315368652,-8.65390968322754]],"countries":["Germany","Portugal"],"title":"molecules Recyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity"},{"arc":[[3.60545492172241,114.710678100586],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Malaysia"],"title":"Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice"},{"arc":[[51.8983383178711,-8.4727897644043],[40.7652282714844,-111.849472045898]],"countries":["Ireland","United States"],"title":"Stimulation of reverse transcriptase generated cDNAs with specific indels by template RNA structure: retrotransposon, dNTP balance, RT-reagent usage"},{"arc":[[35.7868995666504,-93.9436416625977],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two- stage group sequential randomized controlled trial"},{"arc":[[46.2083282470703,6.14274978637695],[46.2083282470703,6.14274978637695]],"countries":["Switzerland"],"title":"The 2014-2015 Ebola outbreak in West Africa: Hands On"},{"arc":[[46.0506210327148,14.5028200149536],[46.0493087768555,14.5045299530029]],"countries":["Slovenia"],"title":"The Role of Human Coronaviruses in Children Hospitalized for Acute Bronchiolitis, Acute Gastroenteritis, and Febrile Seizures: A 2-Year Prospective Study"},{"arc":[[33.5059394836426,-86.799560546875],[51.4570693969727,-2.60121011734009]],"countries":["United States","United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[33.5059394836426,-86.799560546875],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom","United States"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[33.5059394836426,-86.799560546875],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","United States"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[51.4570693969727,-2.60121011734009],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[51.4570693969727,-2.60121011734009],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[55.8721008300781,-4.28659009933472],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[41.1258697509766,16.8666591644287],[41.1200714111328,16.8690299987793]],"countries":["Italy"],"title":"Identification of hepadnavirus in the sera of cats OPEN"},{"arc":[[41.1258697509766,16.8666591644287],[-33.8852996826172,151.188766479492]],"countries":["Australia","Italy"],"title":"Identification of hepadnavirus in the sera of cats OPEN"},{"arc":[[41.1200714111328,16.8690299987793],[-33.8852996826172,151.188766479492]],"countries":["Australia","Italy"],"title":"Identification of hepadnavirus in the sera of cats OPEN"},{"arc":[[32.2318115234375,-110.955078125],[-33.9181594848633,151.228820800781]],"countries":["United States","Australia"],"title":"Acute systemic DNA damage in youth does not impair immune defense with aging"},{"arc":[[51.378589630127,-2.32512998580933],[50.3743896484375,-4.13887977600098]],"countries":["United Kingdom"],"title":"Web GIS in practice III: creating a simple interactive map of England's Strategic Health Authorities using Google Maps API, Google Earth KML, and MSN Virtual Earth Map Control"},{"arc":[[51.4570693969727,-2.60121011734009],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis"},{"arc":[[40.9437103271484,40.2619209289551],[49.26392,-123.21524]],"countries":["Turkey","Canada"],"title":"Metagenomics for pathogen detection in public health"},{"arc":[[51.0766296386719,-114.13208770752],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom","Canada"],"title":"A questionnaire-based survey on the uptake and use of cattle vaccines in the UK"},{"arc":[[37.8056831359863,-122.268104553223],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Assessing the plausibility of subcritical transmission of 2019-nCoV in the United States"},{"arc":[[37.7633209228516,-122.458541870117],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Assessing the plausibility of subcritical transmission of 2019-nCoV in the United States"},{"arc":[[37.8056831359863,-122.268104553223],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection"},{"arc":[[37.8056831359863,-122.268104553223],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection"},{"arc":[[42.2762107849121,-83.7407531738281],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection"},{"arc":[[37.8056831359863,-122.268104553223],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[37.8056831359863,-122.268104553223],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[37.8056831359863,-122.268104553223],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[29.649730682373,-82.3411331176758],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[29.649730682373,-82.3411331176758],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[44.9734497070312,-93.2378997802734],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[44.9734497070312,-93.2378997802734],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[33.6423301696777,-117.840255737305],[51.4414596557617,-0.947839975357056]],"countries":["United States","United Kingdom"],"title":"Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles"},{"arc":[[52.2025413513184,0.119549997150898],[40.7652282714844,-111.849472045898]],"countries":["United Kingdom","United States"],"title":"Stimulation of stop codon readthrough: frequent presence of an extended 3 0 RNA structural element"},{"arc":[[40.0039215087891,-105.26683807373],[30.2783069610596,-97.7634506225586]],"countries":["United States"],"title":"XRN1 Is a Species-SpecificVirus Restriction Factor in Yeasts"},{"arc":[[39.6668891906738,-75.7527618408203],[38.987850189209,-76.9389038085938]],"countries":["United States"],"title":"A rapid, inexpensive yeast-based dual-fluorescence assay of programmed-1 ribosomal frameshifting for high-throughput screening"},{"arc":[[29.649730682373,-82.3411331176758],[45.4067916870117,11.8769426345825]],"countries":["United States","Italy"],"title":"A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea"},{"arc":[[33.9571990966797,-83.3740615844727],[26.7066898345947,88.3561019897461]],"countries":["United States","India"],"title":"Protective Population Behavior Change in Outbreaks of Emerging Infectious Disease 1 2"},{"arc":[[33.9571990966797,-83.3740615844727],[43.1265411376953,-77.6315383911133]],"countries":["United States"],"title":"Moving Forward: Recent Developments for the Ferret Biomedical Research Model"},{"arc":[[60.1698989868164,24.9490509033203],[60.4552116394043,22.2824802398682]],"countries":["Finland"],"title":"Zika Virus Non-Structural Protein NS5 Inhibits the RIG-I Pathway and Interferon Lambda 1 Promoter Activation by Targeting IKK Epsilon"},{"arc":[[8.46434020996094,4.60087013244629],[38.987850189209,-76.9389038085938]],"countries":["Nigeria","United States"],"title":"Lay media reporting of monkeypox in Nigeria Handling editor Seye Abimbola"},{"arc":[[41.464298248291,74.5556259155273],[40.94339,40.26872]],"countries":["Kyrgyzstan","Turkey"],"title":"The Serological and Virological Investigation of Canine Adenovirus Infection on the Dogs"},{"arc":[[41.464298248291,74.5556259155273],[37.9490013122559,27.3695793151855]],"countries":["Kyrgyzstan","Turkey"],"title":"The Serological and Virological Investigation of Canine Adenovirus Infection on the Dogs"},{"arc":[[40.94339,40.26872],[37.9490013122559,27.3695793151855]],"countries":["Turkey"],"title":"The Serological and Virological Investigation of Canine Adenovirus Infection on the Dogs"},{"arc":[[53.8391494750977,10.7079601287842],[51.1082496643066,17.0269107818604]],"countries":["Germany","Poland"],"title":"Substrate specificity profiling of SARS-CoV-2 M pro protease provides basis for anti-COVID-19 drug design"},{"arc":[[38.987850189209,-76.9389038085938],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus)"},{"arc":[[41.550708770752,-8.4261302947998],[43.6221504211426,7.0402398109436]],"countries":["Portugal","France"],"title":"Knock out of the BASIGIN/CD147 chaperone of lactate/H + symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction"},{"arc":[[51.9635810852051,7.61390018463135],[48.524341583252,9.05992984771729]],"countries":["Germany"],"title":"Acclimatory responses of the Daphnia pulex proteome to environmental changes. II. Chronic exposure to different temperatures (10 and 20°C) mainly affects protein metabolism"},{"arc":[[35.9053153991699,-79.0477142333984],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins"},{"arc":[[35.9053153991699,-79.0477142333984],[32.8126068115234,-96.8384094238281]],"countries":["United States"],"title":"MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins"},{"arc":[[35.9053153991699,-79.0477142333984],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"viruses Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism"},{"arc":[[45.4094390869141,11.8717098236084],[45.4067916870117,11.8769426345825]],"countries":["Italy"],"title":"viruses Ebola Virus Entry: From Molecular Characterization to Drug Discovery"},{"arc":[[45.4067916870117,11.8769426345825],[45.186767578125,9.15610694885254]],"countries":["Italy"],"title":"Synthesis, Binding and Antiviral Properties of Potent Core-Extended Naphthalene Diimides Targeting the HIV-1 Long Terminal Repeat Promoter G-Quadruplexes"},{"arc":[[40.4406089782715,-79.953971862793],[48.8460693359375,2.35518002510071]],"countries":["France","United States"],"title":"The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate"},{"arc":[[35.2046813964844,-85.9209289550781],[-25.7666606903076,28.1973991394043]],"countries":["United States","South Africa"],"title":"viruses Overview of Trends in the Application of Metagenomic Techniques in the Analysis of Human Enteric Viral Diversity in Africa's Environmental Regimes"},{"arc":[[32.8126068115234,-96.8384094238281],[32.8126068115234,-96.8384094238281]],"countries":["United States"],"title":"The IFN response in bat cells consists of canonical and non-canonical ISGs with unique temporal expression kinetics"},{"arc":[[40.7652282714844,-111.849472045898],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Br ief Definitive Repor t Interferon lambda 4 expression is suppressed by the host during viral infection"},{"arc":[[44.6417846679688,-89.7367401123047],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance"},{"arc":[[29.7095108032227,-95.3981781005859],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"β 2 -Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study"},{"arc":[[34.3412704467773,108.939842224121],[34.3412704467773,108.939842224121]],"countries":["China"],"title":"Beware of asymptomatic transmission: Study on 2019-nCoV prevention and control measures based on extended SEIR model"}]